id	sid	tid	token	lemma	pos
admet-647	1	1	bioenhancing	bioenhancing	NOUN
admet-647	1	2	effects	effect	NOUN
admet-647	1	3	of	of	ADP
admet-647	1	4	naringin	naringin	NOUN
admet-647	1	5	on	on	ADP
admet-647	1	6	atorvastatin	atorvastatin	PROPN
admet-647	1	7	doi	doi	PROPN
admet-647	1	8	:	:	PUNCT
admet-647	1	9	10.5599	10.5599	NUM
admet-647	1	10	/	/	SYM
admet-647	1	11	admet.5.4.647	admet.5.4.647	PROPN
admet-647	1	12	174	174	NUM
admet-647	1	13	admet	admet	X
admet-647	1	14	&	&	CCONJ
admet-647	1	15	dmpk	dmpk	PROPN
admet-647	1	16	7(3	7(3	NUM
admet-647	1	17	)	)	PUNCT
admet-647	1	18	(	(	PUNCT
admet-647	1	19	2019	2019	NUM
admet-647	1	20	)	)	PUNCT
admet-647	1	21	174	174	NUM
admet-647	1	22	-	-	SYM
admet-647	1	23	182	182	NUM
admet-647	1	24	;	;	PUNCT
admet-647	1	25	doi	doi	NOUN
admet-647	1	26	:	:	PUNCT
admet-647	1	27	http://dx.doi.org/10.5599/admet.647	http://dx.doi.org/10.5599/admet.647	ADJ
admet-647	1	28	open	open	ADJ
admet-647	1	29	access	access	NOUN
admet-647	1	30	:	:	PUNCT
admet-647	1	31	issn	issn	PROPN
admet-647	1	32	:	:	PUNCT
admet-647	1	33	1848	1848	NUM
admet-647	1	34	-	-	SYM
admet-647	1	35	7718	7718	NUM
admet-647	1	36	http://www.pub.iapchem.org/ojs/index.php/admet/index	http://www.pub.iapchem.org/ojs/index.php/admet/index	NOUN
admet-647	1	37	original	original	ADJ
admet-647	1	38	scientific	scientific	ADJ
admet-647	1	39	paper	paper	NOUN
admet-647	1	40	bioenhancing	bioenhancing	NOUN
admet-647	1	41	effects	effect	NOUN
admet-647	1	42	of	of	ADP
admet-647	1	43	naringin	naringin	NOUN
admet-647	1	44	on	on	ADP
admet-647	1	45	atorvastatin	atorvastatin	PROPN
admet-647	1	46	venkatesh	venkatesh	PROPN
admet-647	1	47	sama1	sama1	PROPN
admet-647	1	48	*	*	PUNCT
admet-647	1	49	,	,	PUNCT
admet-647	1	50	balaraju	balaraju	ADJ
admet-647	1	51	pagilla1	pagilla1	NOUN
admet-647	1	52	,	,	PUNCT
admet-647	1	53	rajeswari	rajeswari	ADJ
admet-647	1	54	chiluka1	chiluka1	PROPN
admet-647	1	55	,	,	PUNCT
admet-647	1	56	ravi	ravi	PROPN
admet-647	1	57	alvala1	alvala1	PROPN
admet-647	1	58	,	,	PUNCT
admet-647	1	59	ravi	ravi	PROPN
admet-647	1	60	kumar	kumar	PROPN
admet-647	1	61	pola1	pola1	PROPN
admet-647	1	62	,	,	PUNCT
admet-647	1	63	ramesh	ramesh	PROPN
admet-647	1	64	mullangi2	mullangi2	PROPN
admet-647	1	65	1	1	NUM
admet-647	1	66	g.	g.	NOUN
admet-647	1	67	pulla	pulla	PROPN
admet-647	1	68	reddy	reddy	PROPN
admet-647	1	69	college	college	PROPN
admet-647	1	70	of	of	ADP
admet-647	1	71	pharmacy	pharmacy	NOUN
admet-647	1	72	,	,	PUNCT
admet-647	1	73	mehdipatnam	mehdipatnam	NOUN
admet-647	1	74	,	,	PUNCT
admet-647	1	75	hyderabad-500028	hyderabad-500028	NOUN
admet-647	1	76	,	,	PUNCT
admet-647	1	77	india	india	PROPN
admet-647	1	78	2	2	NUM
admet-647	1	79	jubilantbiosys	jubilantbiosy	NOUN
admet-647	1	80	,	,	PUNCT
admet-647	1	81	industrial	industrial	ADJ
admet-647	1	82	suburb	suburb	NOUN
admet-647	1	83	,	,	PUNCT
admet-647	1	84	yeshwanthpur	yeshwanthpur	VERB
admet-647	1	85	,	,	PUNCT
admet-647	1	86	bangalore-566022	bangalore-566022	NOUN
admet-647	1	87	,	,	PUNCT
admet-647	1	88	india	india	PROPN
admet-647	1	89	*	*	PUNCT
admet-647	1	90	corresponding	correspond	VERB
admet-647	1	91	author	author	NOUN
admet-647	1	92	:	:	PUNCT
admet-647	2	1	e	e	NOUN
admet-647	2	2	-	-	NOUN
admet-647	2	3	mail	mail	NOUN
admet-647	2	4	:	:	PUNCT
admet-647	3	1	venkateshsama@hotmail.com	venkateshsama@hotmail.com	X
admet-647	3	2	;	;	PUNCT
admet-647	3	3	tel	tel	PROPN
admet-647	3	4	.	.	PUNCT
admet-647	3	5	:	:	PUNCT
admet-647	4	1	+91	+91	NOUN
admet-647	4	2	-	-	PUNCT
admet-647	4	3	40	40	NUM
admet-647	4	4	-	-	PUNCT
admet-647	4	5	2351	2351	NUM
admet-647	4	6	7222	7222	NUM
admet-647	4	7	received	receive	VERB
admet-647	4	8	:	:	PUNCT
admet-647	4	9	december	december	PROPN
admet-647	4	10	15	15	NUM
admet-647	4	11	,	,	PUNCT
admet-647	4	12	2018	2018	NUM
admet-647	4	13	;	;	PUNCT
admet-647	4	14	revised	revise	VERB
admet-647	4	15	:	:	PUNCT
admet-647	4	16	march	march	PROPN
admet-647	4	17	18	18	NUM
admet-647	4	18	,	,	PUNCT
admet-647	4	19	2019	2019	NUM
admet-647	4	20	;	;	PUNCT
admet-647	4	21	published	publish	VERB
admet-647	4	22	online	online	ADV
admet-647	4	23	:	:	PUNCT
admet-647	4	24	june	june	PROPN
admet-647	4	25	6	6	NUM
admet-647	4	26	,	,	PUNCT
admet-647	4	27	2019	2019	NUM
admet-647	4	28	abstract	abstract	ADJ
admet-647	4	29	naringin	naringin	NOUN
admet-647	4	30	(	(	PUNCT
admet-647	4	31	cas	cas	PROPN
admet-647	4	32	no	no	NOUN
admet-647	4	33	:	:	PUNCT
admet-647	4	34	10236	10236	NUM
admet-647	4	35	-	-	SYM
admet-647	4	36	47	47	NUM
admet-647	4	37	-	-	PUNCT
admet-647	4	38	2	2	NUM
admet-647	4	39	)	)	PUNCT
admet-647	4	40	is	be	AUX
admet-647	4	41	a	a	DET
admet-647	4	42	flavonone	flavonone	NOUN
admet-647	4	43	glycoside	glycoside	NOUN
admet-647	4	44	obtained	obtain	VERB
admet-647	4	45	from	from	ADP
admet-647	4	46	citrus	citrus	NOUN
admet-647	4	47	paradisi	paradisi	X
admet-647	4	48	(	(	PUNCT
admet-647	4	49	grapefruit	grapefruit	PROPN
admet-647	4	50	)	)	PUNCT
admet-647	4	51	,	,	PUNCT
admet-647	4	52	a	a	DET
admet-647	4	53	natural	natural	ADJ
admet-647	4	54	bioenhancer	bioenhancer	NOUN
admet-647	4	55	and	and	CCONJ
admet-647	4	56	reported	report	VERB
admet-647	4	57	to	to	PART
admet-647	4	58	enhance	enhance	VERB
admet-647	4	59	the	the	DET
admet-647	4	60	bioavailability	bioavailability	NOUN
admet-647	4	61	of	of	ADP
admet-647	4	62	drugs	drug	NOUN
admet-647	4	63	by	by	ADP
admet-647	4	64	inhibiting	inhibit	VERB
admet-647	4	65	cytochrome	cytochrome	NOUN
admet-647	4	66	p450	p450	PROPN
admet-647	4	67	and	and	CCONJ
admet-647	4	68	pglycoprotein	pglycoprotein	ADJ
admet-647	4	69	(	(	PUNCT
admet-647	4	70	p	p	NOUN
admet-647	4	71	-	-	PUNCT
admet-647	4	72	gp	gp	NOUN
admet-647	4	73	)	)	PUNCT
admet-647	4	74	.	.	PUNCT
admet-647	5	1	the	the	DET
admet-647	5	2	aim	aim	NOUN
admet-647	5	3	of	of	ADP
admet-647	5	4	the	the	DET
admet-647	5	5	present	present	ADJ
admet-647	5	6	study	study	NOUN
admet-647	5	7	was	be	AUX
admet-647	5	8	to	to	PART
admet-647	5	9	investigate	investigate	VERB
admet-647	5	10	the	the	DET
admet-647	5	11	effect	effect	NOUN
admet-647	5	12	of	of	ADP
admet-647	5	13	naringin	naringin	NOUN
admet-647	5	14	on	on	ADP
admet-647	5	15	antihyperlipidemic	antihyperlipidemic	ADJ
admet-647	5	16	properties	property	NOUN
admet-647	5	17	of	of	ADP
admet-647	5	18	atorvastatin	atorvastatin	NOUN
admet-647	5	19	(	(	PUNCT
admet-647	5	20	ast	ast	PROPN
admet-647	5	21	)	)	PUNCT
admet-647	5	22	in	in	ADP
admet-647	5	23	tyloxapol	tyloxapol	NOUN
admet-647	5	24	induced	induce	VERB
admet-647	5	25	hyperlipidemic	hyperlipidemic	ADJ
admet-647	5	26	rats	rat	NOUN
admet-647	5	27	and	and	CCONJ
admet-647	5	28	the	the	DET
admet-647	5	29	effects	effect	NOUN
admet-647	5	30	were	be	AUX
admet-647	5	31	supported	support	VERB
admet-647	5	32	with	with	ADP
admet-647	5	33	measurement	measurement	NOUN
admet-647	5	34	of	of	ADP
admet-647	5	35	plasma	plasma	NOUN
admet-647	5	36	concentrations	concentration	NOUN
admet-647	5	37	of	of	ADP
admet-647	5	38	ast	ast	NOUN
admet-647	5	39	by	by	ADP
admet-647	5	40	hplc	hplc	NOUN
admet-647	5	41	method	method	NOUN
admet-647	5	42	.	.	PUNCT
admet-647	6	1	animals	animal	NOUN
admet-647	6	2	received	receive	VERB
admet-647	6	3	ast	ast	NOUN
admet-647	6	4	along	along	ADP
admet-647	6	5	with	with	ADP
admet-647	6	6	naringin	naringin	NOUN
admet-647	6	7	(	(	PUNCT
admet-647	6	8	15	15	NUM
admet-647	6	9	and	and	CCONJ
admet-647	6	10	30	30	NUM
admet-647	6	11	mg	mg	NUM
admet-647	6	12	/	/	SYM
admet-647	6	13	kg	kg	NOUN
admet-647	6	14	)	)	PUNCT
admet-647	6	15	shown	show	VERB
admet-647	6	16	higher	high	ADJ
admet-647	6	17	percent	percent	NOUN
admet-647	6	18	reduction	reduction	NOUN
admet-647	6	19	in	in	ADP
admet-647	6	20	both	both	CCONJ
admet-647	6	21	cholesterol	cholesterol	NOUN
admet-647	6	22	and	and	CCONJ
admet-647	6	23	triglycerides	triglyceride	NOUN
admet-647	6	24	levels	level	NOUN
admet-647	6	25	,	,	PUNCT
admet-647	6	26	when	when	SCONJ
admet-647	6	27	compared	compare	VERB
admet-647	6	28	to	to	ADP
admet-647	6	29	animals	animal	NOUN
admet-647	6	30	received	receive	VERB
admet-647	6	31	ast	ast	NOUN
admet-647	6	32	alone	alone	ADV
admet-647	6	33	at	at	ADP
admet-647	6	34	dose	dose	NOUN
admet-647	6	35	of	of	ADP
admet-647	6	36	25	25	NUM
admet-647	6	37	and	and	CCONJ
admet-647	6	38	50	50	NUM
admet-647	6	39	mg	mg	NUM
admet-647	6	40	/	/	SYM
admet-647	6	41	kg	kg	NOUN
admet-647	6	42	and	and	CCONJ
admet-647	6	43	it	it	PRON
admet-647	6	44	was	be	AUX
admet-647	6	45	found	find	VERB
admet-647	6	46	that	that	SCONJ
admet-647	6	47	the	the	DET
admet-647	6	48	higher	high	ADJ
admet-647	6	49	percent	percent	NOUN
admet-647	6	50	reduction	reduction	NOUN
admet-647	6	51	in	in	ADP
admet-647	6	52	cholesterol	cholesterol	NOUN
admet-647	6	53	and	and	CCONJ
admet-647	6	54	triglycerides	triglyceride	NOUN
admet-647	6	55	was	be	AUX
admet-647	6	56	proportional	proportional	ADJ
admet-647	6	57	to	to	PART
admet-647	6	58	increase	increase	VERB
admet-647	6	59	in	in	ADP
admet-647	6	60	plasma	plasma	NOUN
admet-647	6	61	concentration	concentration	NOUN
admet-647	6	62	of	of	ADP
admet-647	6	63	ast	ast	NOUN
admet-647	6	64	.	.	PUNCT
admet-647	7	1	from	from	ADP
admet-647	7	2	the	the	DET
admet-647	7	3	results	result	NOUN
admet-647	7	4	it	it	PRON
admet-647	7	5	is	be	AUX
admet-647	7	6	evident	evident	ADJ
admet-647	7	7	that	that	SCONJ
admet-647	7	8	the	the	DET
admet-647	7	9	co	co	NOUN
admet-647	7	10	-	-	NOUN
admet-647	7	11	administration	administration	NOUN
admet-647	7	12	of	of	ADP
admet-647	7	13	naringin	naringin	NOUN
admet-647	7	14	along	along	ADV
admet-647	7	15	with	with	ADP
admet-647	7	16	ast	ast	NOUN
admet-647	7	17	increased	increase	VERB
admet-647	7	18	the	the	DET
admet-647	7	19	plasma	plasma	NOUN
admet-647	7	20	concentration	concentration	NOUN
admet-647	7	21	of	of	ADP
admet-647	7	22	ast	ast	NOUN
admet-647	7	23	.	.	PUNCT
admet-647	8	1	the	the	DET
admet-647	8	2	findings	finding	NOUN
admet-647	8	3	of	of	ADP
admet-647	8	4	the	the	DET
admet-647	8	5	present	present	ADJ
admet-647	8	6	study	study	NOUN
admet-647	8	7	confirmed	confirm	VERB
admet-647	8	8	that	that	SCONJ
admet-647	8	9	naringin	naringin	NOUN
admet-647	8	10	could	could	AUX
admet-647	8	11	be	be	AUX
admet-647	8	12	used	use	VERB
admet-647	8	13	as	as	ADP
admet-647	8	14	bioenhancer	bioenhancer	NOUN
admet-647	8	15	.	.	PUNCT
admet-647	9	1	the	the	DET
admet-647	9	2	co	co	NOUN
admet-647	9	3	-	-	NOUN
admet-647	9	4	administration	administration	NOUN
admet-647	9	5	of	of	ADP
admet-647	9	6	ast	ast	PROPN
admet-647	9	7	and	and	CCONJ
admet-647	9	8	the	the	DET
admet-647	9	9	diet	diet	NOUN
admet-647	9	10	with	with	ADP
admet-647	9	11	naringin	naringin	PROPN
admet-647	9	12	(	(	PUNCT
admet-647	9	13	grapefruit	grapefruit	PROPN
admet-647	9	14	)	)	PUNCT
admet-647	9	15	to	to	ADP
admet-647	9	16	the	the	DET
admet-647	9	17	patients	patient	NOUN
admet-647	9	18	may	may	AUX
admet-647	9	19	potentiate	potentiate	VERB
admet-647	9	20	the	the	DET
admet-647	9	21	therapeutic	therapeutic	ADJ
admet-647	9	22	efficacy	efficacy	NOUN
admet-647	9	23	of	of	ADP
admet-647	9	24	ast	ast	PROPN
admet-647	9	25	.	.	PUNCT
admet-647	10	1	keywords	keyword	NOUN
admet-647	10	2	naringin	naringin	NOUN
admet-647	10	3	;	;	PUNCT
admet-647	10	4	bioenhancer	bioenhancer	NOUN
admet-647	10	5	;	;	PUNCT
admet-647	10	6	atorvastatin	atorvastatin	PROPN
admet-647	10	7	;	;	PUNCT
admet-647	10	8	tyloxapol	tyloxapol	NOUN
admet-647	10	9	;	;	PUNCT
admet-647	10	10	plasma	plasma	NOUN
admet-647	10	11	concentrations	concentration	NOUN
admet-647	10	12	;	;	PUNCT
admet-647	10	13	rp	rp	NOUN
admet-647	10	14	-	-	PUNCT
admet-647	10	15	hplc	hplc	NOUN
admet-647	10	16	introduction	introduction	NOUN
admet-647	10	17	recent	recent	ADJ
admet-647	10	18	advancement	advancement	NOUN
admet-647	10	19	in	in	ADP
admet-647	10	20	bioavailability	bioavailability	NOUN
admet-647	10	21	enhancement	enhancement	NOUN
admet-647	10	22	of	of	ADP
admet-647	10	23	drugs	drug	NOUN
admet-647	10	24	by	by	ADP
admet-647	10	25	compounds	compound	NOUN
admet-647	10	26	of	of	ADP
admet-647	10	27	herbal	herbal	ADJ
admet-647	10	28	origin	origin	NOUN
admet-647	10	29	has	have	AUX
admet-647	10	30	produced	produce	VERB
admet-647	10	31	a	a	DET
admet-647	10	32	revolutionary	revolutionary	ADJ
admet-647	10	33	shift	shift	NOUN
admet-647	10	34	in	in	ADP
admet-647	10	35	the	the	DET
admet-647	10	36	way	way	NOUN
admet-647	10	37	of	of	ADP
admet-647	10	38	therapeutics	therapeutic	NOUN
admet-647	10	39	.	.	PUNCT
admet-647	11	1	poorly	poorly	ADV
admet-647	11	2	bioavailable	bioavailable	ADJ
admet-647	11	3	drugs	drug	NOUN
admet-647	11	4	remain	remain	VERB
admet-647	11	5	sub	sub	ADJ
admet-647	11	6	-	-	ADJ
admet-647	11	7	therapeutic	therapeutic	ADJ
admet-647	11	8	because	because	SCONJ
admet-647	11	9	a	a	DET
admet-647	11	10	major	major	ADJ
admet-647	11	11	portion	portion	NOUN
admet-647	11	12	of	of	ADP
admet-647	11	13	a	a	DET
admet-647	11	14	dose	dose	NOUN
admet-647	11	15	never	never	ADV
admet-647	11	16	reaches	reach	VERB
admet-647	11	17	the	the	DET
admet-647	11	18	plasma	plasma	NOUN
admet-647	11	19	or	or	CCONJ
admet-647	11	20	exerts	exert	VERB
admet-647	11	21	its	its	PRON
admet-647	11	22	pharmacological	pharmacological	ADJ
admet-647	11	23	effect	effect	NOUN
admet-647	11	24	unless	unless	SCONJ
admet-647	11	25	and	and	CCONJ
admet-647	11	26	until	until	SCONJ
admet-647	11	27	very	very	ADV
admet-647	11	28	large	large	ADJ
admet-647	11	29	doses	dose	NOUN
admet-647	11	30	are	be	AUX
admet-647	11	31	given	give	VERB
admet-647	11	32	,	,	PUNCT
admet-647	11	33	which	which	PRON
admet-647	11	34	may	may	AUX
admet-647	11	35	lead	lead	VERB
admet-647	11	36	to	to	ADP
admet-647	11	37	serious	serious	ADJ
admet-647	11	38	side	side	NOUN
admet-647	11	39	effects	effect	NOUN
admet-647	11	40	.	.	PUNCT
admet-647	12	1	any	any	DET
admet-647	12	2	significant	significant	ADJ
admet-647	12	3	improvement	improvement	NOUN
admet-647	12	4	in	in	ADP
admet-647	12	5	bioavailability	bioavailability	NOUN
admet-647	12	6	will	will	AUX
admet-647	12	7	result	result	VERB
admet-647	12	8	in	in	ADP
admet-647	12	9	lowering	lower	VERB
admet-647	12	10	the	the	DET
admet-647	12	11	dose	dose	NOUN
admet-647	12	12	or	or	CCONJ
admet-647	12	13	the	the	DET
admet-647	12	14	dose	dose	NOUN
admet-647	12	15	frequency	frequency	NOUN
admet-647	12	16	of	of	ADP
admet-647	12	17	that	that	DET
admet-647	12	18	particular	particular	ADJ
admet-647	12	19	drug	drug	NOUN
admet-647	12	20	.	.	PUNCT
admet-647	13	1	the	the	DET
admet-647	13	2	global	global	ADJ
admet-647	13	3	focus	focus	NOUN
admet-647	13	4	is	be	AUX
admet-647	13	5	now	now	ADV
admet-647	13	6	on	on	ADP
admet-647	13	7	methods	method	NOUN
admet-647	13	8	aimed	aim	VERB
admet-647	13	9	at	at	ADP
admet-647	13	10	reducing	reduce	VERB
admet-647	13	11	drug	drug	NOUN
admet-647	13	12	dosage	dosage	NOUN
admet-647	13	13	,	,	PUNCT
admet-647	13	14	and	and	CCONJ
admet-647	13	15	thus	thus	ADV
admet-647	13	16	drug	drug	NOUN
admet-647	13	17	treatment	treatment	NOUN
admet-647	13	18	cost	cost	NOUN
admet-647	13	19	[	[	X
admet-647	13	20	1	1	NUM
admet-647	13	21	]	]	PUNCT
admet-647	13	22	.	.	PUNCT
admet-647	14	1	bioenhancers	bioenhancer	NOUN
admet-647	14	2	of	of	ADP
admet-647	14	3	herbal	herbal	ADJ
admet-647	14	4	origin	origin	NOUN
admet-647	14	5	are	be	AUX
admet-647	14	6	reported	report	VERB
admet-647	14	7	to	to	PART
admet-647	14	8	enhance	enhance	VERB
admet-647	14	9	the	the	DET
admet-647	14	10	bioavailability	bioavailability	NOUN
admet-647	14	11	and	and	CCONJ
admet-647	14	12	bioefficacy	bioefficacy	NOUN
admet-647	14	13	of	of	ADP
admet-647	14	14	a	a	DET
admet-647	14	15	therapeutic	therapeutic	ADJ
admet-647	14	16	drugs	drug	NOUN
admet-647	14	17	or	or	CCONJ
admet-647	14	18	nutrients	nutrient	NOUN
admet-647	14	19	with	with	ADP
admet-647	14	20	which	which	PRON
admet-647	14	21	it	it	PRON
admet-647	14	22	is	be	AUX
admet-647	14	23	combined	combine	VERB
admet-647	14	24	,	,	PUNCT
admet-647	14	25	without	without	ADP
admet-647	14	26	any	any	DET
admet-647	14	27	typical	typical	ADJ
admet-647	14	28	pharmacological	pharmacological	ADJ
admet-647	14	29	activity	activity	NOUN
admet-647	14	30	of	of	ADP
admet-647	14	31	its	its	PRON
admet-647	14	32	own	own	ADJ
admet-647	14	33	at	at	ADP
admet-647	14	34	the	the	DET
admet-647	14	35	dose	dose	NOUN
admet-647	14	36	used	use	VERB
admet-647	14	37	.	.	PUNCT
admet-647	15	1	the	the	DET
admet-647	15	2	concept	concept	NOUN
admet-647	15	3	of	of	ADP
admet-647	15	4	bioenhancers	bioenhancer	NOUN
admet-647	15	5	of	of	ADP
admet-647	15	6	herbal	herbal	ADJ
admet-647	15	7	origin	origin	NOUN
admet-647	15	8	can	can	AUX
admet-647	15	9	be	be	AUX
admet-647	15	10	tracked	track	VERB
admet-647	15	11	back	back	ADV
admet-647	15	12	from	from	ADP
admet-647	15	13	the	the	DET
admet-647	15	14	ancient	ancient	ADJ
admet-647	15	15	knowledge	knowledge	NOUN
admet-647	15	16	of	of	ADP
admet-647	15	17	indian	indian	ADJ
admet-647	15	18	system	system	NOUN
admet-647	15	19	of	of	ADP
admet-647	15	20	medicine	medicine	NOUN
admet-647	15	21	(	(	PUNCT
admet-647	15	22	ayurveda	ayurveda	PROPN
admet-647	15	23	)	)	PUNCT
admet-647	15	24	.	.	PUNCT
admet-647	16	1	bose	bose	PROPN
admet-647	16	2	(	(	PUNCT
admet-647	16	3	1929	1929	NUM
admet-647	16	4	)	)	PUNCT
admet-647	16	5	reported	report	VERB
admet-647	16	6	an	an	DET
admet-647	16	7	enhanced	enhanced	ADJ
admet-647	16	8	antiasthmatic	antiasthmatic	ADJ
admet-647	16	9	effect	effect	NOUN
admet-647	16	10	of	of	ADP
admet-647	16	11	an	an	DET
admet-647	16	12	ayurvedic	ayurvedic	ADJ
admet-647	16	13	formula	formula	NOUN
admet-647	16	14	containing	contain	VERB
admet-647	16	15	vasaka	vasaka	ADV
admet-647	16	16	(	(	PUNCT
admet-647	16	17	adhatoda	adhatoda	PROPN
admet-647	16	18	vasica	vasica	PROPN
admet-647	16	19	)	)	PUNCT
admet-647	16	20	when	when	SCONJ
admet-647	16	21	administered	administer	VERB
admet-647	16	22	with	with	ADP
admet-647	16	23	long	long	ADJ
admet-647	16	24	pepper	pepper	NOUN
admet-647	17	1	[	[	X
admet-647	17	2	2	2	NUM
admet-647	17	3	]	]	PUNCT
admet-647	17	4	.	.	PUNCT
admet-647	18	1	bioenhancers	bioenhancer	NOUN
admet-647	18	2	act	act	VERB
admet-647	18	3	through	through	ADP
admet-647	18	4	several	several	ADJ
admet-647	18	5	mechanisms	mechanism	NOUN
admet-647	18	6	.	.	PUNCT
admet-647	19	1	they	they	PRON
admet-647	19	2	affect	affect	VERB
admet-647	19	3	the	the	DET
admet-647	19	4	absorption	absorption	NOUN
admet-647	19	5	process	process	NOUN
admet-647	19	6	,	,	PUNCT
admet-647	19	7	drug	drug	NOUN
admet-647	19	8	metabolism	metabolism	NOUN
admet-647	19	9	or	or	CCONJ
admet-647	19	10	on	on	ADP
admet-647	19	11	http://www.pub.iapchem.org/ojs/index.php/admet/index	http://www.pub.iapchem.org/ojs/index.php/admet/index	PROPN
admet-647	19	12	mailto:venkateshsama@hotmail.com	mailto:venkateshsama@hotmail.com	PROPN
admet-647	20	1	admet	admet	PROPN
admet-647	20	2	&	&	CCONJ
admet-647	20	3	dmpk	dmpk	PROPN
admet-647	20	4	7(3	7(3	NUM
admet-647	20	5	)	)	PUNCT
admet-647	20	6	(	(	PUNCT
admet-647	20	7	2019	2019	NUM
admet-647	20	8	)	)	PUNCT
admet-647	20	9	174	174	NUM
admet-647	20	10	-	-	SYM
admet-647	20	11	182	182	NUM
admet-647	20	12	effect	effect	NOUN
admet-647	20	13	of	of	ADP
admet-647	20	14	naringin	naringin	NOUN
admet-647	20	15	on	on	ADP
admet-647	20	16	atorvastatin	atorvastatin	PROPN
admet-647	20	17	doi	doi	PROPN
admet-647	20	18	:	:	PUNCT
admet-647	20	19	10.5599	10.5599	NUM
admet-647	20	20	/	/	SYM
admet-647	20	21	admet.647	admet.647	ADJ
admet-647	20	22	175	175	NUM
admet-647	20	23	drug	drug	NOUN
admet-647	20	24	target	target	NOUN
admet-647	20	25	.	.	PUNCT
admet-647	21	1	among	among	ADP
admet-647	21	2	the	the	DET
admet-647	21	3	known	know	VERB
admet-647	21	4	reasons	reason	NOUN
admet-647	21	5	for	for	ADP
admet-647	21	6	the	the	DET
admet-647	21	7	use	use	NOUN
admet-647	21	8	of	of	ADP
admet-647	21	9	bioenhancers	bioenhancer	NOUN
admet-647	21	10	is	be	AUX
admet-647	21	11	its	its	PRON
admet-647	21	12	non	non	ADJ
admet-647	21	13	-	-	NOUN
admet-647	21	14	toxicity	toxicity	NOUN
admet-647	21	15	,	,	PUNCT
admet-647	21	16	effective	effective	ADJ
admet-647	21	17	at	at	ADP
admet-647	21	18	low	low	ADJ
admet-647	21	19	concentration	concentration	NOUN
admet-647	21	20	levels	level	NOUN
admet-647	21	21	and	and	CCONJ
admet-647	21	22	simple	simple	ADJ
admet-647	21	23	formulation	formulation	NOUN
admet-647	21	24	processes	process	NOUN
admet-647	21	25	.	.	PUNCT
admet-647	22	1	bioenhancers	bioenhancer	NOUN
admet-647	22	2	are	be	AUX
admet-647	22	3	effective	effective	ADJ
admet-647	22	4	when	when	SCONJ
admet-647	22	5	administered	administer	VERB
admet-647	22	6	with	with	ADP
admet-647	22	7	other	other	ADJ
admet-647	22	8	drug	drug	NOUN
admet-647	22	9	classes	class	NOUN
admet-647	22	10	such	such	ADJ
admet-647	22	11	as	as	ADP
admet-647	22	12	antibiotics	antibiotic	NOUN
admet-647	22	13	,	,	PUNCT
admet-647	22	14	antituberculosis	antituberculosis	NOUN
admet-647	22	15	,	,	PUNCT
admet-647	22	16	antiviral	antiviral	NOUN
admet-647	22	17	,	,	PUNCT
admet-647	22	18	antifungal	antifungal	ADJ
admet-647	22	19	and	and	CCONJ
admet-647	22	20	anticancer	anticancer	NOUN
admet-647	22	21	drugs	drug	NOUN
admet-647	22	22	.	.	PUNCT
admet-647	23	1	bioenhancers	bioenhancer	NOUN
admet-647	23	2	also	also	ADV
admet-647	23	3	improve	improve	VERB
admet-647	23	4	oral	oral	ADJ
admet-647	23	5	absorption	absorption	NOUN
admet-647	23	6	of	of	ADP
admet-647	23	7	a	a	DET
admet-647	23	8	wide	wide	ADJ
admet-647	23	9	range	range	NOUN
admet-647	23	10	of	of	ADP
admet-647	23	11	nutrients	nutrient	NOUN
admet-647	23	12	such	such	ADJ
admet-647	23	13	as	as	ADP
admet-647	23	14	vitamins	vitamin	NOUN
admet-647	23	15	,	,	PUNCT
admet-647	23	16	minerals	mineral	NOUN
admet-647	23	17	and	and	CCONJ
admet-647	23	18	amino	amino	ADJ
admet-647	23	19	acids	acid	NOUN
admet-647	23	20	etc	etc	X
admet-647	23	21	.	.	PUNCT
admet-647	24	1	[	[	X
admet-647	24	2	3	3	NUM
admet-647	24	3	]	]	PUNCT
admet-647	24	4	.	.	PUNCT
admet-647	25	1	naringin	naringin	NOUN
admet-647	25	2	(	(	PUNCT
admet-647	25	3	7-[[2	7-[[2	NUM
admet-647	25	4	-	-	ADJ
admet-647	25	5	o-(6	o-(6	ADJ
admet-647	25	6	-	-	PUNCT
admet-647	25	7	deoxy	deoxy	VERB
admet-647	25	8	-	-	PUNCT
admet-647	25	9	α	α	NOUN
admet-647	25	10	-	-	PUNCT
admet-647	25	11	l	l	NOUN
admet-647	25	12	-	-	PUNCT
admet-647	25	13	mannopyranosyl)-β	mannopyranosyl)-β	NOUN
admet-647	25	14	-	-	PUNCT
admet-647	25	15	d	d	PROPN
admet-647	25	16	-	-	PUNCT
admet-647	25	17	glucopyranosyl]oxy]-2,3	glucopyranosyl]oxy]-2,3	NOUN
admet-647	25	18	-	-	PUNCT
admet-647	25	19	dihydro-5	dihydro-5	VERB
admet-647	25	20	-	-	PUNCT
admet-647	25	21	hydroxy-2-(4hydroxyphenyl)-4h-1	hydroxy-2-(4hydroxyphenyl)-4h-1	NOUN
admet-647	25	22	-	-	PUNCT
admet-647	25	23	benzopyran-4	benzopyran-4	NOUN
admet-647	25	24	-	-	PUNCT
admet-647	25	25	one	one	NUM
admet-647	25	26	)	)	PUNCT
admet-647	25	27	,	,	PUNCT
admet-647	25	28	a	a	DET
admet-647	25	29	flavanone	flavanone	NOUN
admet-647	25	30	glycoside	glycoside	NOUN
admet-647	25	31	(	(	PUNCT
admet-647	25	32	rutinoside	rutinoside	INTJ
admet-647	25	33	)	)	PUNCT
admet-647	25	34	,	,	PUNCT
admet-647	25	35	occurs	occur	VERB
admet-647	25	36	naturally	naturally	ADV
admet-647	25	37	in	in	ADP
admet-647	25	38	the	the	DET
admet-647	25	39	pericarp	pericarp	NOUN
admet-647	25	40	of	of	ADP
admet-647	25	41	citrus	citrus	NOUN
admet-647	25	42	fruits	fruit	NOUN
admet-647	25	43	and	and	CCONJ
admet-647	25	44	grapefruits	grapefruit	NOUN
admet-647	25	45	(	(	PUNCT
admet-647	25	46	citrus	citrus	PROPN
admet-647	25	47	paradisi	paradisi	ADJ
admet-647	25	48	;	;	PUNCT
admet-647	25	49	family	family	NOUN
admet-647	25	50	:	:	PUNCT
admet-647	25	51	rutaceae	rutaceae	NOUN
admet-647	25	52	)	)	PUNCT
admet-647	26	1	[	[	X
admet-647	26	2	4	4	NUM
admet-647	26	3	]	]	PUNCT
admet-647	26	4	.	.	PUNCT
admet-647	27	1	naringin	naringin	PROPN
admet-647	27	2	possess	possess	VERB
admet-647	27	3	the	the	DET
admet-647	27	4	ability	ability	NOUN
admet-647	27	5	of	of	ADP
admet-647	27	6	inhibition	inhibition	NOUN
admet-647	27	7	of	of	ADP
admet-647	27	8	the	the	DET
admet-647	27	9	p	p	NOUN
admet-647	27	10	-	-	PUNCT
admet-647	27	11	gp	gp	NOUN
admet-647	27	12	efflux	efflux	NOUN
admet-647	27	13	pump	pump	NOUN
admet-647	27	14	[	[	X
admet-647	27	15	5,6	5,6	NUM
admet-647	27	16	]	]	PUNCT
admet-647	27	17	and	and	CCONJ
admet-647	27	18	also	also	ADV
admet-647	27	19	inhibit	inhibit	VERB
admet-647	27	20	cytochrome	cytochrome	NOUN
admet-647	27	21	p450	p450	PROPN
admet-647	27	22	in	in	ADP
admet-647	27	23	particular	particular	ADJ
admet-647	27	24	cyp3a4	cyp3a4	NOUN
admet-647	27	25	[	[	PUNCT
admet-647	27	26	7	7	NUM
admet-647	27	27	-	-	SYM
admet-647	27	28	9	9	NUM
admet-647	27	29	]	]	PUNCT
admet-647	27	30	.	.	PUNCT
admet-647	28	1	literature	literature	NOUN
admet-647	28	2	search	search	NOUN
admet-647	28	3	revealed	reveal	VERB
admet-647	28	4	that	that	SCONJ
admet-647	28	5	naringin	naringin	NOUN
admet-647	28	6	has	have	VERB
admet-647	28	7	antiviral	antiviral	ADJ
admet-647	28	8	10	10	NUM
admet-647	28	9	]	]	PUNCT
admet-647	28	10	,	,	PUNCT
admet-647	28	11	anticancer	anticancer	NOUN
admet-647	29	1	[	[	X
admet-647	29	2	11	11	NUM
admet-647	29	3	]	]	PUNCT
admet-647	29	4	,	,	PUNCT
admet-647	29	5	hepatoprotective	hepatoprotective	ADJ
admet-647	29	6	[	[	X
admet-647	29	7	12	12	NUM
admet-647	29	8	]	]	PUNCT
admet-647	29	9	,	,	PUNCT
admet-647	29	10	antiinflammatory	antiinflammatory	NOUN
admet-647	30	1	[	[	X
admet-647	31	1	13	13	NUM
admet-647	31	2	]	]	PUNCT
admet-647	31	3	,	,	PUNCT
admet-647	31	4	anti	anti	ADJ
admet-647	31	5	-	-	ADJ
admet-647	31	6	ulcer	ulcer	ADJ
admet-647	31	7	[	[	X
admet-647	31	8	14,15	14,15	NUM
admet-647	31	9	]	]	PUNCT
admet-647	31	10	and	and	CCONJ
admet-647	31	11	antioxidant	antioxidant	ADJ
admet-647	31	12	activities	activity	NOUN
admet-647	31	13	[	[	X
admet-647	31	14	16	16	NUM
admet-647	31	15	]	]	PUNCT
admet-647	31	16	.	.	PUNCT
admet-647	32	1	naringin	naringin	PROPN
admet-647	32	2	has	have	VERB
admet-647	32	3	an	an	DET
admet-647	32	4	inhibitory	inhibitory	ADJ
admet-647	32	5	effect	effect	NOUN
admet-647	32	6	against	against	ADP
admet-647	32	7	cyp3a4	cyp3a4	NOUN
admet-647	32	8	activity	activity	NOUN
admet-647	32	9	in	in	ADP
admet-647	32	10	human	human	ADJ
admet-647	32	11	liver	liver	NOUN
admet-647	32	12	microsomes	microsome	NOUN
admet-647	33	1	[	[	X
admet-647	33	2	9	9	NUM
admet-647	33	3	]	]	PUNCT
admet-647	34	1	and	and	CCONJ
admet-647	34	2	promotes	promote	VERB
admet-647	34	3	ascorbic	ascorbic	NOUN
admet-647	34	4	acid	acid	NOUN
admet-647	34	5	induced	induce	VERB
admet-647	34	6	lipid	lipid	NOUN
admet-647	34	7	peroxidation	peroxidation	NOUN
admet-647	34	8	[	[	X
admet-647	34	9	17	17	NUM
admet-647	34	10	]	]	PUNCT
admet-647	34	11	.	.	PUNCT
admet-647	35	1	naringin	naringin	PROPN
admet-647	35	2	has	have	VERB
admet-647	35	3	a	a	DET
admet-647	35	4	potent	potent	ADJ
admet-647	35	5	acyl	acyl	NOUN
admet-647	35	6	coa	coa	NOUN
admet-647	35	7	-	-	PUNCT
admet-647	35	8	cholesterol	cholesterol	NOUN
admet-647	35	9	-	-	PUNCT
admet-647	35	10	o	o	NOUN
admet-647	35	11	-	-	NOUN
admet-647	35	12	acyltransferase	acyltransferase	INTJ
admet-647	35	13	(	(	PUNCT
admet-647	35	14	acat	acat	ADV
admet-647	35	15	-	-	PUNCT
admet-647	35	16	promotes	promote	VERB
admet-647	35	17	the	the	DET
admet-647	35	18	esterification	esterification	NOUN
admet-647	35	19	of	of	ADP
admet-647	35	20	cholesterol	cholesterol	NOUN
admet-647	35	21	in	in	ADP
admet-647	35	22	blood	blood	NOUN
admet-647	35	23	)	)	PUNCT
admet-647	35	24	inhibitory	inhibitory	ADJ
admet-647	35	25	activity	activity	NOUN
admet-647	35	26	,	,	PUNCT
admet-647	35	27	macrophage	macrophage	ADJ
admet-647	35	28	-	-	PUNCT
admet-647	35	29	lipid	lipid	NOUN
admet-647	35	30	complex	complex	ADJ
admet-647	35	31	accumulation	accumulation	NOUN
admet-647	35	32	inhibitory	inhibitory	ADJ
admet-647	35	33	activity	activity	NOUN
admet-647	35	34	and	and	CCONJ
admet-647	35	35	preventive	preventive	ADJ
admet-647	35	36	or	or	CCONJ
admet-647	35	37	treating	treat	VERB
admet-647	35	38	activity	activity	NOUN
admet-647	35	39	on	on	ADP
admet-647	35	40	the	the	DET
admet-647	35	41	hepatic	hepatic	ADJ
admet-647	35	42	diseases	disease	NOUN
admet-647	35	43	[	[	X
admet-647	35	44	18	18	NUM
admet-647	35	45	]	]	PUNCT
admet-647	35	46	.	.	PUNCT
admet-647	36	1	previous	previous	ADJ
admet-647	36	2	studies	study	NOUN
admet-647	36	3	have	have	AUX
admet-647	36	4	reported	report	VERB
admet-647	36	5	that	that	SCONJ
admet-647	36	6	pretreatment	pretreatment	NOUN
admet-647	36	7	of	of	ADP
admet-647	36	8	naringin	naringin	NOUN
admet-647	36	9	appeared	appear	VERB
admet-647	36	10	to	to	PART
admet-647	36	11	be	be	AUX
admet-647	36	12	effective	effective	ADJ
admet-647	36	13	to	to	PART
admet-647	36	14	alter	alter	VERB
admet-647	36	15	the	the	DET
admet-647	36	16	pharmacokinetics	pharmacokinetic	NOUN
admet-647	36	17	of	of	ADP
admet-647	36	18	drugs	drug	NOUN
admet-647	36	19	(	(	PUNCT
admet-647	36	20	verapamil	verapamil	NOUN
admet-647	36	21	,	,	PUNCT
admet-647	36	22	diltiazem	diltiazem	NOUN
admet-647	36	23	,	,	PUNCT
admet-647	36	24	paclitaxel	paclitaxel	NOUN
admet-647	36	25	,	,	PUNCT
admet-647	36	26	tamoxifen	tamoxifen	PROPN
admet-647	36	27	)	)	PUNCT
admet-647	36	28	that	that	PRON
admet-647	36	29	are	be	AUX
admet-647	36	30	substrates	substrate	NOUN
admet-647	36	31	of	of	ADP
admet-647	36	32	p	p	NOUN
admet-647	36	33	-	-	PUNCT
admet-647	36	34	gp	gp	NOUN
admet-647	36	35	and/or	and/or	CCONJ
admet-647	36	36	cyp3a	cyp3a	PROPN
admet-647	36	37	over	over	ADP
admet-647	36	38	the	the	DET
admet-647	36	39	dose	dose	NOUN
admet-647	36	40	range	range	NOUN
admet-647	36	41	of	of	ADP
admet-647	36	42	3	3	NUM
admet-647	36	43	-	-	SYM
admet-647	36	44	30	30	NUM
admet-647	36	45	mg	mg	PROPN
admet-647	36	46	/	/	SYM
admet-647	36	47	kg	kg	NOUN
admet-647	36	48	in	in	ADP
admet-647	36	49	rats	rat	NOUN
admet-647	36	50	/	/	SYM
admet-647	36	51	rabbits	rabbit	NOUN
admet-647	36	52	[	[	X
admet-647	36	53	19	19	NUM
admet-647	36	54	-	-	SYM
admet-647	36	55	22	22	NUM
admet-647	36	56	]	]	PUNCT
admet-647	36	57	.	.	PUNCT
admet-647	37	1	atorvastatin	atorvastatin	PROPN
admet-647	37	2	(	(	PUNCT
admet-647	37	3	ast	ast	PROPN
admet-647	37	4	)	)	PUNCT
admet-647	37	5	chemically	chemically	ADV
admet-647	37	6	is	be	AUX
admet-647	37	7	a	a	DET
admet-647	37	8	calcium	calcium	NOUN
admet-647	37	9	salt	salt	NOUN
admet-647	37	10	of	of	ADP
admet-647	37	11	(	(	PUNCT
admet-647	37	12	βr	βr	INTJ
admet-647	37	13	,	,	PUNCT
admet-647	37	14	δr)-2-(4	δr)-2-(4	NOUN
admet-647	37	15	-	-	PUNCT
admet-647	37	16	fluorophenyl)-β	fluorophenyl)-β	NOUN
admet-647	37	17	,	,	PUNCT
admet-647	37	18	δ	δ	NOUN
admet-647	37	19	-	-	PUNCT
admet-647	37	20	dihydroxy-5-(1methylethyl)–3	dihydroxy-5-(1methylethyl)–3	NUM
admet-647	37	21	-	-	PUNCT
admet-647	37	22	phenyl-4-[(phenylamino)-carbonyl]-1h	phenyl-4-[(phenylamino)-carbonyl]-1h	NOUN
admet-647	37	23	-	-	PUNCT
admet-647	37	24	pyrrole-1	pyrrole-1	NOUN
admet-647	37	25	-	-	PUNCT
admet-647	37	26	heptanoic	heptanoic	ADJ
admet-647	37	27	acid	acid	NOUN
admet-647	37	28	(	(	PUNCT
admet-647	37	29	2:1	2:1	NUM
admet-647	37	30	)	)	PUNCT
admet-647	37	31	trihydrate	trihydrate	NOUN
admet-647	37	32	.	.	PUNCT
admet-647	38	1	ast	ast	NOUN
admet-647	38	2	(	(	PUNCT
admet-647	38	3	lipitor	lipitor	NOUN
admet-647	38	4	®	®	PROPN
admet-647	38	5	)	)	PUNCT
admet-647	38	6	is	be	AUX
admet-647	38	7	a	a	DET
admet-647	38	8	3	3	NUM
admet-647	38	9	-	-	PUNCT
admet-647	38	10	hydroxy-3	hydroxy-3	NUM
admet-647	38	11	-	-	PUNCT
admet-647	38	12	methyl	methyl	NOUN
admet-647	38	13	-	-	PUNCT
admet-647	38	14	glutaryl	glutaryl	NOUN
admet-647	38	15	coenzyme	coenzyme	PROPN
admet-647	38	16	a	a	DET
admet-647	38	17	(	(	PUNCT
admet-647	38	18	hmg	hmg	NOUN
admet-647	38	19	-	-	PUNCT
admet-647	38	20	coa	coa	NOUN
admet-647	38	21	)	)	PUNCT
admet-647	38	22	reductase	reductase	NOUN
admet-647	38	23	inhibitor	inhibitor	NOUN
admet-647	38	24	and	and	CCONJ
admet-647	38	25	used	use	VERB
admet-647	38	26	for	for	ADP
admet-647	38	27	treating	treat	VERB
admet-647	38	28	various	various	ADJ
admet-647	38	29	dyslipidemic	dyslipidemic	ADJ
admet-647	38	30	disorders	disorder	NOUN
admet-647	38	31	.	.	PUNCT
admet-647	39	1	ast	ast	PROPN
admet-647	39	2	is	be	AUX
admet-647	39	3	rapidly	rapidly	ADV
admet-647	39	4	absorbed	absorb	VERB
admet-647	39	5	from	from	ADP
admet-647	39	6	gastrointestinal	gastrointestinal	ADJ
admet-647	39	7	tract	tract	NOUN
admet-647	39	8	.	.	PUNCT
admet-647	40	1	the	the	DET
admet-647	40	2	extent	extent	NOUN
admet-647	40	3	of	of	ADP
admet-647	40	4	absorption	absorption	NOUN
admet-647	40	5	increases	increase	NOUN
admet-647	40	6	in	in	ADP
admet-647	40	7	proportion	proportion	NOUN
admet-647	40	8	to	to	ADP
admet-647	40	9	the	the	DET
admet-647	40	10	dose	dose	NOUN
admet-647	40	11	and	and	CCONJ
admet-647	40	12	the	the	DET
admet-647	40	13	absolute	absolute	ADJ
admet-647	40	14	bioavailability	bioavailability	NOUN
admet-647	40	15	is	be	AUX
admet-647	40	16	12	12	NUM
admet-647	40	17	%	%	NOUN
admet-647	40	18	.	.	PUNCT
admet-647	41	1	protein	protein	NOUN
admet-647	41	2	binding	bind	VERB
admet-647	41	3	is	be	AUX
admet-647	41	4	very	very	ADV
admet-647	41	5	high	high	ADJ
admet-647	41	6	(	(	PUNCT
admet-647	41	7	≥98	≥98	NUM
admet-647	41	8	%	%	NOUN
admet-647	41	9	)	)	PUNCT
admet-647	41	10	and	and	CCONJ
admet-647	41	11	undergoes	undergo	VERB
admet-647	41	12	extensive	extensive	ADJ
admet-647	41	13	hepatic	hepatic	ADJ
admet-647	41	14	or	or	CCONJ
admet-647	41	15	extra	extra	ADJ
admet-647	41	16	hepatic	hepatic	ADJ
admet-647	41	17	metabolism	metabolism	NOUN
admet-647	41	18	.	.	PUNCT
admet-647	42	1	pharmacokinetic	pharmacokinetic	ADJ
admet-647	42	2	studies	study	NOUN
admet-647	42	3	of	of	ADP
admet-647	42	4	ast	ast	NOUN
admet-647	42	5	revealed	reveal	VERB
admet-647	42	6	the	the	DET
admet-647	42	7	formation	formation	NOUN
admet-647	42	8	of	of	ADP
admet-647	42	9	ortho	ortho	PROPN
admet-647	42	10	and	and	CCONJ
admet-647	42	11	parahydroxylated	parahydroxylate	VERB
admet-647	42	12	derivatives	derivative	NOUN
admet-647	42	13	as	as	ADP
admet-647	42	14	primary	primary	ADJ
admet-647	42	15	metabolites	metabolite	NOUN
admet-647	42	16	.	.	PUNCT
admet-647	43	1	the	the	DET
admet-647	43	2	cytochrome	cytochrome	NOUN
admet-647	43	3	p450	p450	PROPN
admet-647	43	4	family	family	NOUN
admet-647	43	5	in	in	ADP
admet-647	43	6	particular	particular	ADJ
admet-647	43	7	cyp3a4	cyp3a4	NOUN
admet-647	43	8	is	be	AUX
admet-647	43	9	potential	potential	ADJ
admet-647	43	10	to	to	PART
admet-647	43	11	catalyse	catalyse	VERB
admet-647	43	12	the	the	DET
admet-647	43	13	formation	formation	NOUN
admet-647	43	14	of	of	ADP
admet-647	43	15	ortho	ortho	PROPN
admet-647	43	16	and	and	CCONJ
admet-647	43	17	parahydroxylated	parahydroxylate	VERB
admet-647	43	18	derivatives	derivative	NOUN
admet-647	43	19	[	[	X
admet-647	43	20	23,24	23,24	NOUN
admet-647	43	21	]	]	PUNCT
admet-647	43	22	.	.	PUNCT
admet-647	44	1	the	the	DET
admet-647	44	2	wide	wide	ADJ
admet-647	44	3	range	range	NOUN
admet-647	44	4	of	of	ADP
admet-647	44	5	doses	dose	NOUN
admet-647	44	6	ranging	range	VERB
admet-647	44	7	from	from	ADP
admet-647	44	8	10	10	NUM
admet-647	44	9	-	-	SYM
admet-647	44	10	80	80	NUM
admet-647	44	11	mg	mg	NOUN
admet-647	44	12	of	of	ADP
admet-647	44	13	ast	ast	NOUN
admet-647	44	14	is	be	AUX
admet-647	44	15	in	in	ADP
admet-647	44	16	use	use	NOUN
admet-647	44	17	as	as	ADP
admet-647	44	18	per	per	ADP
admet-647	44	19	the	the	DET
admet-647	44	20	lipid	lipid	NOUN
admet-647	44	21	lowering	lower	VERB
admet-647	44	22	profile	profile	NOUN
admet-647	44	23	requirement	requirement	NOUN
admet-647	44	24	.	.	PUNCT
admet-647	45	1	due	due	ADP
admet-647	45	2	to	to	ADP
admet-647	45	3	low	low	ADJ
admet-647	45	4	bioavailability	bioavailability	NOUN
admet-647	45	5	of	of	ADP
admet-647	45	6	ast	ast	X
admet-647	45	7	high	high	ADJ
admet-647	45	8	dosing	dose	VERB
admet-647	45	9	and/or	and/or	CCONJ
admet-647	45	10	repeated	repeat	VERB
admet-647	45	11	administration	administration	NOUN
admet-647	45	12	is	be	AUX
admet-647	45	13	required	require	VERB
admet-647	45	14	to	to	PART
admet-647	45	15	achieve	achieve	VERB
admet-647	45	16	steady	steady	ADJ
admet-647	45	17	state	state	NOUN
admet-647	45	18	of	of	ADP
admet-647	45	19	cmax	cmax	NOUN
admet-647	45	20	.	.	PUNCT
admet-647	46	1	this	this	DET
admet-647	46	2	research	research	NOUN
admet-647	46	3	paper	paper	NOUN
admet-647	46	4	aims	aim	VERB
admet-647	46	5	at	at	ADP
admet-647	46	6	reporting	report	VERB
admet-647	46	7	the	the	DET
admet-647	46	8	effect	effect	NOUN
admet-647	46	9	of	of	ADP
admet-647	46	10	naringin	naringin	NOUN
admet-647	46	11	on	on	ADP
admet-647	46	12	the	the	DET
admet-647	46	13	antihyperlipidemic	antihyperlipidemic	ADJ
admet-647	46	14	activity	activity	NOUN
admet-647	46	15	of	of	ADP
admet-647	46	16	ast	ast	NOUN
admet-647	46	17	in	in	ADP
admet-647	46	18	tyloxapol	tyloxapol	NOUN
admet-647	46	19	induced	induce	VERB
admet-647	46	20	hyperlipidemia	hyperlipidemia	NOUN
admet-647	46	21	in	in	ADP
admet-647	46	22	wistar	wistar	PROPN
admet-647	46	23	rats	rat	NOUN
admet-647	46	24	.	.	PUNCT
admet-647	47	1	the	the	DET
admet-647	47	2	observed	observed	ADJ
admet-647	47	3	activity	activity	NOUN
admet-647	47	4	was	be	AUX
admet-647	47	5	correlated	correlate	VERB
admet-647	47	6	with	with	ADP
admet-647	47	7	plasma	plasma	NOUN
admet-647	47	8	concentration	concentration	NOUN
admet-647	47	9	of	of	ADP
admet-647	47	10	ast	ast	NOUN
admet-647	47	11	in	in	ADP
admet-647	47	12	experimental	experimental	ADJ
admet-647	47	13	animals	animal	NOUN
admet-647	47	14	.	.	PUNCT
admet-647	48	1	materials	material	NOUN
admet-647	48	2	and	and	CCONJ
admet-647	48	3	methods	method	NOUN
admet-647	48	4	chemicals	chemical	NOUN
admet-647	48	5	and	and	CCONJ
admet-647	48	6	reagents	reagent	NOUN
admet-647	48	7	a	a	DET
admet-647	48	8	gift	gift	NOUN
admet-647	48	9	sample	sample	NOUN
admet-647	48	10	of	of	ADP
admet-647	48	11	ast	ast	NOUN
admet-647	48	12	(	(	PUNCT
admet-647	48	13	purity	purity	NOUN
admet-647	48	14	>	>	X
admet-647	48	15	99.5	99.5	NUM
admet-647	48	16	%	%	NOUN
admet-647	48	17	)	)	PUNCT
admet-647	48	18	is	be	AUX
admet-647	48	19	obtained	obtain	VERB
admet-647	48	20	from	from	ADP
admet-647	48	21	m	m	PROPN
admet-647	48	22	/	/	SYM
admet-647	48	23	s	s	PROPN
admet-647	48	24	,	,	PUNCT
admet-647	48	25	biocon	biocon	NOUN
admet-647	48	26	pharmaceuticals	pharmaceutical	NOUN
admet-647	48	27	,	,	PUNCT
admet-647	48	28	bangalore	bangalore	PROPN
admet-647	48	29	,	,	PUNCT
admet-647	48	30	india	india	PROPN
admet-647	48	31	.	.	PUNCT
admet-647	49	1	naringin	naringin	PROPN
admet-647	49	2	procured	procure	VERB
admet-647	49	3	from	from	ADP
admet-647	49	4	sigma	sigma	PROPN
admet-647	49	5	-	-	PUNCT
admet-647	49	6	aldrich	aldrich	PROPN
admet-647	49	7	,	,	PUNCT
admet-647	49	8	mumbai	mumbai	PROPN
admet-647	49	9	,	,	PUNCT
admet-647	49	10	india	india	PROPN
admet-647	49	11	.	.	PUNCT
admet-647	50	1	tyloxapol	tyloxapol	NOUN
admet-647	50	2	(	(	PUNCT
admet-647	50	3	isooctyl	isooctyl	NOUN
admet-647	50	4	-	-	PUNCT
admet-647	50	5	polyoxyethylene	polyoxyethylene	NOUN
admet-647	50	6	phenol	phenol	NOUN
admet-647	50	7	/	/	SYM
admet-647	50	8	triton	triton	PROPN
admet-647	50	9	wr	wr	PROPN
admet-647	50	10	1339	1339	NUM
admet-647	50	11	)	)	PUNCT
admet-647	50	12	was	be	AUX
admet-647	50	13	purchased	purchase	VERB
admet-647	50	14	from	from	ADP
admet-647	50	15	himedia	himedia	PROPN
admet-647	50	16	(	(	PUNCT
admet-647	50	17	b.	b.	NOUN
admet-647	51	1	no	no	NOUN
admet-647	51	2	:	:	PUNCT
admet-647	51	3	25301	25301	NUM
admet-647	51	4	-	-	SYM
admet-647	51	5	02	02	NUM
admet-647	51	6	-	-	PUNCT
admet-647	51	7	4	4	NUM
admet-647	51	8	)	)	PUNCT
admet-647	51	9	mumbai	mumbai	PROPN
admet-647	51	10	,	,	PUNCT
admet-647	51	11	india	india	PROPN
admet-647	51	12	.	.	PUNCT
admet-647	52	1	hplc	hplc	PROPN
admet-647	52	2	grade	grade	NOUN
admet-647	52	3	water	water	NOUN
admet-647	52	4	,	,	PUNCT
admet-647	52	5	acetonitrile	acetonitrile	NOUN
admet-647	52	6	,	,	PUNCT
admet-647	52	7	methanol	methanol	NOUN
admet-647	52	8	and	and	CCONJ
admet-647	52	9	orthophosphoric	orthophosphoric	ADJ
admet-647	52	10	acid	acid	NOUN
admet-647	52	11	were	be	AUX
admet-647	52	12	purchased	purchase	VERB
admet-647	52	13	from	from	ADP
admet-647	52	14	sd	sd	ADP
admet-647	52	15	fine	fine	ADJ
admet-647	52	16	-	-	PUNCT
admet-647	52	17	chem	chem	NOUN
admet-647	52	18	limited	limited	ADJ
admet-647	52	19	and	and	CCONJ
admet-647	52	20	sodium	sodium	NOUN
admet-647	52	21	dihydrogen	dihydrogen	NOUN
admet-647	52	22	orthophosphate	orthophosphate	NOUN
admet-647	52	23	from	from	ADP
admet-647	52	24	otto	otto	PROPN
admet-647	52	25	chemicals	chemicals	PROPN
admet-647	52	26	,	,	PUNCT
admet-647	52	27	mumbai	mumbai	PROPN
admet-647	52	28	,	,	PUNCT
admet-647	52	29	india	india	PROPN
admet-647	52	30	.	.	PUNCT
admet-647	53	1	disodium	disodium	NOUN
admet-647	53	2	salt	salt	NOUN
admet-647	53	3	of	of	ADP
admet-647	53	4	edta	edta	NOUN
admet-647	53	5	is	be	AUX
admet-647	53	6	procured	procure	VERB
admet-647	53	7	from	from	ADP
admet-647	53	8	sd	sd	ADP
admet-647	53	9	finechem	finechem	NOUN
admet-647	53	10	limited	limit	VERB
admet-647	53	11	,	,	PUNCT
admet-647	53	12	mumbai	mumbai	PROPN
admet-647	53	13	,	,	PUNCT
admet-647	53	14	india	india	PROPN
admet-647	53	15	.	.	PUNCT
admet-647	54	1	anesthetic	anesthetic	ADJ
admet-647	54	2	ether	ether	NOUN
admet-647	54	3	is	be	AUX
admet-647	54	4	obtained	obtain	VERB
admet-647	54	5	from	from	ADP
admet-647	54	6	tkm	tkm	PROPN
admet-647	54	7	pharma	pharma	PROPN
admet-647	54	8	,	,	PUNCT
admet-647	54	9	hyderabad	hyderabad	PROPN
admet-647	54	10	,	,	PUNCT
admet-647	54	11	india	india	PROPN
admet-647	54	12	.	.	PUNCT
admet-647	55	1	diagnostic	diagnostic	ADJ
admet-647	55	2	kits	kit	NOUN
admet-647	55	3	for	for	ADP
admet-647	55	4	total	total	ADJ
admet-647	55	5	cholesterol	cholesterol	NOUN
admet-647	55	6	and	and	CCONJ
admet-647	55	7	triglycerides	triglyceride	NOUN
admet-647	55	8	were	be	AUX
admet-647	55	9	obtained	obtain	VERB
admet-647	55	10	from	from	ADP
admet-647	55	11	span	span	NOUN
admet-647	55	12	diagnostics	diagnostics	PROPN
admet-647	55	13	ltd	ltd	PROPN
admet-647	55	14	,	,	PUNCT
admet-647	55	15	surat	surat	PROPN
admet-647	55	16	,	,	PUNCT
admet-647	55	17	r.	r.	PROPN
admet-647	55	18	mullangi	mullangi	VERB
admet-647	55	19	et	et	PROPN
admet-647	55	20	al	al	PROPN
admet-647	55	21	.	.	PROPN
admet-647	55	22	admet	admet	PROPN
admet-647	55	23	&	&	CCONJ
admet-647	55	24	dmpk	dmpk	PROPN
admet-647	55	25	7(3	7(3	NUM
admet-647	55	26	)	)	PUNCT
admet-647	55	27	(	(	PUNCT
admet-647	55	28	2019	2019	NUM
admet-647	55	29	)	)	PUNCT
admet-647	55	30	174	174	NUM
admet-647	55	31	-	-	SYM
admet-647	55	32	182	182	NUM
admet-647	55	33	176	176	NUM
admet-647	55	34	gujarat	gujarat	NOUN
admet-647	55	35	,	,	PUNCT
admet-647	55	36	india	india	PROPN
admet-647	55	37	.	.	PUNCT
admet-647	56	1	cellulose	cellulose	NOUN
admet-647	56	2	acetate	acetate	PROPN
admet-647	56	3	filters	filter	NOUN
admet-647	56	4	,	,	PUNCT
admet-647	56	5	pore	pore	ADJ
admet-647	56	6	size	size	NOUN
admet-647	56	7	0.2	0.2	NUM
admet-647	56	8	µm	µm	NUM
admet-647	56	9	obtained	obtain	VERB
admet-647	56	10	from	from	ADP
admet-647	56	11	sartorius	sartorius	NOUN
admet-647	56	12	stedim	stedim	PROPN
admet-647	56	13	biotech	biotech	NOUN
admet-647	56	14	,	,	PUNCT
admet-647	56	15	germany	germany	PROPN
admet-647	56	16	.	.	PUNCT
admet-647	57	1	all	all	DET
admet-647	57	2	aqueous	aqueous	ADJ
admet-647	57	3	solutions	solution	NOUN
admet-647	57	4	including	include	VERB
admet-647	57	5	the	the	DET
admet-647	57	6	buffer	buffer	NOUN
admet-647	57	7	for	for	ADP
admet-647	57	8	mobile	mobile	ADJ
admet-647	57	9	phase	phase	NOUN
admet-647	57	10	was	be	AUX
admet-647	57	11	prepared	prepare	VERB
admet-647	57	12	with	with	ADP
admet-647	57	13	hplc	hplc	NOUN
admet-647	57	14	grade	grade	NOUN
admet-647	57	15	water	water	NOUN
admet-647	57	16	.	.	PUNCT
admet-647	58	1	control	control	PROPN
admet-647	58	2	wistar	wistar	PROPN
admet-647	58	3	rat	rat	PROPN
admet-647	58	4	plasma	plasma	NOUN
admet-647	58	5	was	be	AUX
admet-647	58	6	obtained	obtain	VERB
admet-647	58	7	from	from	ADP
admet-647	58	8	department	department	NOUN
admet-647	58	9	of	of	ADP
admet-647	58	10	pharmacology	pharmacology	NOUN
admet-647	58	11	,	,	PUNCT
admet-647	58	12	g.	g.	PROPN
admet-647	58	13	pulla	pulla	PROPN
admet-647	58	14	reddy	reddy	PROPN
admet-647	58	15	college	college	PROPN
admet-647	58	16	of	of	ADP
admet-647	58	17	pharmacy	pharmacy	PROPN
admet-647	58	18	,	,	PUNCT
admet-647	58	19	hyderabad	hyderabad	PROPN
admet-647	58	20	,	,	PUNCT
admet-647	58	21	india	india	PROPN
admet-647	58	22	.	.	PUNCT
admet-647	59	1	experimental	experimental	ADJ
admet-647	59	2	animals	animal	NOUN
admet-647	59	3	male	male	PROPN
admet-647	59	4	wistar	wistar	PROPN
admet-647	59	5	rats	rat	NOUN
admet-647	59	6	weighing	weigh	VERB
admet-647	59	7	(	(	PUNCT
admet-647	59	8	~3	~3	NOUN
admet-647	59	9	months	month	NOUN
admet-647	59	10	age	age	NOUN
admet-647	59	11	,	,	PUNCT
admet-647	59	12	weighing	weigh	VERB
admet-647	59	13	180	180	NUM
admet-647	59	14	-	-	SYM
admet-647	59	15	200	200	NUM
admet-647	59	16	g	g	NOUN
admet-647	59	17	)	)	PUNCT
admet-647	59	18	were	be	AUX
admet-647	59	19	procured	procure	VERB
admet-647	59	20	from	from	ADP
admet-647	59	21	national	national	PROPN
admet-647	59	22	institute	institute	PROPN
admet-647	59	23	of	of	ADP
admet-647	59	24	nutrition	nutrition	PROPN
admet-647	59	25	,	,	PUNCT
admet-647	59	26	hyderabad	hyderabad	PROPN
admet-647	59	27	,	,	PUNCT
admet-647	59	28	india	india	PROPN
admet-647	59	29	.	.	PUNCT
admet-647	60	1	animals	animal	NOUN
admet-647	60	2	were	be	AUX
admet-647	60	3	maintained	maintain	VERB
admet-647	60	4	in	in	ADP
admet-647	60	5	standard	standard	ADJ
admet-647	60	6	cages	cage	NOUN
admet-647	60	7	under	under	ADP
admet-647	60	8	controlled	control	VERB
admet-647	60	9	laboratory	laboratory	NOUN
admet-647	60	10	conditions	condition	NOUN
admet-647	60	11	.	.	PUNCT
admet-647	61	1	the	the	DET
admet-647	61	2	animals	animal	NOUN
admet-647	61	3	had	have	VERB
admet-647	61	4	free	free	ADJ
admet-647	61	5	access	access	NOUN
admet-647	61	6	to	to	ADP
admet-647	61	7	feed	feed	NOUN
admet-647	61	8	(	(	PUNCT
admet-647	61	9	national	national	PROPN
admet-647	61	10	institute	institute	PROPN
admet-647	61	11	of	of	ADP
admet-647	61	12	nutrition	nutrition	PROPN
admet-647	61	13	,	,	PUNCT
admet-647	61	14	hyderabad	hyderabad	PROPN
admet-647	61	15	)	)	PUNCT
admet-647	61	16	and	and	CCONJ
admet-647	61	17	water	water	NOUN
admet-647	61	18	ad	ad	NOUN
admet-647	61	19	libitium	libitium	NOUN
admet-647	61	20	during	during	ADP
admet-647	61	21	quarantine	quarantine	NOUN
admet-647	61	22	period	period	NOUN
admet-647	61	23	of	of	ADP
admet-647	61	24	seven	seven	NUM
admet-647	61	25	days	day	NOUN
admet-647	61	26	.	.	PUNCT
admet-647	62	1	animals	animal	NOUN
admet-647	62	2	were	be	AUX
admet-647	62	3	fasted	fast	VERB
admet-647	62	4	~12	~12	PUNCT
admet-647	62	5	h	h	NOUN
admet-647	62	6	before	before	ADP
admet-647	62	7	experiment	experiment	NOUN
admet-647	62	8	but	but	CCONJ
admet-647	62	9	had	have	AUX
admet-647	62	10	been	be	AUX
admet-647	62	11	allowed	allow	VERB
admet-647	62	12	free	free	ADJ
admet-647	62	13	access	access	NOUN
admet-647	62	14	to	to	ADP
admet-647	62	15	water	water	NOUN
admet-647	62	16	.	.	PUNCT
admet-647	63	1	the	the	DET
admet-647	63	2	institutional	institutional	ADJ
admet-647	63	3	animal	animal	NOUN
admet-647	63	4	ethics	ethic	NOUN
admet-647	63	5	committee	committee	PROPN
admet-647	63	6	of	of	ADP
admet-647	63	7	g.	g.	PROPN
admet-647	63	8	pulla	pulla	PROPN
admet-647	63	9	reddy	reddy	PROPN
admet-647	63	10	college	college	PROPN
admet-647	63	11	of	of	ADP
admet-647	63	12	pharmacy	pharmacy	PROPN
admet-647	63	13	,	,	PUNCT
admet-647	63	14	hyderabad	hyderabad	PROPN
admet-647	63	15	,	,	PUNCT
admet-647	63	16	india	india	PROPN
admet-647	63	17	has	have	AUX
admet-647	63	18	approved	approve	VERB
admet-647	63	19	the	the	DET
admet-647	63	20	animal	animal	NOUN
admet-647	63	21	experimental	experimental	ADJ
admet-647	63	22	protocols	protocol	NOUN
admet-647	63	23	.	.	PUNCT
admet-647	64	1	effect	effect	NOUN
admet-647	64	2	of	of	ADP
admet-647	64	3	naringin	naringin	NOUN
admet-647	64	4	on	on	ADP
admet-647	64	5	ast	ast	NOUN
admet-647	64	6	in	in	ADP
admet-647	64	7	tyloxapol	tyloxapol	NOUN
admet-647	64	8	induced	induce	VERB
admet-647	64	9	hyperlipidemia	hyperlipidemia	NOUN
admet-647	64	10	the	the	DET
admet-647	64	11	method	method	NOUN
admet-647	64	12	tyloxapol	tyloxapol	NOUN
admet-647	64	13	induced	induce	VERB
admet-647	64	14	hyperlipidemia	hyperlipidemia	NOUN
admet-647	64	15	in	in	ADP
admet-647	64	16	rats	rat	NOUN
admet-647	64	17	was	be	AUX
admet-647	64	18	performed	perform	VERB
admet-647	64	19	as	as	SCONJ
admet-647	64	20	described	describe	VERB
admet-647	64	21	by	by	ADP
admet-647	64	22	vogel	vogel	NOUN
admet-647	64	23	[	[	X
admet-647	64	24	25	25	NUM
admet-647	64	25	]	]	PUNCT
admet-647	64	26	.	.	PUNCT
admet-647	65	1	hyperlipidemia	hyperlipidemia	NOUN
admet-647	65	2	was	be	AUX
admet-647	65	3	induced	induce	VERB
admet-647	65	4	by	by	ADP
admet-647	65	5	single	single	ADJ
admet-647	65	6	intraperitonial	intraperitonial	ADJ
admet-647	65	7	injection	injection	NOUN
admet-647	65	8	of	of	ADP
admet-647	65	9	15	15	NUM
admet-647	65	10	%	%	NOUN
admet-647	65	11	w	w	PROPN
admet-647	65	12	/	/	SYM
admet-647	65	13	v	v	NUM
admet-647	65	14	tyloxapol	tyloxapol	NOUN
admet-647	65	15	in	in	ADP
admet-647	65	16	sterile	sterile	ADJ
admet-647	65	17	normal	normal	ADJ
admet-647	65	18	saline	saline	NOUN
admet-647	65	19	at	at	ADP
admet-647	65	20	a	a	DET
admet-647	65	21	dose	dose	NOUN
admet-647	65	22	of	of	ADP
admet-647	65	23	400	400	NUM
admet-647	65	24	mg	mg	NUM
admet-647	65	25	/	/	SYM
admet-647	65	26	kg	kg	PROPN
admet-647	65	27	.	.	PUNCT
admet-647	66	1	after	after	ADP
admet-647	66	2	30	30	NUM
admet-647	66	3	h	h	NOUN
admet-647	66	4	,	,	PUNCT
admet-647	66	5	rats	rat	NOUN
admet-647	66	6	with	with	ADP
admet-647	66	7	marked	mark	VERB
admet-647	66	8	hypercholesterol	hypercholesterol	NOUN
admet-647	66	9	were	be	AUX
admet-647	66	10	separated	separate	VERB
admet-647	66	11	and	and	CCONJ
admet-647	66	12	divided	divide	VERB
admet-647	66	13	into	into	ADP
admet-647	66	14	10	10	NUM
admet-647	66	15	groups	group	NOUN
admet-647	66	16	of	of	ADP
admet-647	66	17	6	6	NUM
admet-647	66	18	animals	animal	NOUN
admet-647	66	19	each	each	PRON
admet-647	66	20	.	.	PUNCT
admet-647	67	1	all	all	DET
admet-647	67	2	the	the	DET
admet-647	67	3	test	test	NOUN
admet-647	67	4	substances	substance	NOUN
admet-647	67	5	were	be	AUX
admet-647	67	6	administered	administer	VERB
admet-647	67	7	orally	orally	ADV
admet-647	67	8	as	as	ADP
admet-647	67	9	a	a	DET
admet-647	67	10	fine	fine	ADJ
admet-647	67	11	aqueous	aqueous	ADJ
admet-647	67	12	suspension	suspension	NOUN
admet-647	67	13	of	of	ADP
admet-647	67	14	0.5	0.5	NUM
admet-647	67	15	%	%	NOUN
admet-647	67	16	w	w	PROPN
admet-647	67	17	/	/	SYM
admet-647	67	18	v	v	NOUN
admet-647	67	19	carboxy	carboxy	ADJ
admet-647	67	20	methyl	methyl	NOUN
admet-647	67	21	cellulose	cellulose	NOUN
admet-647	67	22	(	(	PUNCT
admet-647	67	23	cmc	cmc	PROPN
admet-647	67	24	)	)	PUNCT
admet-647	67	25	.	.	PUNCT
admet-647	68	1	group	group	NOUN
admet-647	68	2	1	1	NUM
admet-647	68	3	served	serve	VERB
admet-647	68	4	as	as	ADP
admet-647	68	5	disease	disease	NOUN
admet-647	68	6	control	control	NOUN
admet-647	68	7	and	and	CCONJ
admet-647	68	8	received	receive	VERB
admet-647	68	9	vehicle	vehicle	NOUN
admet-647	68	10	.	.	PUNCT
admet-647	69	1	group	group	NOUN
admet-647	69	2	2	2	NUM
admet-647	69	3	and	and	CCONJ
admet-647	69	4	3	3	NUM
admet-647	69	5	received	receive	VERB
admet-647	69	6	naringin	naringin	NOUN
admet-647	69	7	at	at	ADP
admet-647	69	8	a	a	DET
admet-647	69	9	dose	dose	NOUN
admet-647	69	10	of	of	ADP
admet-647	69	11	15	15	NUM
admet-647	69	12	and	and	CCONJ
admet-647	69	13	30	30	NUM
admet-647	69	14	mg	mg	NUM
admet-647	69	15	/	/	SYM
admet-647	69	16	kg	kg	PROPN
admet-647	69	17	,	,	PUNCT
admet-647	69	18	respectively	respectively	ADV
admet-647	69	19	.	.	PUNCT
admet-647	70	1	animals	animal	NOUN
admet-647	70	2	of	of	ADP
admet-647	70	3	group	group	NOUN
admet-647	70	4	4	4	NUM
admet-647	70	5	received	receive	VERB
admet-647	70	6	ast	ast	NOUN
admet-647	70	7	at	at	ADP
admet-647	70	8	a	a	DET
admet-647	70	9	dose	dose	NOUN
admet-647	70	10	of	of	ADP
admet-647	70	11	25	25	NUM
admet-647	70	12	mg	mg	PROPN
admet-647	70	13	/	/	SYM
admet-647	70	14	kg	kg	PROPN
admet-647	70	15	;	;	PUNCT
admet-647	70	16	group	group	NOUN
admet-647	70	17	5	5	NUM
admet-647	70	18	and	and	CCONJ
admet-647	70	19	6	6	NUM
admet-647	70	20	received	receive	VERB
admet-647	70	21	ast	ast	NOUN
admet-647	70	22	along	along	ADP
admet-647	70	23	with	with	ADP
admet-647	70	24	naringin	naringin	NOUN
admet-647	70	25	at	at	ADP
admet-647	70	26	25	25	NUM
admet-647	70	27	&	&	CCONJ
admet-647	70	28	15	15	NUM
admet-647	70	29	and	and	CCONJ
admet-647	70	30	25	25	NUM
admet-647	70	31	&	&	CCONJ
admet-647	70	32	30	30	NUM
admet-647	70	33	mg	mg	PROPN
admet-647	70	34	/	/	SYM
admet-647	70	35	kg	kg	PROPN
admet-647	70	36	,	,	PUNCT
admet-647	70	37	respectively	respectively	ADV
admet-647	70	38	.	.	PUNCT
admet-647	71	1	group	group	PROPN
admet-647	71	2	7	7	NUM
admet-647	71	3	received	receive	VERB
admet-647	71	4	ast	ast	NOUN
admet-647	71	5	50	50	NUM
admet-647	71	6	mg	mg	PROPN
admet-647	71	7	/	/	SYM
admet-647	71	8	kg	kg	PROPN
admet-647	71	9	;	;	PUNCT
admet-647	71	10	animals	animal	NOUN
admet-647	71	11	of	of	ADP
admet-647	71	12	group	group	NOUN
admet-647	71	13	8	8	NUM
admet-647	71	14	and	and	CCONJ
admet-647	71	15	9	9	NUM
admet-647	71	16	received	receive	VERB
admet-647	71	17	ast	ast	NOUN
admet-647	71	18	along	along	ADP
admet-647	71	19	with	with	ADP
admet-647	71	20	naringin	naringin	NOUN
admet-647	71	21	at	at	ADP
admet-647	71	22	50	50	NUM
admet-647	71	23	&	&	CCONJ
admet-647	71	24	15	15	NUM
admet-647	71	25	and	and	CCONJ
admet-647	71	26	50	50	NUM
admet-647	71	27	&	&	CCONJ
admet-647	71	28	30	30	NUM
admet-647	71	29	mg	mg	PROPN
admet-647	71	30	/	/	SYM
admet-647	71	31	kg	kg	PROPN
admet-647	71	32	,	,	PUNCT
admet-647	71	33	respectively	respectively	ADV
admet-647	71	34	.	.	PUNCT
admet-647	72	1	group	group	NOUN
admet-647	72	2	10	10	NUM
admet-647	72	3	animals	animal	NOUN
admet-647	72	4	served	serve	VERB
admet-647	72	5	as	as	ADP
admet-647	72	6	normal	normal	ADJ
admet-647	72	7	control	control	NOUN
admet-647	72	8	.	.	PUNCT
admet-647	73	1	ast	ast	PROPN
admet-647	73	2	was	be	AUX
admet-647	73	3	administered	administer	VERB
admet-647	73	4	30	30	NUM
admet-647	73	5	min	min	NOUN
admet-647	73	6	after	after	ADP
admet-647	73	7	oral	oral	ADJ
admet-647	73	8	dose	dose	NOUN
admet-647	73	9	of	of	ADP
admet-647	73	10	naringin	naringin	NOUN
admet-647	73	11	.	.	PUNCT
admet-647	74	1	blood	blood	NOUN
admet-647	74	2	samples	sample	NOUN
admet-647	74	3	(	(	PUNCT
admet-647	74	4	~200	~200	X
admet-647	74	5	µl	µl	NOUN
admet-647	74	6	)	)	PUNCT
admet-647	74	7	have	have	AUX
admet-647	74	8	been	be	AUX
admet-647	74	9	collected	collect	VERB
admet-647	74	10	through	through	ADP
admet-647	74	11	retro	retro	ADJ
admet-647	74	12	-	-	PUNCT
admet-647	74	13	orbital	orbital	ADJ
admet-647	74	14	puncture	puncture	NOUN
admet-647	74	15	under	under	ADP
admet-647	74	16	light	light	ADJ
admet-647	74	17	ether	ether	NOUN
admet-647	74	18	anesthesia	anesthesia	ADV
admet-647	74	19	just	just	ADV
admet-647	74	20	prior	prior	ADV
admet-647	74	21	to	to	ADP
admet-647	74	22	and	and	CCONJ
admet-647	74	23	at	at	ADP
admet-647	74	24	1	1	NUM
admet-647	74	25	st	st	PROPN
admet-647	74	26	,	,	PUNCT
admet-647	74	27	2	2	NUM
admet-647	74	28	nd	nd	NOUN
admet-647	74	29	and	and	CCONJ
admet-647	74	30	4	4	NUM
admet-647	74	31	th	th	NUM
admet-647	74	32	h	h	NOUN
admet-647	74	33	after	after	ADP
admet-647	74	34	ast	ast	PROPN
admet-647	74	35	administration	administration	PROPN
admet-647	74	36	in	in	ADP
admet-647	74	37	vials	vial	NOUN
admet-647	74	38	containing	contain	VERB
admet-647	74	39	disodium	disodium	NOUN
admet-647	74	40	edta	edta	NOUN
admet-647	74	41	as	as	ADP
admet-647	74	42	an	an	DET
admet-647	74	43	anticoagulant	anticoagulant	NOUN
admet-647	74	44	.	.	PUNCT
admet-647	75	1	plasma	plasma	NOUN
admet-647	75	2	was	be	AUX
admet-647	75	3	separated	separate	VERB
admet-647	75	4	and	and	CCONJ
admet-647	75	5	divided	divide	VERB
admet-647	75	6	into	into	ADP
admet-647	75	7	two	two	NUM
admet-647	75	8	aliquots	aliquot	NOUN
admet-647	75	9	.	.	PUNCT
admet-647	76	1	one	one	NUM
admet-647	76	2	aliquot	aliquot	NOUN
admet-647	76	3	was	be	AUX
admet-647	76	4	immediately	immediately	ADV
admet-647	76	5	used	use	VERB
admet-647	76	6	to	to	PART
admet-647	76	7	estimate	estimate	VERB
admet-647	76	8	total	total	ADJ
admet-647	76	9	cholesterol	cholesterol	NOUN
admet-647	76	10	and	and	CCONJ
admet-647	76	11	triglycerides	triglyceride	NOUN
admet-647	76	12	levels	level	NOUN
admet-647	76	13	using	use	VERB
admet-647	76	14	commercially	commercially	ADV
admet-647	76	15	available	available	ADJ
admet-647	76	16	kits	kit	NOUN
admet-647	76	17	at	at	ADP
admet-647	76	18	510	510	NUM
admet-647	76	19	nm	nm	NOUN
admet-647	76	20	.	.	PUNCT
admet-647	77	1	the	the	DET
admet-647	77	2	other	other	ADJ
admet-647	77	3	aliquot	aliquot	NOUN
admet-647	77	4	was	be	AUX
admet-647	77	5	stored	store	VERB
admet-647	77	6	at	at	ADP
admet-647	77	7	-20	-20	NUM
admet-647	77	8	±	±	NUM
admet-647	77	9	5	5	NUM
admet-647	77	10	°	°	ADP
admet-647	77	11	c	c	NOUN
admet-647	77	12	until	until	ADP
admet-647	77	13	analysis	analysis	NOUN
admet-647	77	14	for	for	ADP
admet-647	77	15	the	the	DET
admet-647	77	16	quantification	quantification	NOUN
admet-647	77	17	of	of	ADP
admet-647	77	18	ast	ast	NOUN
admet-647	77	19	.	.	PUNCT
admet-647	78	1	the	the	DET
admet-647	78	2	percentage	percentage	NOUN
admet-647	78	3	variation	variation	NOUN
admet-647	78	4	of	of	ADP
admet-647	78	5	total	total	ADJ
admet-647	78	6	cholesterol	cholesterol	NOUN
admet-647	78	7	and	and	CCONJ
admet-647	78	8	triglycerides	triglyceride	NOUN
admet-647	78	9	were	be	AUX
admet-647	78	10	calculated	calculate	VERB
admet-647	78	11	for	for	ADP
admet-647	78	12	each	each	DET
admet-647	78	13	group	group	NOUN
admet-647	78	14	using	use	VERB
admet-647	78	15	the	the	DET
admet-647	78	16	following	follow	VERB
admet-647	78	17	formula	formula	NOUN
admet-647	78	18	:	:	PUNCT
admet-647	78	19	%	%	NOUN
admet-647	78	20	variation	variation	NOUN
admet-647	78	21	in	in	ADP
admet-647	78	22	total	total	ADJ
admet-647	78	23	cholesterol	cholesterol	NOUN
admet-647	78	24	and	and	CCONJ
admet-647	78	25	triglycerides	triglyceride	NOUN
admet-647	78	26	=	=	SYM
admet-647	78	27	{	{	PUNCT
admet-647	78	28	ci	ci	PROPN
admet-647	78	29	-	-	PUNCT
admet-647	78	30	ct	ct	PROPN
admet-647	78	31	}	}	PUNCT
admet-647	78	32	×100/	×100/	NOUN
admet-647	78	33	ci	ci	NOUN
admet-647	78	34	where	where	SCONJ
admet-647	78	35	,	,	PUNCT
admet-647	78	36	ci	ci	PROPN
admet-647	78	37	is	be	AUX
admet-647	78	38	the	the	DET
admet-647	78	39	concentration	concentration	NOUN
admet-647	78	40	of	of	ADP
admet-647	78	41	disease	disease	NOUN
admet-647	78	42	control	control	NOUN
admet-647	78	43	and	and	CCONJ
admet-647	78	44	ct	ct	PRON
admet-647	78	45	is	be	AUX
admet-647	78	46	the	the	DET
admet-647	78	47	concentration	concentration	NOUN
admet-647	78	48	of	of	ADP
admet-647	78	49	ast	ast	NOUN
admet-647	78	50	at	at	ADP
admet-647	78	51	1st	1st	ADJ
admet-647	78	52	,	,	PUNCT
admet-647	78	53	2nd	2nd	ADJ
admet-647	78	54	and	and	CCONJ
admet-647	78	55	4th	4th	ADJ
admet-647	78	56	hour	hour	NOUN
admet-647	78	57	.	.	PUNCT
admet-647	79	1	quantitation	quantitation	NOUN
admet-647	79	2	of	of	ADP
admet-647	79	3	ast	ast	NOUN
admet-647	79	4	in	in	ADP
admet-647	79	5	rat	rat	NOUN
admet-647	79	6	plasma	plasma	NOUN
admet-647	79	7	samples	sample	NOUN
admet-647	79	8	by	by	ADP
admet-647	79	9	rp	rp	NOUN
admet-647	79	10	-	-	PUNCT
admet-647	79	11	hplc	hplc	NOUN
admet-647	79	12	quantitation	quantitation	NOUN
admet-647	79	13	of	of	ADP
admet-647	79	14	ast	ast	NOUN
admet-647	79	15	in	in	ADP
admet-647	79	16	rat	rat	NOUN
admet-647	79	17	plasma	plasma	NOUN
admet-647	79	18	samples	sample	NOUN
admet-647	79	19	were	be	AUX
admet-647	79	20	carried	carry	VERB
admet-647	79	21	out	out	ADP
admet-647	79	22	by	by	ADP
admet-647	79	23	rp	rp	NOUN
admet-647	79	24	-	-	PUNCT
admet-647	79	25	hplc	hplc	NOUN
admet-647	79	26	using	use	VERB
admet-647	79	27	earlier	early	ADV
admet-647	79	28	reported	report	VERB
admet-647	79	29	method	method	NOUN
admet-647	79	30	with	with	ADP
admet-647	79	31	minor	minor	ADJ
admet-647	79	32	modifications	modification	NOUN
admet-647	79	33	[	[	X
admet-647	79	34	26	26	NUM
admet-647	79	35	]	]	PUNCT
admet-647	79	36	.	.	PUNCT
admet-647	80	1	hplc	hplc	NOUN
admet-647	80	2	(	(	PUNCT
admet-647	80	3	shimadzu	shimadzu	PROPN
admet-647	80	4	,	,	PUNCT
admet-647	80	5	japan	japan	PROPN
admet-647	80	6	)	)	PUNCT
admet-647	80	7	is	be	AUX
admet-647	80	8	equipped	equip	VERB
admet-647	80	9	with	with	ADP
admet-647	80	10	lc-20	lc-20	NOUN
admet-647	80	11	at	at	ADP
admet-647	80	12	vp	vp	PROPN
admet-647	80	13	system	system	NOUN
admet-647	80	14	controller	controller	NOUN
admet-647	80	15	,	,	PUNCT
admet-647	80	16	lc20	lc20	PROPN
admet-647	80	17	at	at	ADP
admet-647	80	18	pump	pump	NOUN
admet-647	80	19	,	,	PUNCT
admet-647	80	20	spd-20a	spd-20a	NUM
admet-647	80	21	uv	uv	NOUN
admet-647	80	22	detector	detector	NOUN
admet-647	80	23	and	and	CCONJ
admet-647	80	24	a	a	DET
admet-647	80	25	phenomenex	phenomenex	ADJ
admet-647	80	26	-	-	PUNCT
admet-647	80	27	c18	c18	NOUN
admet-647	80	28	column	column	NOUN
admet-647	80	29	(	(	PUNCT
admet-647	80	30	250	250	NUM
admet-647	80	31	×	×	NOUN
admet-647	80	32	2.6	2.6	NUM
admet-647	80	33	mm	mm	NOUN
admet-647	80	34	,	,	PUNCT
admet-647	80	35	5	5	NUM
admet-647	80	36	µm	µm	NOUN
admet-647	80	37	)	)	PUNCT
admet-647	80	38	.	.	PUNCT
admet-647	81	1	the	the	DET
admet-647	81	2	data	datum	NOUN
admet-647	81	3	were	be	AUX
admet-647	81	4	acquired	acquire	VERB
admet-647	81	5	and	and	CCONJ
admet-647	81	6	processed	process	VERB
admet-647	81	7	using	use	VERB
admet-647	81	8	lc	lc	PROPN
admet-647	81	9	solutions	solution	NOUN
admet-647	81	10	(	(	PUNCT
admet-647	81	11	version	version	NOUN
admet-647	81	12	3.1	3.1	NUM
admet-647	81	13	)	)	PUNCT
admet-647	81	14	software	software	NOUN
admet-647	81	15	.	.	PUNCT
admet-647	82	1	to	to	ADP
admet-647	82	2	an	an	DET
admet-647	82	3	aliquot	aliquot	NOUN
admet-647	82	4	of	of	ADP
admet-647	82	5	100	100	NUM
admet-647	82	6	µl	µl	NOUN
admet-647	82	7	of	of	ADP
admet-647	82	8	rat	rat	NOUN
admet-647	82	9	plasma	plasma	NOUN
admet-647	82	10	,	,	PUNCT
admet-647	82	11	200	200	NUM
admet-647	82	12	µl	µl	NOUN
admet-647	82	13	of	of	ADP
admet-647	82	14	methanol	methanol	NOUN
admet-647	82	15	was	be	AUX
admet-647	82	16	added	add	VERB
admet-647	82	17	.	.	PUNCT
admet-647	83	1	the	the	DET
admet-647	83	2	mixture	mixture	NOUN
admet-647	83	3	was	be	AUX
admet-647	83	4	vortexed	vortexe	VERB
admet-647	83	5	for	for	ADP
admet-647	83	6	20	20	NUM
admet-647	83	7	min	min	NOUN
admet-647	83	8	followed	follow	VERB
admet-647	83	9	by	by	ADP
admet-647	83	10	centrifugation	centrifugation	NOUN
admet-647	83	11	at	at	ADP
admet-647	83	12	3000	3000	NUM
admet-647	83	13	rpm	rpm	NOUN
admet-647	83	14	for	for	ADP
admet-647	83	15	10	10	NUM
admet-647	83	16	min	min	NOUN
admet-647	83	17	at	at	ADP
admet-647	83	18	4	4	NUM
admet-647	83	19	°	°	NOUN
admet-647	83	20	c	c	NOUN
admet-647	83	21	.	.	PUNCT
admet-647	84	1	the	the	DET
admet-647	84	2	organic	organic	ADJ
admet-647	84	3	layer	layer	NOUN
admet-647	84	4	was	be	AUX
admet-647	84	5	separated	separate	VERB
admet-647	84	6	and	and	CCONJ
admet-647	84	7	filtered	filter	VERB
admet-647	84	8	through	through	ADP
admet-647	84	9	a	a	DET
admet-647	84	10	0.2	0.2	NUM
admet-647	84	11	µm	µm	NOUN
admet-647	84	12	cellulose	cellulose	NOUN
admet-647	84	13	acetate	acetate	NOUN
admet-647	84	14	filter	filter	NOUN
admet-647	84	15	.	.	PUNCT
admet-647	85	1	the	the	DET
admet-647	85	2	chromatographic	chromatographic	ADJ
admet-647	85	3	resolution	resolution	NOUN
admet-647	85	4	of	of	ADP
admet-647	85	5	ast	ast	NOUN
admet-647	85	6	was	be	AUX
admet-647	85	7	achieved	achieve	VERB
admet-647	85	8	by	by	ADP
admet-647	85	9	using	use	VERB
admet-647	85	10	the	the	DET
admet-647	85	11	admet	admet	PROPN
admet-647	85	12	&	&	CCONJ
admet-647	85	13	dmpk	dmpk	PROPN
admet-647	85	14	7(3	7(3	NUM
admet-647	85	15	)	)	PUNCT
admet-647	85	16	(	(	PUNCT
admet-647	85	17	2019	2019	NUM
admet-647	85	18	)	)	PUNCT
admet-647	85	19	174	174	NUM
admet-647	85	20	-	-	SYM
admet-647	85	21	182	182	NUM
admet-647	85	22	effect	effect	NOUN
admet-647	85	23	of	of	ADP
admet-647	85	24	naringin	naringin	NOUN
admet-647	85	25	on	on	ADP
admet-647	85	26	atorvastatin	atorvastatin	PROPN
admet-647	85	27	doi	doi	PROPN
admet-647	85	28	:	:	PUNCT
admet-647	85	29	10.5599	10.5599	NUM
admet-647	85	30	/	/	SYM
admet-647	85	31	admet.647	admet.647	ADJ
admet-647	85	32	177	177	NUM
admet-647	85	33	isocratic	isocratic	ADJ
admet-647	85	34	mobile	mobile	ADJ
admet-647	85	35	phase	phase	NOUN
admet-647	85	36	consists	consist	VERB
admet-647	85	37	of	of	ADP
admet-647	85	38	acetonitrile	acetonitrile	NOUN
admet-647	85	39	:	:	PUNCT
admet-647	85	40	0.05	0.05	NUM
admet-647	85	41	m	m	NUM
admet-647	85	42	sodium	sodium	NOUN
admet-647	85	43	phosphate	phosphate	NOUN
admet-647	85	44	buffer	buffer	NOUN
admet-647	85	45	(	(	PUNCT
admet-647	85	46	ph	ph	NOUN
admet-647	85	47	4	4	NUM
admet-647	85	48	;	;	PUNCT
admet-647	85	49	65:35	65:35	NUM
admet-647	85	50	,	,	PUNCT
admet-647	85	51	v	v	NOUN
admet-647	85	52	/	/	SYM
admet-647	85	53	v	v	NOUN
admet-647	85	54	)	)	PUNCT
admet-647	85	55	delivered	deliver	VERB
admet-647	85	56	at	at	ADP
admet-647	85	57	a	a	DET
admet-647	85	58	flow	flow	NOUN
admet-647	85	59	rate	rate	NOUN
admet-647	85	60	of	of	ADP
admet-647	85	61	1.0	1.0	NUM
admet-647	85	62	ml	ml	NOUN
admet-647	85	63	/	/	SYM
admet-647	85	64	min	min	NOUN
admet-647	85	65	and	and	CCONJ
admet-647	85	66	the	the	DET
admet-647	85	67	eluent	eluent	NOUN
admet-647	85	68	was	be	AUX
admet-647	85	69	monitored	monitor	VERB
admet-647	85	70	by	by	ADP
admet-647	85	71	uv	uv	NOUN
admet-647	85	72	detector	detector	NOUN
admet-647	85	73	set	set	VERB
admet-647	85	74	at	at	ADP
admet-647	85	75	236	236	NUM
admet-647	85	76	nm	nm	NOUN
admet-647	85	77	.	.	PUNCT
admet-647	86	1	an	an	DET
admet-647	86	2	aliquot	aliquot	NOUN
admet-647	86	3	of	of	ADP
admet-647	86	4	20	20	NUM
admet-647	86	5	µl	µl	NOUN
admet-647	86	6	of	of	ADP
admet-647	86	7	organic	organic	ADJ
admet-647	86	8	layer	layer	NOUN
admet-647	86	9	was	be	AUX
admet-647	86	10	injected	inject	VERB
admet-647	86	11	onto	onto	ADP
admet-647	86	12	column	column	NOUN
admet-647	86	13	and	and	CCONJ
admet-647	86	14	corresponding	correspond	VERB
admet-647	86	15	peak	peak	NOUN
admet-647	86	16	areas	area	NOUN
admet-647	86	17	were	be	AUX
admet-647	86	18	noted	note	VERB
admet-647	86	19	.	.	PUNCT
admet-647	87	1	the	the	DET
admet-647	87	2	calibration	calibration	NOUN
admet-647	87	3	curve	curve	NOUN
admet-647	87	4	(	(	PUNCT
admet-647	87	5	y=	y=	PRON
admet-647	87	6	86.89x	86.89x	NUM
admet-647	87	7	+	+	CCONJ
admet-647	87	8	3832	3832	NUM
admet-647	87	9	)	)	PUNCT
admet-647	87	10	was	be	AUX
admet-647	87	11	found	find	VERB
admet-647	87	12	to	to	PART
admet-647	87	13	be	be	AUX
admet-647	87	14	linear	linear	ADJ
admet-647	87	15	from	from	ADP
admet-647	87	16	100	100	NUM
admet-647	87	17	to	to	ADP
admet-647	87	18	2000	2000	NUM
admet-647	87	19	ng	ng	PROPN
admet-647	87	20	/	/	SYM
admet-647	87	21	ml	ml	PROPN
admet-647	88	1	(	(	PUNCT
admet-647	88	2	r	r	NOUN
admet-647	88	3	2	2	NUM
admet-647	88	4	=	=	NOUN
admet-647	88	5	0.9987	0.9987	NUM
admet-647	88	6	)	)	PUNCT
admet-647	88	7	.	.	PUNCT
admet-647	89	1	statistical	statistical	ADJ
admet-647	89	2	analysis	analysis	NOUN
admet-647	89	3	all	all	DET
admet-647	89	4	the	the	DET
admet-647	89	5	values	value	NOUN
admet-647	89	6	were	be	AUX
admet-647	89	7	expressed	express	VERB
admet-647	89	8	as	as	ADP
admet-647	89	9	a	a	DET
admet-647	89	10	mean	mean	PROPN
admet-647	89	11	±	±	NUM
admet-647	89	12	sem	sem	NOUN
admet-647	89	13	.	.	PUNCT
admet-647	90	1	results	result	NOUN
admet-647	90	2	were	be	AUX
admet-647	90	3	analyzed	analyze	VERB
admet-647	90	4	statistically	statistically	ADV
admet-647	90	5	using	use	VERB
admet-647	90	6	one	one	NUM
admet-647	90	7	-	-	PUNCT
admet-647	90	8	way	way	NOUN
admet-647	90	9	analysis	analysis	NOUN
admet-647	90	10	of	of	ADP
admet-647	90	11	variance	variance	NOUN
admet-647	90	12	(	(	PUNCT
admet-647	90	13	anova	anova	PROPN
admet-647	90	14	)	)	PUNCT
admet-647	90	15	following	follow	VERB
admet-647	90	16	dunnett	dunnett	PROPN
admet-647	90	17	test	test	NOUN
admet-647	90	18	.	.	PUNCT
admet-647	91	1	values	value	NOUN
admet-647	91	2	of	of	ADP
admet-647	91	3	p<0.05	p<0.05	NOUN
admet-647	91	4	were	be	AUX
admet-647	91	5	considered	consider	VERB
admet-647	91	6	statistically	statistically	ADV
admet-647	91	7	significant	significant	ADJ
admet-647	91	8	.	.	PUNCT
admet-647	92	1	results	result	NOUN
admet-647	92	2	effect	effect	NOUN
admet-647	92	3	of	of	ADP
admet-647	92	4	naringin	naringin	NOUN
admet-647	92	5	on	on	ADP
admet-647	92	6	ast	ast	NOUN
admet-647	92	7	in	in	ADP
admet-647	92	8	tyloxapol	tyloxapol	NOUN
admet-647	92	9	induced	induce	VERB
admet-647	92	10	hyperlipidemia	hyperlipidemia	NOUN
admet-647	92	11	effect	effect	NOUN
admet-647	92	12	on	on	ADP
admet-647	92	13	total	total	ADJ
admet-647	92	14	cholesterol	cholesterol	PROPN
admet-647	92	15	administration	administration	NOUN
admet-647	92	16	of	of	ADP
admet-647	92	17	tyloxapol	tyloxapol	NOUN
admet-647	92	18	has	have	AUX
admet-647	92	19	significantly	significantly	ADV
admet-647	92	20	increased	increase	VERB
admet-647	92	21	the	the	DET
admet-647	92	22	total	total	ADJ
admet-647	92	23	cholesterol	cholesterol	NOUN
admet-647	92	24	after	after	SCONJ
admet-647	92	25	30	30	NUM
admet-647	92	26	h.	h.	NOUN
admet-647	92	27	it	it	PRON
admet-647	92	28	was	be	AUX
admet-647	92	29	observed	observe	VERB
admet-647	92	30	that	that	SCONJ
admet-647	92	31	cholesterol	cholesterol	NOUN
admet-647	92	32	levels	level	NOUN
admet-647	92	33	were	be	AUX
admet-647	92	34	raised	raise	VERB
admet-647	92	35	by	by	ADP
admet-647	92	36	2.5	2.5	NUM
admet-647	92	37	folds	fold	NOUN
admet-647	92	38	.	.	PUNCT
admet-647	93	1	the	the	DET
admet-647	93	2	administration	administration	NOUN
admet-647	93	3	of	of	ADP
admet-647	93	4	ast	ast	NOUN
admet-647	93	5	alone	alone	ADV
admet-647	93	6	at	at	ADP
admet-647	93	7	two	two	NUM
admet-647	93	8	test	test	NOUN
admet-647	93	9	dose	dose	NOUN
admet-647	93	10	levels	level	NOUN
admet-647	93	11	caused	cause	VERB
admet-647	93	12	a	a	DET
admet-647	93	13	statistical	statistical	ADJ
admet-647	93	14	significant	significant	ADJ
admet-647	93	15	(	(	PUNCT
admet-647	93	16	p<0.001	p<0.001	PROPN
admet-647	93	17	)	)	PUNCT
admet-647	93	18	dose	dose	VERB
admet-647	93	19	dependent	dependent	ADJ
admet-647	93	20	decrease	decrease	NOUN
admet-647	93	21	in	in	ADP
admet-647	93	22	total	total	ADJ
admet-647	93	23	cholesterol	cholesterol	NOUN
admet-647	93	24	levels	level	NOUN
admet-647	93	25	with	with	ADP
admet-647	93	26	maximum	maximum	ADJ
admet-647	93	27	reduction	reduction	NOUN
admet-647	93	28	observed	observe	VERB
admet-647	93	29	at	at	ADP
admet-647	93	30	2	2	NUM
admet-647	93	31	nd	nd	NOUN
admet-647	93	32	h	h	NOUN
admet-647	93	33	after	after	ADP
admet-647	93	34	drug	drug	NOUN
admet-647	93	35	administration	administration	PROPN
admet-647	93	36	(	(	PUNCT
admet-647	93	37	table	table	NOUN
admet-647	93	38	1	1	NUM
admet-647	93	39	)	)	PUNCT
admet-647	93	40	.	.	PUNCT
admet-647	94	1	among	among	ADP
admet-647	94	2	the	the	DET
admet-647	94	3	two	two	NUM
admet-647	94	4	test	test	NOUN
admet-647	94	5	dose	dose	NOUN
admet-647	94	6	levels	level	NOUN
admet-647	94	7	,	,	PUNCT
admet-647	94	8	ast	ast	VERB
admet-647	94	9	with	with	ADP
admet-647	94	10	50	50	NUM
admet-647	94	11	mg	mg	NOUN
admet-647	94	12	/	/	SYM
admet-647	94	13	kg	kg	PROPN
admet-647	94	14	has	have	AUX
admet-647	94	15	produced	produce	VERB
admet-647	94	16	maximum	maximum	ADJ
admet-647	94	17	protection	protection	NOUN
admet-647	94	18	,	,	PUNCT
admet-647	94	19	with	with	ADP
admet-647	94	20	%	%	NOUN
admet-647	94	21	reduction	reduction	NOUN
admet-647	94	22	of	of	ADP
admet-647	94	23	total	total	ADJ
admet-647	94	24	cholesterol	cholesterol	NOUN
admet-647	94	25	was	be	AUX
admet-647	94	26	19.09	19.09	NUM
admet-647	94	27	,	,	PUNCT
admet-647	94	28	whereas	whereas	SCONJ
admet-647	94	29	a	a	DET
admet-647	94	30	percentage	percentage	NOUN
admet-647	94	31	reduction	reduction	NOUN
admet-647	94	32	of	of	ADP
admet-647	94	33	total	total	ADJ
admet-647	94	34	cholesterol	cholesterol	NOUN
admet-647	94	35	in	in	ADP
admet-647	94	36	animals	animal	NOUN
admet-647	94	37	received	receive	VERB
admet-647	94	38	25	25	NUM
admet-647	94	39	mg	mg	NOUN
admet-647	94	40	/	/	SYM
admet-647	94	41	kg	kg	PROPN
admet-647	94	42	was	be	AUX
admet-647	94	43	12.70	12.70	NUM
admet-647	94	44	(	(	PUNCT
admet-647	94	45	table	table	NOUN
admet-647	94	46	1	1	NUM
admet-647	94	47	)	)	PUNCT
admet-647	94	48	.	.	PUNCT
admet-647	95	1	the	the	DET
admet-647	95	2	effect	effect	NOUN
admet-647	95	3	of	of	ADP
admet-647	95	4	naringin	naringin	NOUN
admet-647	95	5	alone	alone	ADV
admet-647	95	6	on	on	ADP
admet-647	95	7	hyperlipidemia	hyperlipidemia	NOUN
admet-647	95	8	was	be	AUX
admet-647	95	9	not	not	PART
admet-647	95	10	significant	significant	ADJ
admet-647	95	11	.	.	PUNCT
admet-647	96	1	the	the	DET
admet-647	96	2	percent	percent	NOUN
admet-647	96	3	reduction	reduction	NOUN
admet-647	96	4	in	in	ADP
admet-647	96	5	total	total	ADJ
admet-647	96	6	cholesterol	cholesterol	NOUN
admet-647	96	7	was	be	AUX
admet-647	96	8	1.89	1.89	NUM
admet-647	96	9	and	and	CCONJ
admet-647	96	10	4.93	4.93	NUM
admet-647	96	11	with	with	ADP
admet-647	96	12	15	15	NUM
admet-647	96	13	and	and	CCONJ
admet-647	96	14	30	30	NUM
admet-647	96	15	mg	mg	NUM
admet-647	96	16	/	/	SYM
admet-647	96	17	kg	kg	PROPN
admet-647	96	18	,	,	PUNCT
admet-647	96	19	respectively	respectively	ADV
admet-647	96	20	at	at	ADP
admet-647	96	21	2	2	NUM
admet-647	96	22	h	h	PROPN
admet-647	96	23	post	post	PROPN
admet-647	96	24	administration	administration	NOUN
admet-647	96	25	of	of	ADP
admet-647	96	26	naringin	naringin	PROPN
admet-647	96	27	(	(	PUNCT
admet-647	96	28	table	table	NOUN
admet-647	96	29	1	1	NUM
admet-647	96	30	)	)	PUNCT
admet-647	96	31	.	.	PUNCT
admet-647	97	1	the	the	DET
admet-647	97	2	coadministration	coadministration	NOUN
admet-647	97	3	of	of	ADP
admet-647	97	4	naringin	naringin	NOUN
admet-647	97	5	(	(	PUNCT
admet-647	97	6	15	15	NUM
admet-647	97	7	and	and	CCONJ
admet-647	97	8	30	30	NUM
admet-647	97	9	mg	mg	NUM
admet-647	97	10	/	/	SYM
admet-647	97	11	kg	kg	NOUN
admet-647	97	12	)	)	PUNCT
admet-647	97	13	with	with	ADP
admet-647	97	14	ast	ast	NOUN
admet-647	97	15	at	at	ADP
admet-647	97	16	two	two	NUM
admet-647	97	17	test	test	NOUN
admet-647	97	18	dose	dose	NOUN
admet-647	97	19	levels	level	NOUN
admet-647	97	20	(	(	PUNCT
admet-647	97	21	25	25	NUM
admet-647	97	22	and	and	CCONJ
admet-647	97	23	50	50	NUM
admet-647	97	24	mg	mg	NUM
admet-647	97	25	/	/	SYM
admet-647	97	26	kg	kg	NOUN
admet-647	97	27	)	)	PUNCT
admet-647	97	28	has	have	AUX
admet-647	97	29	produced	produce	VERB
admet-647	97	30	significant	significant	ADJ
admet-647	97	31	reduction	reduction	NOUN
admet-647	97	32	in	in	ADP
admet-647	97	33	total	total	ADJ
admet-647	97	34	cholesterol	cholesterol	NOUN
admet-647	97	35	levels	level	NOUN
admet-647	97	36	and	and	CCONJ
admet-647	97	37	is	be	AUX
admet-647	97	38	quantitatively	quantitatively	ADV
admet-647	97	39	high	high	ADJ
admet-647	97	40	at	at	ADP
admet-647	97	41	2nd	2nd	ADJ
admet-647	97	42	and	and	CCONJ
admet-647	97	43	4th	4th	ADJ
admet-647	97	44	h	h	NOUN
admet-647	97	45	after	after	ADP
admet-647	97	46	treatment	treatment	NOUN
admet-647	97	47	when	when	SCONJ
admet-647	97	48	compared	compare	VERB
admet-647	97	49	to	to	ADP
admet-647	97	50	ast	ast	VERB
admet-647	97	51	alone	alone	ADJ
admet-647	97	52	treated	treat	VERB
admet-647	97	53	animals	animal	NOUN
admet-647	97	54	(	(	PUNCT
admet-647	97	55	table	table	NOUN
admet-647	97	56	1	1	NUM
admet-647	97	57	)	)	PUNCT
admet-647	97	58	.	.	PUNCT
admet-647	98	1	however	however	ADV
admet-647	98	2	,	,	PUNCT
admet-647	98	3	the	the	DET
admet-647	98	4	maximum	maximum	ADJ
admet-647	98	5	percent	percent	NOUN
admet-647	98	6	reduction	reduction	NOUN
admet-647	98	7	was	be	AUX
admet-647	98	8	noted	note	VERB
admet-647	98	9	at	at	ADP
admet-647	98	10	2nd	2nd	PROPN
admet-647	98	11	h.	h.	PROPN
admet-647	98	12	the	the	DET
admet-647	98	13	reduction	reduction	NOUN
admet-647	98	14	in	in	ADP
admet-647	98	15	total	total	ADJ
admet-647	98	16	cholesterol	cholesterol	NOUN
admet-647	98	17	with	with	ADP
admet-647	98	18	ast	ast	NOUN
admet-647	98	19	(	(	PUNCT
admet-647	98	20	50	50	NUM
admet-647	98	21	mg	mg	PROPN
admet-647	98	22	/	/	SYM
admet-647	98	23	kg	kg	NOUN
admet-647	98	24	)	)	PUNCT
admet-647	98	25	when	when	SCONJ
admet-647	98	26	co	co	VERB
admet-647	98	27	-	-	VERB
admet-647	98	28	administered	administer	VERB
admet-647	98	29	with	with	ADP
admet-647	98	30	naringin	naringin	NOUN
admet-647	98	31	(	(	PUNCT
admet-647	98	32	15	15	NUM
admet-647	98	33	and	and	CCONJ
admet-647	98	34	30	30	NUM
admet-647	98	35	mg	mg	NUM
admet-647	98	36	/	/	SYM
admet-647	98	37	kg	kg	PROPN
admet-647	98	38	)	)	PUNCT
admet-647	98	39	was	be	AUX
admet-647	98	40	33.00	33.00	NUM
admet-647	98	41	and	and	CCONJ
admet-647	98	42	41.46	41.46	NUM
admet-647	98	43	%	%	NOUN
admet-647	98	44	,	,	PUNCT
admet-647	98	45	respectively	respectively	ADV
admet-647	98	46	where	where	SCONJ
admet-647	98	47	the	the	DET
admet-647	98	48	total	total	ADJ
admet-647	98	49	cholesterol	cholesterol	NOUN
admet-647	98	50	is	be	AUX
admet-647	98	51	reduced	reduce	VERB
admet-647	98	52	by	by	ADP
admet-647	98	53	19.09	19.09	NUM
admet-647	98	54	%	%	NOUN
admet-647	98	55	in	in	ADP
admet-647	98	56	animals	animal	NOUN
admet-647	98	57	received	receive	VERB
admet-647	98	58	50	50	NUM
admet-647	98	59	mg	mg	PROPN
admet-647	98	60	/	/	SYM
admet-647	98	61	kg	kg	PROPN
admet-647	98	62	ast	ast	ADV
admet-647	98	63	alone	alone	ADV
admet-647	98	64	.	.	PUNCT
admet-647	99	1	similarly	similarly	ADV
admet-647	99	2	,	,	PUNCT
admet-647	99	3	the	the	DET
admet-647	99	4	reduction	reduction	NOUN
admet-647	99	5	in	in	ADP
admet-647	99	6	total	total	ADJ
admet-647	99	7	cholesterol	cholesterol	NOUN
admet-647	99	8	was	be	AUX
admet-647	99	9	24.02	24.02	NUM
admet-647	99	10	and	and	CCONJ
admet-647	99	11	31.30	31.30	NUM
admet-647	99	12	%	%	NOUN
admet-647	99	13	in	in	ADP
admet-647	99	14	animals	animal	NOUN
admet-647	99	15	received	receive	VERB
admet-647	99	16	the	the	DET
admet-647	99	17	ast	ast	NOUN
admet-647	99	18	(	(	PUNCT
admet-647	99	19	25	25	NUM
admet-647	99	20	mg	mg	PROPN
admet-647	99	21	/	/	SYM
admet-647	99	22	kg	kg	NOUN
admet-647	99	23	)	)	PUNCT
admet-647	99	24	along	along	ADP
admet-647	99	25	with	with	ADP
admet-647	99	26	naringin	naringin	NOUN
admet-647	99	27	(	(	PUNCT
admet-647	99	28	15	15	NUM
admet-647	99	29	and	and	CCONJ
admet-647	99	30	30	30	NUM
admet-647	99	31	mg	mg	NUM
admet-647	99	32	/	/	SYM
admet-647	99	33	kg	kg	PROPN
admet-647	99	34	)	)	PUNCT
admet-647	99	35	.	.	PUNCT
admet-647	100	1	the	the	DET
admet-647	100	2	reduction	reduction	NOUN
admet-647	100	3	in	in	ADP
admet-647	100	4	total	total	ADJ
admet-647	100	5	cholesterol	cholesterol	NOUN
admet-647	100	6	is	be	AUX
admet-647	100	7	12.70	12.70	NUM
admet-647	100	8	%	%	NOUN
admet-647	100	9	when	when	SCONJ
admet-647	100	10	treated	treat	VERB
admet-647	100	11	with	with	ADP
admet-647	100	12	ast	ast	NOUN
admet-647	100	13	(	(	PUNCT
admet-647	100	14	25	25	NUM
admet-647	100	15	mg	mg	PROPN
admet-647	100	16	/	/	SYM
admet-647	100	17	kg	kg	NOUN
admet-647	100	18	)	)	PUNCT
admet-647	100	19	alone	alone	ADV
admet-647	100	20	(	(	PUNCT
admet-647	100	21	table	table	NOUN
admet-647	100	22	1	1	NUM
admet-647	100	23	)	)	PUNCT
admet-647	100	24	.	.	PUNCT
admet-647	101	1	effect	effect	NOUN
admet-647	101	2	on	on	ADP
admet-647	101	3	triglycerides	triglyceride	NOUN
admet-647	101	4	administration	administration	NOUN
admet-647	101	5	of	of	ADP
admet-647	101	6	tyloxapol	tyloxapol	NOUN
admet-647	101	7	has	have	AUX
admet-647	101	8	increased	increase	VERB
admet-647	101	9	the	the	DET
admet-647	101	10	triglycerides	triglyceride	NOUN
admet-647	101	11	levels	level	NOUN
admet-647	101	12	to	to	ADP
admet-647	101	13	9	9	NUM
admet-647	101	14	to	to	ADP
admet-647	101	15	9.5	9.5	NUM
admet-647	101	16	-	-	PUNCT
admet-647	101	17	folds	fold	NOUN
admet-647	101	18	from	from	ADP
admet-647	101	19	normal	normal	ADJ
admet-647	101	20	levels	level	NOUN
admet-647	101	21	.	.	PUNCT
admet-647	102	1	the	the	DET
admet-647	102	2	increased	increase	VERB
admet-647	102	3	triglycerides	triglyceride	NOUN
admet-647	102	4	levels	level	NOUN
admet-647	102	5	were	be	AUX
admet-647	102	6	in	in	ADP
admet-647	102	7	the	the	DET
admet-647	102	8	range	range	NOUN
admet-647	102	9	of	of	ADP
admet-647	102	10	650	650	NUM
admet-647	102	11	to	to	PART
admet-647	102	12	695	695	NUM
admet-647	102	13	mg	mg	NUM
admet-647	102	14	/	/	SYM
admet-647	102	15	dl	dl	PROPN
admet-647	102	16	,	,	PUNCT
admet-647	102	17	when	when	SCONJ
admet-647	102	18	compared	compare	VERB
admet-647	102	19	to	to	ADP
admet-647	102	20	initial	initial	ADJ
admet-647	102	21	levels	level	NOUN
admet-647	102	22	in	in	ADP
admet-647	102	23	the	the	DET
admet-647	102	24	range	range	NOUN
admet-647	102	25	of	of	ADP
admet-647	102	26	60	60	NUM
admet-647	102	27	-	-	SYM
admet-647	102	28	80	80	NUM
admet-647	102	29	mg	mg	PROPN
admet-647	102	30	/	/	SYM
admet-647	102	31	dl	dl	PROPN
admet-647	102	32	.	.	PUNCT
admet-647	102	33	there	there	PRON
admet-647	102	34	is	be	VERB
admet-647	102	35	no	no	DET
admet-647	102	36	significant	significant	ADJ
admet-647	102	37	fall	fall	NOUN
admet-647	102	38	in	in	ADP
admet-647	102	39	triglyceride	triglyceride	ADJ
admet-647	102	40	levels	level	NOUN
admet-647	102	41	in	in	ADP
admet-647	102	42	control	control	NOUN
admet-647	102	43	rats	rat	NOUN
admet-647	102	44	during	during	ADP
admet-647	102	45	the	the	DET
admet-647	102	46	course	course	NOUN
admet-647	102	47	of	of	ADP
admet-647	102	48	experiment	experiment	NOUN
admet-647	102	49	.	.	PUNCT
admet-647	103	1	the	the	DET
admet-647	103	2	effect	effect	NOUN
admet-647	103	3	of	of	ADP
admet-647	103	4	naringin	naringin	NOUN
admet-647	103	5	alone	alone	ADV
admet-647	103	6	on	on	ADP
admet-647	103	7	triglyceride	triglyceride	ADJ
admet-647	103	8	levels	level	NOUN
admet-647	103	9	was	be	AUX
admet-647	103	10	not	not	PART
admet-647	103	11	significant	significant	ADJ
admet-647	103	12	and	and	CCONJ
admet-647	103	13	the	the	DET
admet-647	103	14	fall	fall	NOUN
admet-647	103	15	in	in	ADP
admet-647	103	16	the	the	DET
admet-647	103	17	triglyceride	triglyceride	ADJ
admet-647	103	18	levels	level	NOUN
admet-647	103	19	in	in	ADP
admet-647	103	20	naringin	naringin	NOUN
admet-647	103	21	treated	treat	VERB
admet-647	103	22	rats	rat	NOUN
admet-647	103	23	is	be	AUX
admet-647	103	24	2.04	2.04	NUM
admet-647	103	25	and	and	CCONJ
admet-647	103	26	4.08	4.08	NUM
admet-647	103	27	%	%	NOUN
admet-647	103	28	with	with	ADP
admet-647	103	29	15	15	NUM
admet-647	103	30	and	and	CCONJ
admet-647	103	31	30	30	NUM
admet-647	103	32	mg	mg	NUM
admet-647	103	33	/	/	SYM
admet-647	103	34	kg	kg	PROPN
admet-647	103	35	doses	dose	NOUN
admet-647	103	36	,	,	PUNCT
admet-647	103	37	respectively	respectively	ADV
admet-647	103	38	,	,	PUNCT
admet-647	103	39	when	when	SCONJ
admet-647	103	40	compared	compare	VERB
admet-647	103	41	to	to	PART
admet-647	103	42	control	control	VERB
admet-647	103	43	rats	rat	NOUN
admet-647	103	44	(	(	PUNCT
admet-647	103	45	table	table	NOUN
admet-647	103	46	2	2	NUM
admet-647	103	47	)	)	PUNCT
admet-647	103	48	.	.	PUNCT
admet-647	104	1	the	the	DET
admet-647	104	2	administration	administration	NOUN
admet-647	104	3	of	of	ADP
admet-647	104	4	ast	ast	PROPN
admet-647	104	5	alone	alone	ADV
admet-647	104	6	has	have	AUX
admet-647	104	7	produced	produce	VERB
admet-647	104	8	a	a	DET
admet-647	104	9	significant	significant	ADJ
admet-647	104	10	dose	dose	NOUN
admet-647	104	11	dependent	dependent	ADJ
admet-647	104	12	fall	fall	NOUN
admet-647	104	13	in	in	ADP
admet-647	104	14	triglyceride	triglyceride	ADJ
admet-647	104	15	levels	level	NOUN
admet-647	104	16	.	.	PUNCT
admet-647	105	1	the	the	DET
admet-647	105	2	maximum	maximum	ADJ
admet-647	105	3	reduction	reduction	NOUN
admet-647	105	4	was	be	AUX
admet-647	105	5	observed	observe	VERB
admet-647	105	6	at	at	ADP
admet-647	105	7	2nd	2nd	ADJ
admet-647	105	8	h	h	NOUN
admet-647	105	9	of	of	ADP
admet-647	105	10	the	the	DET
admet-647	105	11	experiment	experiment	NOUN
admet-647	105	12	with	with	ADP
admet-647	105	13	percentage	percentage	NOUN
admet-647	105	14	reduction	reduction	NOUN
admet-647	105	15	of	of	ADP
admet-647	105	16	13.40	13.40	NUM
admet-647	105	17	and	and	CCONJ
admet-647	105	18	17.15	17.15	NUM
admet-647	105	19	at	at	ADP
admet-647	105	20	dose	dose	NOUN
admet-647	105	21	levels	level	NOUN
admet-647	105	22	of	of	ADP
admet-647	105	23	25	25	NUM
admet-647	105	24	and	and	CCONJ
admet-647	105	25	50	50	NUM
admet-647	105	26	mg	mg	NUM
admet-647	105	27	/	/	SYM
admet-647	105	28	kg	kg	PROPN
admet-647	105	29	,	,	PUNCT
admet-647	105	30	respectively	respectively	ADV
admet-647	105	31	(	(	PUNCT
admet-647	105	32	table	table	NOUN
admet-647	105	33	2	2	NUM
admet-647	105	34	)	)	PUNCT
admet-647	105	35	.	.	PUNCT
admet-647	106	1	the	the	DET
admet-647	106	2	coadministration	coadministration	NOUN
admet-647	106	3	of	of	ADP
admet-647	106	4	naringin	naringin	NOUN
admet-647	106	5	(	(	PUNCT
admet-647	106	6	15	15	NUM
admet-647	106	7	and	and	CCONJ
admet-647	106	8	30	30	NUM
admet-647	106	9	mg	mg	NUM
admet-647	106	10	/	/	SYM
admet-647	106	11	kg	kg	NOUN
admet-647	106	12	)	)	PUNCT
admet-647	106	13	along	along	ADP
admet-647	106	14	with	with	ADP
admet-647	106	15	ast	ast	NOUN
admet-647	106	16	at	at	ADP
admet-647	106	17	two	two	NUM
admet-647	106	18	test	test	NOUN
admet-647	106	19	dose	dose	NOUN
admet-647	106	20	levels	level	NOUN
admet-647	106	21	statistically	statistically	ADV
admet-647	106	22	significant	significant	ADJ
admet-647	106	23	increase	increase	NOUN
admet-647	106	24	in	in	ADP
admet-647	106	25	the	the	DET
admet-647	106	26	fall	fall	NOUN
admet-647	106	27	in	in	ADP
admet-647	106	28	triglyceride	triglyceride	ADJ
admet-647	106	29	levels	level	NOUN
admet-647	106	30	when	when	SCONJ
admet-647	106	31	compared	compare	VERB
admet-647	106	32	to	to	ADP
admet-647	106	33	ast	ast	VERB
admet-647	106	34	alone	alone	ADJ
admet-647	106	35	treated	treat	VERB
admet-647	106	36	animals	animal	NOUN
admet-647	106	37	.	.	PUNCT
admet-647	107	1	the	the	DET
admet-647	107	2	percent	percent	NOUN
admet-647	107	3	reduction	reduction	NOUN
admet-647	107	4	in	in	ADP
admet-647	107	5	animals	animal	NOUN
admet-647	107	6	treated	treat	VERB
admet-647	107	7	with	with	ADP
admet-647	107	8	ast	ast	NOUN
admet-647	107	9	along	along	ADP
admet-647	107	10	with	with	ADP
admet-647	107	11	naringin	naringin	NOUN
admet-647	107	12	(	(	PUNCT
admet-647	107	13	25	25	NUM
admet-647	107	14	+	+	NUM
admet-647	107	15	15	15	NUM
admet-647	107	16	;	;	PUNCT
admet-647	107	17	25	25	NUM
admet-647	107	18	+	+	NUM
admet-647	107	19	30	30	NUM
admet-647	107	20	mg	mg	NUM
admet-647	107	21	/	/	SYM
admet-647	107	22	kg	kg	PROPN
admet-647	107	23	)	)	PUNCT
admet-647	107	24	was	be	AUX
admet-647	107	25	20.03	20.03	NUM
admet-647	107	26	and	and	CCONJ
admet-647	107	27	26.77	26.77	NUM
admet-647	107	28	,	,	PUNCT
admet-647	107	29	respectively	respectively	ADV
admet-647	107	30	.	.	PUNCT
admet-647	108	1	whereas	whereas	SCONJ
admet-647	108	2	the	the	DET
admet-647	108	3	percent	percent	NOUN
admet-647	108	4	reduction	reduction	NOUN
admet-647	108	5	was	be	AUX
admet-647	108	6	28.10	28.10	NUM
admet-647	108	7	and	and	CCONJ
admet-647	108	8	38.98	38.98	NUM
admet-647	108	9	with	with	ADP
admet-647	108	10	test	test	NOUN
admet-647	108	11	dose	dose	NOUN
admet-647	108	12	of	of	ADP
admet-647	108	13	ast	ast	NOUN
admet-647	108	14	and	and	CCONJ
admet-647	108	15	naringin	naringin	NOUN
admet-647	108	16	at	at	ADP
admet-647	108	17	50	50	NUM
admet-647	108	18	r.	r.	PROPN
admet-647	108	19	mullangi	mullangi	PROPN
admet-647	108	20	et	et	PROPN
admet-647	108	21	al	al	PROPN
admet-647	108	22	.	.	PROPN
admet-647	108	23	admet	admet	PROPN
admet-647	108	24	&	&	CCONJ
admet-647	108	25	dmpk	dmpk	PROPN
admet-647	108	26	7(3	7(3	NUM
admet-647	108	27	)	)	PUNCT
admet-647	108	28	(	(	PUNCT
admet-647	108	29	2019	2019	NUM
admet-647	108	30	)	)	PUNCT
admet-647	108	31	174	174	NUM
admet-647	108	32	-	-	SYM
admet-647	108	33	182	182	NUM
admet-647	108	34	178	178	NUM
admet-647	108	35	+	+	CCONJ
admet-647	108	36	15	15	NUM
admet-647	108	37	and	and	CCONJ
admet-647	108	38	50	50	NUM
admet-647	108	39	+	+	NUM
admet-647	108	40	30	30	NUM
admet-647	108	41	mg	mg	NUM
admet-647	108	42	/	/	SYM
admet-647	108	43	kg	kg	PROPN
admet-647	108	44	,	,	PUNCT
admet-647	108	45	respectively	respectively	ADV
admet-647	108	46	after	after	ADP
admet-647	108	47	2	2	NUM
admet-647	108	48	h	h	NOUN
admet-647	108	49	post	post	NOUN
admet-647	108	50	-	-	NOUN
admet-647	108	51	treatment	treatment	NOUN
admet-647	108	52	.	.	PUNCT
admet-647	109	1	the	the	DET
admet-647	109	2	results	result	NOUN
admet-647	109	3	pertaining	pertain	VERB
admet-647	109	4	to	to	PART
admet-647	109	5	effect	effect	VERB
admet-647	109	6	on	on	ADP
admet-647	109	7	triglyceride	triglyceride	ADJ
admet-647	109	8	levels	level	NOUN
admet-647	109	9	were	be	AUX
admet-647	109	10	shown	show	VERB
admet-647	109	11	in	in	ADP
admet-647	109	12	table	table	NOUN
admet-647	109	13	2	2	NUM
admet-647	109	14	.	.	PUNCT
admet-647	109	15	table	table	NOUN
admet-647	109	16	1	1	NUM
admet-647	109	17	.	.	PUNCT
admet-647	109	18	effect	effect	NOUN
admet-647	109	19	of	of	ADP
admet-647	109	20	naringin	naringin	NOUN
admet-647	109	21	on	on	ADP
admet-647	109	22	atorvastatin	atorvastatin	PROPN
admet-647	109	23	(	(	PUNCT
admet-647	109	24	ast	ast	PROPN
admet-647	109	25	)	)	PUNCT
admet-647	109	26	on	on	ADP
admet-647	109	27	total	total	ADJ
admet-647	109	28	cholesterol	cholesterol	NOUN
admet-647	109	29	levels	level	NOUN
admet-647	109	30	induced	induce	VERB
admet-647	109	31	by	by	ADP
admet-647	109	32	tyloxapol	tyloxapol	NOUN
admet-647	109	33	in	in	ADP
admet-647	109	34	male	male	PROPN
admet-647	109	35	wistar	wistar	PROPN
admet-647	109	36	rats	rat	NOUN
admet-647	109	37	values	value	NOUN
admet-647	109	38	are	be	AUX
admet-647	109	39	expressed	express	VERB
admet-647	109	40	as	as	ADP
admet-647	109	41	mean	mean	PROPN
admet-647	109	42	±	±	NUM
admet-647	109	43	sem	sem	NOUN
admet-647	109	44	,	,	PUNCT
admet-647	109	45	*	*	PUNCT
admet-647	109	46	*	*	PUNCT
admet-647	109	47	p<0.01	p<0.01	PROPN
admet-647	109	48	,	,	PUNCT
admet-647	109	49	*	*	PUNCT
admet-647	109	50	*	*	PUNCT
admet-647	109	51	*	*	PUNCT
admet-647	109	52	p<0.001	p<0.001	X
admet-647	109	53	;	;	PUNCT
admet-647	109	54	n=6	n=6	NOUN
admet-647	109	55	figures	figure	NOUN
admet-647	109	56	in	in	ADP
admet-647	109	57	parenthesis	parenthesis	NOUN
admet-647	109	58	indicate	indicate	VERB
admet-647	109	59	the	the	DET
admet-647	109	60	percentage	percentage	NOUN
admet-647	109	61	decrease	decrease	NOUN
admet-647	109	62	in	in	ADP
admet-647	109	63	total	total	ADJ
admet-647	109	64	cholesterol	cholesterol	NOUN
admet-647	109	65	levels	level	NOUN
admet-647	109	66	quantitation	quantitation	NOUN
admet-647	109	67	of	of	ADP
admet-647	109	68	ast	ast	NOUN
admet-647	109	69	in	in	ADP
admet-647	109	70	rat	rat	NOUN
admet-647	109	71	plasma	plasma	NOUN
admet-647	109	72	samples	sample	NOUN
admet-647	109	73	by	by	ADP
admet-647	109	74	rp	rp	NOUN
admet-647	109	75	-	-	PUNCT
admet-647	109	76	hplc	hplc	NOUN
admet-647	109	77	the	the	DET
admet-647	109	78	plasma	plasma	NOUN
admet-647	109	79	concentration	concentration	NOUN
admet-647	109	80	of	of	ADP
admet-647	109	81	ast	ast	NOUN
admet-647	109	82	was	be	AUX
admet-647	109	83	determined	determine	VERB
admet-647	109	84	in	in	ADP
admet-647	109	85	hyperlipidemic	hyperlipidemic	ADJ
admet-647	109	86	rats	rat	NOUN
admet-647	109	87	at	at	ADP
admet-647	109	88	1	1	NUM
admet-647	109	89	,	,	PUNCT
admet-647	109	90	2	2	NUM
admet-647	109	91	and	and	CCONJ
admet-647	109	92	4th	4th	ADJ
admet-647	109	93	h	h	NOUN
admet-647	109	94	after	after	ADP
admet-647	109	95	oral	oral	ADJ
admet-647	109	96	administration	administration	NOUN
admet-647	109	97	of	of	ADP
admet-647	109	98	ast	ast	NOUN
admet-647	109	99	alone	alone	ADV
admet-647	109	100	and	and	CCONJ
admet-647	109	101	ast	ast	VERB
admet-647	109	102	along	along	ADP
admet-647	109	103	with	with	ADP
admet-647	109	104	naringin	naringin	NOUN
admet-647	109	105	.	.	PUNCT
admet-647	110	1	hplc	hplc	NOUN
admet-647	110	2	chromatograms	chromatogram	NOUN
admet-647	110	3	of	of	ADP
admet-647	110	4	(	(	PUNCT
admet-647	110	5	a	a	X
admet-647	110	6	)	)	PUNCT
admet-647	110	7	rat	rat	NOUN
admet-647	110	8	blank	blank	ADJ
admet-647	110	9	plasma	plasma	NOUN
admet-647	110	10	(	(	PUNCT
admet-647	110	11	b	b	X
admet-647	110	12	)	)	PUNCT
admet-647	110	13	rat	rat	NOUN
admet-647	110	14	plasma	plasma	NOUN
admet-647	110	15	spiked	spike	VERB
admet-647	110	16	with	with	ADP
admet-647	110	17	ast	ast	NOUN
admet-647	110	18	(	(	PUNCT
admet-647	110	19	300	300	NUM
admet-647	110	20	ng	ng	NOUN
admet-647	110	21	/	/	SYM
admet-647	110	22	ml	ml	PROPN
admet-647	110	23	)	)	PUNCT
admet-647	110	24	and	and	CCONJ
admet-647	110	25	(	(	PUNCT
admet-647	110	26	c	c	NOUN
admet-647	110	27	)	)	PUNCT
admet-647	110	28	1	1	NUM
admet-647	110	29	h	h	NOUN
admet-647	110	30	in	in	ADP
admet-647	110	31	vivo	vivo	ADJ
admet-647	110	32	rat	rat	NOUN
admet-647	110	33	plasma	plasma	NOUN
admet-647	110	34	sample	sample	NOUN
admet-647	110	35	obtained	obtain	VERB
admet-647	110	36	after	after	ADP
admet-647	110	37	oral	oral	ADJ
admet-647	110	38	administration	administration	NOUN
admet-647	110	39	of	of	ADP
admet-647	110	40	ast	ast	NOUN
admet-647	110	41	at	at	ADP
admet-647	110	42	50	50	NUM
admet-647	110	43	mg	mg	PROPN
admet-647	110	44	/	/	SYM
admet-647	110	45	kg	kg	NOUN
admet-647	110	46	along	along	ADP
admet-647	110	47	with	with	ADP
admet-647	110	48	naringin	naringin	PROPN
admet-647	110	49	15	15	NUM
admet-647	110	50	mg	mg	PROPN
admet-647	110	51	/	/	SYM
admet-647	110	52	kg	kg	PROPN
admet-647	111	1	(	(	PUNCT
admet-647	111	2	group	group	NOUN
admet-647	111	3	9	9	NUM
admet-647	111	4	)	)	PUNCT
admet-647	111	5	were	be	AUX
admet-647	111	6	shown	show	VERB
admet-647	111	7	in	in	ADP
admet-647	111	8	figure	figure	NOUN
admet-647	111	9	1	1	NUM
admet-647	111	10	.	.	PUNCT
admet-647	112	1	the	the	DET
admet-647	112	2	maximum	maximum	ADJ
admet-647	112	3	plasma	plasma	NOUN
admet-647	112	4	concentration	concentration	NOUN
admet-647	112	5	of	of	ADP
admet-647	112	6	ast	ast	NOUN
admet-647	112	7	was	be	AUX
admet-647	112	8	observed	observe	VERB
admet-647	112	9	at	at	ADP
admet-647	112	10	2nd	2nd	ADJ
admet-647	112	11	h	h	NOUN
admet-647	112	12	after	after	ADP
admet-647	112	13	oral	oral	ADJ
admet-647	112	14	administration	administration	NOUN
admet-647	112	15	of	of	ADP
admet-647	112	16	ast	ast	PROPN
admet-647	112	17	and	and	CCONJ
admet-647	112	18	it	it	PRON
admet-647	112	19	was	be	AUX
admet-647	112	20	found	find	VERB
admet-647	112	21	to	to	PART
admet-647	112	22	be	be	AUX
admet-647	112	23	43.33	43.33	NUM
admet-647	112	24	and	and	CCONJ
admet-647	112	25	198.92	198.92	NUM
admet-647	112	26	ng	ng	PROPN
admet-647	112	27	/	/	SYM
admet-647	112	28	ml	ml	X
admet-647	112	29	at	at	ADP
admet-647	112	30	dose	dose	NOUN
admet-647	112	31	levels	level	NOUN
admet-647	112	32	of	of	ADP
admet-647	112	33	25	25	NUM
admet-647	112	34	and	and	CCONJ
admet-647	112	35	50	50	NUM
admet-647	112	36	mg	mg	NUM
admet-647	112	37	/	/	SYM
admet-647	112	38	kg	kg	PROPN
admet-647	112	39	,	,	PUNCT
admet-647	112	40	respectively	respectively	ADV
admet-647	112	41	in	in	ADP
admet-647	112	42	ast	ast	NOUN
admet-647	112	43	alone	alone	ADV
admet-647	112	44	treated	treat	VERB
admet-647	112	45	animals	animal	NOUN
admet-647	112	46	.	.	PUNCT
admet-647	113	1	table	table	NOUN
admet-647	113	2	3	3	NUM
admet-647	113	3	the	the	DET
admet-647	113	4	plasma	plasma	NOUN
admet-647	113	5	concentration	concentration	NOUN
admet-647	113	6	of	of	ADP
admet-647	113	7	ast	ast	NOUN
admet-647	113	8	.	.	PUNCT
admet-647	114	1	the	the	DET
admet-647	114	2	concentration	concentration	NOUN
admet-647	114	3	of	of	ADP
admet-647	114	4	ast	ast	NOUN
admet-647	114	5	is	be	AUX
admet-647	114	6	increased	increase	VERB
admet-647	114	7	proportionally	proportionally	ADV
admet-647	114	8	with	with	ADP
admet-647	114	9	increase	increase	NOUN
admet-647	114	10	in	in	ADP
admet-647	114	11	naringin	naringin	PROPN
admet-647	114	12	dose	dose	PROPN
admet-647	114	13	.	.	PUNCT
admet-647	115	1	the	the	DET
admet-647	115	2	plasma	plasma	NOUN
admet-647	115	3	concentration	concentration	NOUN
admet-647	115	4	of	of	ADP
admet-647	115	5	ast	ast	NOUN
admet-647	115	6	has	have	AUX
admet-647	115	7	increased	increase	VERB
admet-647	115	8	with	with	ADP
admet-647	115	9	the	the	DET
admet-647	115	10	co	co	NOUN
admet-647	115	11	-	-	NOUN
admet-647	115	12	administration	administration	NOUN
admet-647	115	13	of	of	ADP
admet-647	115	14	naringin	naringin	NOUN
admet-647	115	15	at	at	ADP
admet-647	115	16	dose	dose	NOUN
admet-647	115	17	levels	level	NOUN
admet-647	115	18	of	of	ADP
admet-647	115	19	25	25	NUM
admet-647	115	20	+	+	SYM
admet-647	115	21	15	15	NUM
admet-647	115	22	,	,	PUNCT
admet-647	115	23	25	25	NUM
admet-647	115	24	+	+	SYM
admet-647	115	25	30	30	NUM
admet-647	115	26	,	,	PUNCT
admet-647	115	27	50	50	NUM
admet-647	115	28	+	+	SYM
admet-647	115	29	15	15	NUM
admet-647	115	30	and	and	CCONJ
admet-647	115	31	50	50	NUM
admet-647	115	32	+	+	NUM
admet-647	115	33	30	30	NUM
admet-647	115	34	mg	mg	NUM
admet-647	115	35	/	/	SYM
admet-647	115	36	kg	kg	PROPN
admet-647	115	37	was	be	AUX
admet-647	115	38	found	find	VERB
admet-647	115	39	to	to	PART
admet-647	115	40	be	be	AUX
admet-647	115	41	288.5	288.5	NUM
admet-647	115	42	,	,	PUNCT
admet-647	115	43	663.81	663.81	NUM
admet-647	115	44	,	,	PUNCT
admet-647	115	45	793.03	793.03	NUM
admet-647	115	46	and	and	CCONJ
admet-647	115	47	1233.72	1233.72	NUM
admet-647	115	48	ng	ng	PROPN
admet-647	115	49	/	/	SYM
admet-647	115	50	ml	ml	PROPN
admet-647	115	51	,	,	PUNCT
admet-647	115	52	respectively	respectively	ADV
admet-647	115	53	.	.	PUNCT
admet-647	116	1	group	group	NOUN
admet-647	116	2	treatment	treatment	PROPN
admet-647	116	3	dose	dose	PROPN
admet-647	116	4	(	(	PUNCT
admet-647	116	5	mg	mg	PROPN
admet-647	116	6	/	/	SYM
admet-647	116	7	kg	kg	NOUN
admet-647	116	8	)	)	PUNCT
admet-647	116	9	plasma	plasma	NOUN
admet-647	116	10	concentration	concentration	NOUN
admet-647	116	11	of	of	ADP
admet-647	116	12	total	total	ADJ
admet-647	116	13	cholesterol	cholesterol	NOUN
admet-647	116	14	(	(	PUNCT
admet-647	116	15	mg	mg	PROPN
admet-647	116	16	/	/	SYM
admet-647	116	17	dl	dl	NOUN
admet-647	116	18	)	)	PUNCT
admet-647	116	19	0	0	NUM
admet-647	116	20	min	min	NOUN
admet-647	116	21	1	1	NUM
admet-647	116	22	h	h	NOUN
admet-647	116	23	2	2	NUM
admet-647	116	24	h	h	NOUN
admet-647	116	25	4	4	NUM
admet-647	116	26	h	h	NOUN
admet-647	117	1	i	i	PRON
admet-647	117	2	disease	disease	NOUN
admet-647	117	3	control	control	VERB
admet-647	117	4	132.2	132.2	NUM
admet-647	117	5	±	±	NUM
admet-647	117	6	3.07	3.07	NUM
admet-647	117	7	127.8	127.8	NUM
admet-647	117	8	±	±	NUM
admet-647	117	9	2.28	2.28	NUM
admet-647	117	10	137.8	137.8	NUM
admet-647	117	11	±	±	NUM
admet-647	117	12	2.27	2.27	NUM
admet-647	117	13	124.0	124.0	NUM
admet-647	117	14	±	±	NUM
admet-647	117	15	2.44	2.44	NUM
admet-647	117	16	ii	ii	NOUN
admet-647	117	17	naringin	naringin	NOUN
admet-647	117	18	15	15	NUM
admet-647	117	19	132.2	132.2	NUM
admet-647	117	20	±	±	NUM
admet-647	117	21	1.99	1.99	NUM
admet-647	117	22	126.5	126.5	NUM
admet-647	117	23	±	±	NUM
admet-647	117	24	2.94	2.94	NUM
admet-647	117	25	(	(	PUNCT
admet-647	117	26	1.02	1.02	NUM
admet-647	117	27	)	)	PUNCT
admet-647	117	28	135.2	135.2	NUM
admet-647	117	29	±	±	NUM
admet-647	117	30	2.35	2.35	NUM
admet-647	117	31	(	(	PUNCT
admet-647	117	32	1.89	1.89	NUM
admet-647	117	33	)	)	PUNCT
admet-647	117	34	122.2	122.2	NUM
admet-647	117	35	±	±	NUM
admet-647	117	36	2.30	2.30	NUM
admet-647	117	37	(	(	PUNCT
admet-647	117	38	1.45	1.45	NUM
admet-647	117	39	)	)	PUNCT
admet-647	117	40	iii	iii	NOUN
admet-647	117	41	naringin	naringin	NOUN
admet-647	117	42	30	30	NUM
admet-647	117	43	129.7	129.7	NUM
admet-647	117	44	±	±	NUM
admet-647	117	45	2.26	2.26	NUM
admet-647	117	46	125.3	125.3	NUM
admet-647	117	47	±	±	NUM
admet-647	117	48	2.10	2.10	NUM
admet-647	117	49	(	(	PUNCT
admet-647	117	50	1.96	1.96	NUM
admet-647	117	51	)	)	PUNCT
admet-647	117	52	131.0	131.0	NUM
admet-647	117	53	±	±	NUM
admet-647	117	54	2.78	2.78	NUM
admet-647	117	55	(	(	PUNCT
admet-647	117	56	4.93	4.93	NUM
admet-647	117	57	)	)	PUNCT
admet-647	117	58	119.2	119.2	NUM
admet-647	117	59	±	±	NUM
admet-647	117	60	2.02	2.02	NUM
admet-647	117	61	(	(	PUNCT
admet-647	117	62	3.87	3.87	NUM
admet-647	117	63	)	)	PUNCT
admet-647	117	64	iv	iv	NOUN
admet-647	117	65	ast	ast	NOUN
admet-647	117	66	25	25	NUM
admet-647	117	67	135.3	135.3	NUM
admet-647	117	68	±	±	NUM
admet-647	117	69	3.08	3.08	NUM
admet-647	117	70	118.8	118.8	NUM
admet-647	117	71	±	±	NUM
admet-647	117	72	2.72	2.72	NUM
admet-647	117	73	(	(	PUNCT
admet-647	117	74	7.04	7.04	NUM
admet-647	117	75	)	)	PUNCT
admet-647	117	76	120.3	120.3	NUM
admet-647	117	77	±	±	NUM
admet-647	117	78	2.92	2.92	NUM
admet-647	117	79	*	*	PUNCT
admet-647	117	80	*	*	PUNCT
admet-647	117	81	*	*	PUNCT
admet-647	117	82	(	(	PUNCT
admet-647	117	83	12.70	12.70	NUM
admet-647	117	84	)	)	PUNCT
admet-647	117	85	110.0	110.0	NUM
admet-647	117	86	±	±	NUM
admet-647	117	87	2.01	2.01	NUM
admet-647	117	88	*	*	PUNCT
admet-647	117	89	*	*	PUNCT
admet-647	117	90	*	*	PUNCT
admet-647	117	91	(	(	PUNCT
admet-647	117	92	11.29	11.29	NUM
admet-647	117	93	)	)	PUNCT
admet-647	117	94	v	v	NOUN
admet-647	117	95	ast	ast	NOUN
admet-647	117	96	+	+	CCONJ
admet-647	117	97	naringin	naringin	NOUN
admet-647	117	98	25	25	NUM
admet-647	117	99	+	+	NUM
admet-647	117	100	15	15	NUM
admet-647	117	101	134.2	134.2	NUM
admet-647	117	102	±	±	NUM
admet-647	117	103	2.34	2.34	NUM
admet-647	117	104	111.3	111.3	NUM
admet-647	117	105	±	±	NUM
admet-647	117	106	2.51	2.51	NUM
admet-647	117	107	*	*	PUNCT
admet-647	117	108	*	*	PUNCT
admet-647	117	109	*	*	PUNCT
admet-647	117	110	(	(	PUNCT
admet-647	117	111	12.91	12.91	NUM
admet-647	117	112	)	)	PUNCT
admet-647	117	113	104.7	104.7	NUM
admet-647	117	114	±	±	NUM
admet-647	117	115	2.07	2.07	NUM
admet-647	117	116	*	*	PUNCT
admet-647	117	117	*	*	PUNCT
admet-647	117	118	*	*	PUNCT
admet-647	117	119	(	(	PUNCT
admet-647	117	120	24.02	24.02	NUM
admet-647	117	121	)	)	PUNCT
admet-647	117	122	98.83	98.83	NUM
admet-647	117	123	±	±	NUM
admet-647	117	124	2.70	2.70	NUM
admet-647	117	125	*	*	PUNCT
admet-647	117	126	*	*	PUNCT
admet-647	117	127	*	*	PUNCT
admet-647	117	128	(	(	PUNCT
admet-647	117	129	20.30	20.30	NUM
admet-647	117	130	)	)	PUNCT
admet-647	117	131	vi	vi	NOUN
admet-647	117	132	ast	ast	NOUN
admet-647	117	133	+	+	CCONJ
admet-647	117	134	naringin	naringin	NOUN
admet-647	117	135	25	25	NUM
admet-647	117	136	+	+	NUM
admet-647	117	137	30	30	NUM
admet-647	117	138	132.0	132.0	NUM
admet-647	117	139	±	±	NUM
admet-647	117	140	3.07	3.07	NUM
admet-647	117	141	108.8	108.8	NUM
admet-647	117	142	±	±	NUM
admet-647	117	143	3.19	3.19	NUM
admet-647	117	144	*	*	PUNCT
admet-647	117	145	*	*	PUNCT
admet-647	117	146	*	*	PUNCT
admet-647	117	147	(	(	PUNCT
admet-647	117	148	14.87	14.87	NUM
admet-647	117	149	)	)	PUNCT
admet-647	117	150	94.67	94.67	NUM
admet-647	117	151	±	±	NUM
admet-647	117	152	2.60	2.60	NUM
admet-647	117	153	*	*	PUNCT
admet-647	117	154	*	*	PUNCT
admet-647	117	155	*	*	PUNCT
admet-647	117	156	(	(	PUNCT
admet-647	117	157	31.30	31.30	NUM
admet-647	117	158	)	)	PUNCT
admet-647	117	159	94.17	94.17	NUM
admet-647	117	160	±	±	NUM
admet-647	117	161	2.71	2.71	NUM
admet-647	117	162	*	*	PUNCT
admet-647	117	163	*	*	PUNCT
admet-647	117	164	*	*	PUNCT
admet-647	117	165	(	(	PUNCT
admet-647	117	166	24.06	24.06	NUM
admet-647	117	167	)	)	PUNCT
admet-647	117	168	vii	vii	PROPN
admet-647	117	169	ast	ast	PROPN
admet-647	117	170	50	50	NUM
admet-647	117	171	132.8	132.8	NUM
admet-647	117	172	±	±	NUM
admet-647	117	173	2.33	2.33	NUM
admet-647	117	174	115.7	115.7	NUM
admet-647	117	175	±	±	NUM
admet-647	117	176	2.96	2.96	NUM
admet-647	117	177	*	*	PUNCT
admet-647	117	178	(	(	PUNCT
admet-647	117	179	9.47	9.47	NUM
admet-647	117	180	)	)	PUNCT
admet-647	117	181	111.5	111.5	NUM
admet-647	117	182	±	±	NOUN
admet-647	117	183	2.95	2.95	NUM
admet-647	117	184	*	*	PUNCT
admet-647	117	185	*	*	PUNCT
admet-647	117	186	*	*	PUNCT
admet-647	117	187	(	(	PUNCT
admet-647	117	188	19.09	19.09	NUM
admet-647	117	189	)	)	PUNCT
admet-647	117	190	106.2	106.2	NUM
admet-647	117	191	±	±	NUM
admet-647	117	192	2.30	2.30	NUM
admet-647	117	193	*	*	PUNCT
admet-647	117	194	*	*	PUNCT
admet-647	117	195	*	*	PUNCT
admet-647	117	196	(	(	PUNCT
admet-647	117	197	14.35	14.35	NUM
admet-647	117	198	)	)	PUNCT
admet-647	117	199	viii	viii	ADJ
admet-647	117	200	ast	ast	NOUN
admet-647	117	201	+	+	CCONJ
admet-647	117	202	naringin	naringin	NOUN
admet-647	117	203	50	50	NUM
admet-647	117	204	+	+	NUM
admet-647	117	205	15	15	NUM
admet-647	117	206	134.7	134.7	NUM
admet-647	117	207	±	±	NUM
admet-647	117	208	2.98	2.98	NUM
admet-647	117	209	110.7	110.7	NUM
admet-647	117	210	±	±	NUM
admet-647	117	211	2.81	2.81	NUM
admet-647	117	212	*	*	PUNCT
admet-647	117	213	*	*	PUNCT
admet-647	117	214	*	*	PUNCT
admet-647	117	215	(	(	PUNCT
admet-647	117	216	13.38	13.38	NUM
admet-647	117	217	)	)	PUNCT
admet-647	117	218	92.33	92.33	NUM
admet-647	117	219	±	±	NUM
admet-647	117	220	2.02	2.02	NUM
admet-647	117	221	*	*	PUNCT
admet-647	117	222	*	*	PUNCT
admet-647	117	223	*	*	PUNCT
admet-647	117	224	(	(	PUNCT
admet-647	117	225	33.00	33.00	NUM
admet-647	117	226	)	)	PUNCT
admet-647	117	227	95.00	95.00	NUM
admet-647	117	228	±	±	NUM
admet-647	117	229	2.60	2.60	NUM
admet-647	117	230	*	*	PUNCT
admet-647	117	231	*	*	PUNCT
admet-647	117	232	*	*	PUNCT
admet-647	117	233	(	(	PUNCT
admet-647	117	234	23.39	23.39	NUM
admet-647	117	235	)	)	PUNCT
admet-647	117	236	ix	ix	ADP
admet-647	117	237	ast	ast	PROPN
admet-647	118	1	+	+	CCONJ
admet-647	118	2	naringin	naringin	VERB
admet-647	118	3	50	50	NUM
admet-647	118	4	+	+	NUM
admet-647	118	5	30	30	NUM
admet-647	118	6	135.8	135.8	NUM
admet-647	118	7	±	±	NUM
admet-647	118	8	2.41	2.41	NUM
admet-647	118	9	106.2	106.2	NUM
admet-647	118	10	±	±	NUM
admet-647	118	11	3.04	3.04	NUM
admet-647	118	12	*	*	PUNCT
admet-647	118	13	*	*	PUNCT
admet-647	118	14	*	*	PUNCT
admet-647	118	15	(	(	PUNCT
admet-647	118	16	16.90	16.90	NUM
admet-647	118	17	)	)	PUNCT
admet-647	118	18	80.67	80.67	NUM
admet-647	118	19	±	±	NUM
admet-647	118	20	1.94	1.94	NUM
admet-647	118	21	*	*	PUNCT
admet-647	118	22	*	*	PUNCT
admet-647	118	23	*	*	PUNCT
admet-647	118	24	(	(	PUNCT
admet-647	118	25	41.46	41.46	NUM
admet-647	118	26	)	)	PUNCT
admet-647	118	27	88.17	88.17	NUM
admet-647	118	28	±	±	NUM
admet-647	118	29	2.41	2.41	NUM
admet-647	118	30	*	*	PUNCT
admet-647	118	31	*	*	PUNCT
admet-647	118	32	*	*	PUNCT
admet-647	118	33	(	(	PUNCT
admet-647	118	34	28.90	28.90	NUM
admet-647	118	35	)	)	PUNCT
admet-647	118	36	x	x	SYM
admet-647	118	37	normal	normal	ADJ
admet-647	118	38	54.0	54.0	NUM
admet-647	118	39	±	±	NUM
admet-647	118	40	1.91	1.91	NUM
admet-647	118	41	54.30	54.30	NUM
admet-647	118	42	±	±	NUM
admet-647	118	43	1.82	1.82	NUM
admet-647	118	44	54.50	54.50	NUM
admet-647	118	45	±	±	NUM
admet-647	118	46	1.45	1.45	NUM
admet-647	118	47	53.50	53.50	NUM
admet-647	118	48	±	±	NUM
admet-647	118	49	1.94	1.94	NUM
admet-647	118	50	admet	admet	NOUN
admet-647	118	51	&	&	CCONJ
admet-647	118	52	dmpk	dmpk	PROPN
admet-647	118	53	7(3	7(3	NUM
admet-647	118	54	)	)	PUNCT
admet-647	118	55	(	(	PUNCT
admet-647	118	56	2019	2019	NUM
admet-647	118	57	)	)	PUNCT
admet-647	118	58	174	174	NUM
admet-647	118	59	-	-	SYM
admet-647	118	60	182	182	NUM
admet-647	118	61	effect	effect	NOUN
admet-647	118	62	of	of	ADP
admet-647	118	63	naringin	naringin	NOUN
admet-647	118	64	on	on	ADP
admet-647	118	65	atorvastatin	atorvastatin	PROPN
admet-647	118	66	doi	doi	PROPN
admet-647	118	67	:	:	PUNCT
admet-647	118	68	10.5599	10.5599	NUM
admet-647	118	69	/	/	SYM
admet-647	118	70	admet.647	admet.647	ADJ
admet-647	118	71	179	179	NUM
admet-647	118	72	table	table	NOUN
admet-647	118	73	2	2	NUM
admet-647	118	74	.	.	PUNCT
admet-647	118	75	effect	effect	NOUN
admet-647	118	76	of	of	ADP
admet-647	118	77	naringin	naringin	NOUN
admet-647	118	78	on	on	ADP
admet-647	118	79	atorvastatin	atorvastatin	PROPN
admet-647	118	80	(	(	PUNCT
admet-647	118	81	ast	ast	PROPN
admet-647	118	82	)	)	PUNCT
admet-647	118	83	on	on	ADP
admet-647	118	84	triglyceride	triglyceride	ADJ
admet-647	118	85	levels	level	NOUN
admet-647	118	86	induced	induce	VERB
admet-647	118	87	by	by	ADP
admet-647	118	88	tyloxapol	tyloxapol	NOUN
admet-647	118	89	in	in	ADP
admet-647	118	90	male	male	PROPN
admet-647	118	91	wistar	wistar	PROPN
admet-647	118	92	rats	rat	NOUN
admet-647	118	93	values	value	NOUN
admet-647	118	94	are	be	AUX
admet-647	118	95	expressed	express	VERB
admet-647	118	96	as	as	ADP
admet-647	118	97	mean	mean	PROPN
admet-647	118	98	±	±	NUM
admet-647	118	99	sem	sem	NOUN
admet-647	118	100	,	,	PUNCT
admet-647	118	101	*	*	PUNCT
admet-647	118	102	*	*	PUNCT
admet-647	118	103	p<0.01	p<0.01	PROPN
admet-647	118	104	,	,	PUNCT
admet-647	118	105	*	*	PUNCT
admet-647	118	106	*	*	PUNCT
admet-647	118	107	*	*	PUNCT
admet-647	118	108	p<0.001	p<0.001	X
admet-647	118	109	;	;	PUNCT
admet-647	118	110	n=6	n=6	NOUN
admet-647	118	111	figures	figure	NOUN
admet-647	118	112	in	in	ADP
admet-647	118	113	parenthesis	parenthesis	NOUN
admet-647	118	114	indicate	indicate	VERB
admet-647	118	115	the	the	DET
admet-647	118	116	percentage	percentage	NOUN
admet-647	118	117	decrease	decrease	NOUN
admet-647	118	118	in	in	ADP
admet-647	118	119	total	total	ADJ
admet-647	118	120	triglycreide	triglycreide	NOUN
admet-647	118	121	levels	level	NOUN
admet-647	118	122	table	table	VERB
admet-647	118	123	3	3	NUM
admet-647	118	124	.	.	PUNCT
admet-647	118	125	effect	effect	NOUN
admet-647	118	126	of	of	ADP
admet-647	118	127	naringin	naringin	NOUN
admet-647	118	128	on	on	ADP
admet-647	118	129	pharmacokinetic	pharmacokinetic	ADJ
admet-647	118	130	profile	profile	NOUN
admet-647	118	131	of	of	ADP
admet-647	118	132	atorvastatin	atorvastatin	PROPN
admet-647	118	133	(	(	PUNCT
admet-647	118	134	ast	ast	PROPN
admet-647	118	135	)	)	PUNCT
admet-647	118	136	in	in	ADP
admet-647	118	137	tyloxapol	tyloxapol	NOUN
admet-647	118	138	induced	induce	VERB
admet-647	118	139	hyperlipidemia	hyperlipidemia	NOUN
admet-647	118	140	male	male	PROPN
admet-647	118	141	wistar	wistar	PROPN
admet-647	118	142	rats	rats	PROPN
admet-647	118	143	group	group	NOUN
admet-647	118	144	treatment	treatment	NOUN
admet-647	118	145	dose	dose	PROPN
admet-647	118	146	(	(	PUNCT
admet-647	118	147	mg	mg	PROPN
admet-647	118	148	/	/	SYM
admet-647	118	149	kg	kg	NOUN
admet-647	118	150	)	)	PUNCT
admet-647	118	151	plasma	plasma	NOUN
admet-647	118	152	concentration	concentration	NOUN
admet-647	118	153	of	of	ADP
admet-647	118	154	total	total	ADJ
admet-647	118	155	triglycerides	triglyceride	NOUN
admet-647	118	156	(	(	PUNCT
admet-647	118	157	mg	mg	PROPN
admet-647	118	158	/	/	SYM
admet-647	118	159	dl	dl	NOUN
admet-647	118	160	)	)	PUNCT
admet-647	119	1	0	0	NUM
admet-647	119	2	min	min	NOUN
admet-647	119	3	1	1	NUM
admet-647	119	4	h	h	NOUN
admet-647	119	5	2	2	NUM
admet-647	119	6	h	h	NOUN
admet-647	119	7	4	4	NUM
admet-647	119	8	h	h	NOUN
admet-647	119	9	i	i	PRON
admet-647	119	10	disease	disease	NOUN
admet-647	119	11	control	control	VERB
admet-647	119	12	652.5	652.5	NUM
admet-647	119	13	±	±	NUM
admet-647	119	14	2.74	2.74	NUM
admet-647	119	15	670.8	670.8	NUM
admet-647	119	16	±	±	NUM
admet-647	119	17	1.83	1.83	NUM
admet-647	119	18	694.0	694.0	NUM
admet-647	119	19	±	±	NUM
admet-647	119	20	3.07	3.07	NUM
admet-647	119	21	662.2	662.2	NUM
admet-647	119	22	±	±	NUM
admet-647	119	23	2.63	2.63	NUM
admet-647	119	24	ii	ii	NOUN
admet-647	119	25	naringin	naringin	NOUN
admet-647	119	26	15	15	NUM
admet-647	119	27	666.8	666.8	NUM
admet-647	119	28	±	±	NUM
admet-647	119	29	2.30	2.30	NUM
admet-647	119	30	661.3	661.3	NUM
admet-647	119	31	±	±	NUM
admet-647	119	32	2.27	2.27	NUM
admet-647	119	33	(	(	PUNCT
admet-647	119	34	1.42	1.42	NUM
admet-647	119	35	)	)	PUNCT
admet-647	119	36	674.2	674.2	NUM
admet-647	119	37	±	±	NUM
admet-647	119	38	2.27	2.27	NUM
admet-647	119	39	*	*	PUNCT
admet-647	119	40	*	*	PUNCT
admet-647	119	41	*	*	PUNCT
admet-647	119	42	(	(	PUNCT
admet-647	119	43	2.85	2.85	NUM
admet-647	119	44	)	)	PUNCT
admet-647	119	45	648.7	648.7	NUM
admet-647	119	46	±	±	NUM
admet-647	119	47	2.45	2.45	NUM
admet-647	119	48	*	*	PUNCT
admet-647	119	49	*	*	PUNCT
admet-647	119	50	(	(	PUNCT
admet-647	119	51	2.04	2.04	NUM
admet-647	119	52	)	)	PUNCT
admet-647	119	53	iii	iii	NOUN
admet-647	119	54	naringin	naringin	NOUN
admet-647	119	55	30	30	NUM
admet-647	119	56	663.8	663.8	NUM
admet-647	119	57	±	±	NUM
admet-647	119	58	1.90	1.90	NUM
admet-647	119	59	650.5	650.5	NUM
admet-647	119	60	±	±	NUM
admet-647	119	61	2.47	2.47	NUM
admet-647	119	62	*	*	PUNCT
admet-647	119	63	*	*	PUNCT
admet-647	119	64	*	*	PUNCT
admet-647	119	65	(	(	PUNCT
admet-647	119	66	3.03	3.03	NUM
admet-647	119	67	)	)	PUNCT
admet-647	119	68	659.8	659.8	NUM
admet-647	119	69	±	±	NUM
admet-647	119	70	2.35	2.35	NUM
admet-647	119	71	*	*	PUNCT
admet-647	119	72	*	*	PUNCT
admet-647	119	73	*	*	PUNCT
admet-647	119	74	(	(	PUNCT
admet-647	119	75	4.93	4.93	NUM
admet-647	119	76	)	)	PUNCT
admet-647	119	77	635.2	635.2	NUM
admet-647	119	78	±	±	NUM
admet-647	119	79	2.02	2.02	NUM
admet-647	119	80	*	*	PUNCT
admet-647	119	81	*	*	PUNCT
admet-647	119	82	*	*	PUNCT
admet-647	119	83	(	(	PUNCT
admet-647	119	84	4.08	4.08	NUM
admet-647	119	85	)	)	PUNCT
admet-647	119	86	iv	iv	NOUN
admet-647	119	87	ast	ast	NOUN
admet-647	119	88	25	25	NUM
admet-647	119	89	664.0	664.0	NUM
admet-647	119	90	±	±	NUM
admet-647	119	91	2.87	2.87	NUM
admet-647	119	92	640.2	640.2	NUM
admet-647	119	93	±	±	NUM
admet-647	119	94	2.25	2.25	NUM
admet-647	119	95	*	*	PUNCT
admet-647	119	96	*	*	PUNCT
admet-647	119	97	*	*	PUNCT
admet-647	119	98	(	(	PUNCT
admet-647	119	99	4.56	4.56	NUM
admet-647	119	100	)	)	PUNCT
admet-647	119	101	601.0	601.0	NUM
admet-647	119	102	±	±	NUM
admet-647	119	103	2.49	2.49	NUM
admet-647	119	104	*	*	PUNCT
admet-647	119	105	*	*	PUNCT
admet-647	119	106	*	*	PUNCT
admet-647	119	107	(	(	PUNCT
admet-647	119	108	13.40	13.40	NUM
admet-647	119	109	)	)	PUNCT
admet-647	119	110	591.2	591.2	NUM
admet-647	119	111	±	±	NUM
admet-647	119	112	2.27	2.27	NUM
admet-647	119	113	*	*	PUNCT
admet-647	119	114	*	*	PUNCT
admet-647	119	115	*	*	PUNCT
admet-647	119	116	(	(	PUNCT
admet-647	119	117	10.72	10.72	NUM
admet-647	119	118	)	)	PUNCT
admet-647	119	119	v	v	NOUN
admet-647	119	120	ast	ast	NOUN
admet-647	119	121	+	+	CCONJ
admet-647	119	122	naringin	naringin	NOUN
admet-647	119	123	25	25	NUM
admet-647	119	124	+	+	NUM
admet-647	119	125	15	15	NUM
admet-647	119	126	660.3	660.3	NUM
admet-647	119	127	±	±	NUM
admet-647	119	128	2.36	2.36	NUM
admet-647	119	129	615.0	615.0	NUM
admet-647	119	130	±	±	NUM
admet-647	119	131	2.78	2.78	NUM
admet-647	119	132	*	*	PUNCT
admet-647	119	133	*	*	PUNCT
admet-647	119	134	*	*	PUNCT
admet-647	119	135	(	(	PUNCT
admet-647	119	136	8.32	8.32	NUM
admet-647	119	137	)	)	PUNCT
admet-647	119	138	555.0	555.0	NUM
admet-647	119	139	±	±	NUM
admet-647	119	140	1.93	1.93	NUM
admet-647	119	141	*	*	PUNCT
admet-647	119	142	*	*	PUNCT
admet-647	119	143	*	*	PUNCT
admet-647	119	144	(	(	PUNCT
admet-647	119	145	20.03	20.03	NUM
admet-647	119	146	)	)	PUNCT
admet-647	119	147	567.7	567.7	NUM
admet-647	119	148	±	±	NUM
admet-647	119	149	2.99	2.99	NUM
admet-647	119	150	*	*	PUNCT
admet-647	119	151	*	*	PUNCT
admet-647	119	152	*	*	PUNCT
admet-647	119	153	(	(	PUNCT
admet-647	119	154	14.27	14.27	NUM
admet-647	119	155	)	)	PUNCT
admet-647	119	156	vi	vi	NOUN
admet-647	119	157	ast	ast	NOUN
admet-647	119	158	+	+	CCONJ
admet-647	119	159	naringin	naringin	NOUN
admet-647	119	160	25	25	NUM
admet-647	119	161	+	+	NUM
admet-647	119	162	30	30	NUM
admet-647	119	163	668.0	668.0	NUM
admet-647	119	164	±	±	NUM
admet-647	119	165	2.54	2.54	NUM
admet-647	119	166	594.2	594.2	NUM
admet-647	119	167	±	±	NUM
admet-647	119	168	2.89	2.89	NUM
admet-647	119	169	*	*	PUNCT
admet-647	119	170	*	*	PUNCT
admet-647	119	171	*	*	PUNCT
admet-647	119	172	(	(	PUNCT
admet-647	119	173	11.4	11.4	NUM
admet-647	119	174	)	)	PUNCT
admet-647	119	175	508.2	508.2	NUM
admet-647	119	176	±	±	NUM
admet-647	119	177	2.75	2.75	NUM
admet-647	119	178	*	*	PUNCT
admet-647	119	179	*	*	PUNCT
admet-647	119	180	*	*	PUNCT
admet-647	119	181	(	(	PUNCT
admet-647	119	182	26.77	26.77	NUM
admet-647	119	183	)	)	PUNCT
admet-647	119	184	522.0	522.0	NUM
admet-647	119	185	±	±	NUM
admet-647	119	186	2.12	2.12	NUM
admet-647	119	187	*	*	PUNCT
admet-647	119	188	*	*	PUNCT
admet-647	119	189	*	*	PUNCT
admet-647	119	190	(	(	PUNCT
admet-647	119	191	21.17	21.17	NUM
admet-647	119	192	)	)	PUNCT
admet-647	119	193	vii	vii	PROPN
admet-647	119	194	ast	ast	PROPN
admet-647	119	195	50	50	NUM
admet-647	119	196	660.5	660.5	NUM
admet-647	119	197	±	±	NUM
admet-647	119	198	1.97	1.97	NUM
admet-647	119	199	630.5	630.5	NUM
admet-647	119	200	±	±	NOUN
admet-647	119	201	2.71	2.71	NUM
admet-647	119	202	*	*	PUNCT
admet-647	119	203	*	*	PUNCT
admet-647	119	204	*	*	PUNCT
admet-647	119	205	(	(	PUNCT
admet-647	119	206	6.01	6.01	NUM
admet-647	119	207	)	)	PUNCT
admet-647	119	208	575.0	575.0	NUM
admet-647	119	209	±	±	NUM
admet-647	119	210	1.75	1.75	NUM
admet-647	119	211	*	*	PUNCT
admet-647	119	212	*	*	PUNCT
admet-647	119	213	*	*	PUNCT
admet-647	119	214	(	(	PUNCT
admet-647	119	215	17.15	17.15	NUM
admet-647	119	216	)	)	PUNCT
admet-647	119	217	575.7	575.7	NUM
admet-647	119	218	±	±	NUM
admet-647	119	219	2.10	2.10	NUM
admet-647	119	220	*	*	PUNCT
admet-647	119	221	*	*	PUNCT
admet-647	119	222	*	*	PUNCT
admet-647	119	223	(	(	PUNCT
admet-647	119	224	13.06	13.06	NUM
admet-647	119	225	)	)	PUNCT
admet-647	119	226	viii	viii	ADJ
admet-647	119	227	ast	ast	NOUN
admet-647	119	228	+	+	CCONJ
admet-647	119	229	naringin	naringin	NOUN
admet-647	119	230	50	50	NUM
admet-647	119	231	+	+	NUM
admet-647	119	232	15	15	NUM
admet-647	119	233	670.2	670.2	NUM
admet-647	119	234	±	±	NUM
admet-647	119	235	2.86	2.86	NUM
admet-647	119	236	589.8	589.8	NUM
admet-647	119	237	±	±	NUM
admet-647	119	238	3.16	3.16	NUM
admet-647	119	239	*	*	PUNCT
admet-647	119	240	*	*	PUNCT
admet-647	119	241	*	*	PUNCT
admet-647	119	242	(	(	PUNCT
admet-647	119	243	12.08	12.08	NUM
admet-647	119	244	)	)	PUNCT
admet-647	119	245	499.0	499.0	NUM
admet-647	119	246	±	±	NUM
admet-647	119	247	2.06	2.06	NUM
admet-647	119	248	*	*	PUNCT
admet-647	119	249	*	*	PUNCT
admet-647	119	250	*	*	PUNCT
admet-647	119	251	(	(	PUNCT
admet-647	119	252	28.10	28.10	NUM
admet-647	119	253	)	)	PUNCT
admet-647	119	254	522.3	522.3	NUM
admet-647	119	255	±	±	NUM
admet-647	119	256	1.76	1.76	NUM
admet-647	119	257	*	*	PUNCT
admet-647	119	258	*	*	PUNCT
admet-647	119	259	*	*	PUNCT
admet-647	119	260	(	(	PUNCT
admet-647	119	261	21.13	21.13	NUM
admet-647	119	262	)	)	PUNCT
admet-647	119	263	ix	ix	ADP
admet-647	119	264	ast	ast	PROPN
admet-647	120	1	+	+	CCONJ
admet-647	120	2	naringin	naringin	VERB
admet-647	120	3	50	50	NUM
admet-647	120	4	+	+	NUM
admet-647	120	5	30	30	NUM
admet-647	120	6	670.3	670.3	NUM
admet-647	120	7	±	±	NUM
admet-647	120	8	2.43	2.43	NUM
admet-647	120	9	563.8	563.8	NUM
admet-647	120	10	±	±	NUM
admet-647	120	11	2.64	2.64	NUM
admet-647	120	12	*	*	PUNCT
admet-647	120	13	*	*	PUNCT
admet-647	120	14	*	*	PUNCT
admet-647	120	15	(	(	PUNCT
admet-647	120	16	15.95	15.95	NUM
admet-647	120	17	)	)	PUNCT
admet-647	120	18	423.5	423.5	NUM
admet-647	120	19	±	±	NUM
admet-647	120	20	2.32	2.32	NUM
admet-647	120	21	*	*	PUNCT
admet-647	120	22	*	*	PUNCT
admet-647	120	23	*	*	PUNCT
admet-647	120	24	(	(	PUNCT
admet-647	120	25	38.98	38.98	NUM
admet-647	120	26	)	)	PUNCT
admet-647	120	27	482.3	482.3	NUM
admet-647	120	28	±	±	NUM
admet-647	120	29	2.43	2.43	NUM
admet-647	120	30	*	*	PUNCT
admet-647	120	31	*	*	PUNCT
admet-647	120	32	*	*	PUNCT
admet-647	120	33	(	(	PUNCT
admet-647	120	34	27.17	27.17	NUM
admet-647	120	35	)	)	PUNCT
admet-647	120	36	x	x	SYM
admet-647	120	37	normal	normal	ADJ
admet-647	120	38	71.50	71.50	NUM
admet-647	120	39	±	±	NUM
admet-647	120	40	2.46	2.46	NUM
admet-647	120	41	73.50	73.50	NUM
admet-647	120	42	±	±	NUM
admet-647	120	43	1.74	1.74	NUM
admet-647	120	44	74.00	74.00	NUM
admet-647	120	45	±	±	NUM
admet-647	120	46	1.62	1.62	NUM
admet-647	120	47	73.17	73.17	NUM
admet-647	120	48	±	±	NUM
admet-647	120	49	2.02	2.02	NUM
admet-647	120	50	group	group	NOUN
admet-647	120	51	treatment	treatment	NOUN
admet-647	120	52	dose	dose	NOUN
admet-647	120	53	(	(	PUNCT
admet-647	120	54	mg	mg	PROPN
admet-647	120	55	/	/	SYM
admet-647	120	56	kg	kg	NOUN
admet-647	120	57	)	)	PUNCT
admet-647	120	58	concentration	concentration	NOUN
admet-647	120	59	(	(	PUNCT
admet-647	120	60	ng	ng	NOUN
admet-647	120	61	/	/	SYM
admet-647	120	62	ml	ml	NOUN
admet-647	120	63	)	)	PUNCT
admet-647	120	64	1st	1st	ADJ
admet-647	120	65	hour	hour	NOUN
admet-647	120	66	2nd	2nd	ADJ
admet-647	120	67	hour	hour	NOUN
admet-647	120	68	4th	4th	ADJ
admet-647	120	69	hour	hour	NOUN
admet-647	120	70	iv	iv	NUM
admet-647	120	71	ast	ast	NOUN
admet-647	120	72	25	25	NUM
admet-647	120	73	20.53	20.53	NUM
admet-647	120	74	43.33	43.33	NUM
admet-647	120	75	39.48	39.48	NUM
admet-647	120	76	v	v	NOUN
admet-647	120	77	ast	ast	NOUN
admet-647	120	78	+	+	CCONJ
admet-647	120	79	naringin	naringin	NOUN
admet-647	120	80	25	25	NUM
admet-647	120	81	+	+	NUM
admet-647	120	82	15	15	NUM
admet-647	120	83	144.7	144.7	NUM
admet-647	120	84	288.5	288.5	NUM
admet-647	120	85	226.3	226.3	NUM
admet-647	120	86	vi	vi	NOUN
admet-647	120	87	ast	ast	NOUN
admet-647	120	88	+	+	CCONJ
admet-647	120	89	naringin	naringin	NOUN
admet-647	120	90	25	25	NUM
admet-647	120	91	+	+	NUM
admet-647	120	92	30	30	NUM
admet-647	120	93	484.8	484.8	NUM
admet-647	120	94	663.8	663.8	NUM
admet-647	120	95	596.4	596.4	NUM
admet-647	120	96	vii	vii	PROPN
admet-647	120	97	ast	ast	PROPN
admet-647	120	98	50	50	NUM
admet-647	120	99	82.86	82.86	NUM
admet-647	120	100	198.9	198.9	NUM
admet-647	120	101	159.2	159.2	NUM
admet-647	120	102	viii	viii	ADJ
admet-647	120	103	ast	ast	NOUN
admet-647	120	104	+	+	CCONJ
admet-647	120	105	naringin	naringin	NOUN
admet-647	120	106	50	50	NUM
admet-647	120	107	+	+	NUM
admet-647	120	108	15	15	NUM
admet-647	120	109	301.9	301.9	NUM
admet-647	120	110	793.0	793.0	NUM
admet-647	120	111	650.7	650.7	NUM
admet-647	120	112	ix	ix	ADV
admet-647	120	113	ast	ast	NOUN
admet-647	120	114	+	+	CCONJ
admet-647	120	115	naringin	naringin	NOUN
admet-647	120	116	50	50	NUM
admet-647	121	1	+	+	NUM
admet-647	121	2	30	30	NUM
admet-647	121	3	508.9	508.9	NUM
admet-647	121	4	1233.7	1233.7	NUM
admet-647	121	5	951.5	951.5	NUM
admet-647	121	6	r.	r.	PROPN
admet-647	121	7	mullangi	mullangi	PROPN
admet-647	121	8	et	et	PROPN
admet-647	121	9	al	al	PROPN
admet-647	121	10	.	.	PROPN
admet-647	121	11	admet	admet	PROPN
admet-647	121	12	&	&	CCONJ
admet-647	121	13	dmpk	dmpk	PROPN
admet-647	121	14	7(3	7(3	NUM
admet-647	121	15	)	)	PUNCT
admet-647	121	16	(	(	PUNCT
admet-647	121	17	2019	2019	NUM
admet-647	121	18	)	)	PUNCT
admet-647	121	19	174	174	NUM
admet-647	121	20	-	-	SYM
admet-647	121	21	182	182	NUM
admet-647	121	22	180	180	NUM
admet-647	121	23	figure	figure	NOUN
admet-647	121	24	1	1	NUM
admet-647	121	25	.	.	PUNCT
admet-647	122	1	hplc	hplc	NOUN
admet-647	122	2	chromatograms	chromatogram	NOUN
admet-647	122	3	of	of	ADP
admet-647	122	4	(	(	PUNCT
admet-647	122	5	a	a	X
admet-647	122	6	)	)	PUNCT
admet-647	122	7	rat	rat	NOUN
admet-647	122	8	blank	blank	ADJ
admet-647	122	9	plasma	plasma	NOUN
admet-647	122	10	(	(	PUNCT
admet-647	122	11	b	b	X
admet-647	122	12	)	)	PUNCT
admet-647	122	13	rat	rat	NOUN
admet-647	122	14	plasma	plasma	NOUN
admet-647	122	15	spiked	spike	VERB
admet-647	122	16	with	with	ADP
admet-647	122	17	ast	ast	NOUN
admet-647	122	18	(	(	PUNCT
admet-647	122	19	300	300	NUM
admet-647	122	20	ng	ng	NOUN
admet-647	122	21	/	/	SYM
admet-647	122	22	ml	ml	PROPN
admet-647	122	23	)	)	PUNCT
admet-647	122	24	and	and	CCONJ
admet-647	122	25	(	(	PUNCT
admet-647	122	26	c	c	NOUN
admet-647	122	27	)	)	PUNCT
admet-647	122	28	1	1	NUM
admet-647	122	29	h	h	NOUN
admet-647	122	30	in	in	ADP
admet-647	122	31	vivo	vivo	ADJ
admet-647	122	32	rat	rat	NOUN
admet-647	122	33	plasma	plasma	NOUN
admet-647	122	34	sample	sample	NOUN
admet-647	122	35	obtained	obtain	VERB
admet-647	122	36	after	after	ADP
admet-647	122	37	oral	oral	ADJ
admet-647	122	38	administration	administration	NOUN
admet-647	122	39	of	of	ADP
admet-647	122	40	ast	ast	NOUN
admet-647	122	41	at	at	ADP
admet-647	122	42	50	50	NUM
admet-647	122	43	mg	mg	PROPN
admet-647	122	44	/	/	SYM
admet-647	122	45	kg	kg	NOUN
admet-647	122	46	along	along	ADP
admet-647	122	47	with	with	ADP
admet-647	122	48	naringin	naringin	PROPN
admet-647	122	49	15	15	NUM
admet-647	122	50	mg	mg	PROPN
admet-647	122	51	/	/	SYM
admet-647	122	52	kg	kg	PROPN
admet-647	123	1	(	(	PUNCT
admet-647	123	2	group	group	NOUN
admet-647	123	3	9	9	NUM
admet-647	123	4	)	)	PUNCT
admet-647	123	5	.	.	PUNCT
admet-647	124	1	discussion	discussion	NOUN
admet-647	124	2	a	a	DET
admet-647	124	3	bioenhancer	bioenhancer	NOUN
admet-647	124	4	is	be	AUX
admet-647	124	5	an	an	DET
admet-647	124	6	agent	agent	NOUN
admet-647	124	7	capable	capable	ADJ
admet-647	124	8	of	of	ADP
admet-647	124	9	enhancing	enhance	VERB
admet-647	124	10	the	the	DET
admet-647	124	11	bioavailability	bioavailability	NOUN
admet-647	124	12	/	/	SYM
admet-647	124	13	bioefficacy	bioefficacy	NOUN
admet-647	124	14	of	of	ADP
admet-647	124	15	a	a	DET
admet-647	124	16	particular	particular	ADJ
admet-647	124	17	drug	drug	NOUN
admet-647	124	18	with	with	ADP
admet-647	124	19	which	which	PRON
admet-647	124	20	it	it	PRON
admet-647	124	21	is	be	AUX
admet-647	124	22	co	co	ADJ
admet-647	124	23	-	-	VERB
admet-647	124	24	administered	administered	ADJ
admet-647	124	25	.	.	PUNCT
admet-647	125	1	naringin	naringin	NOUN
admet-647	125	2	is	be	AUX
admet-647	125	3	a	a	DET
admet-647	125	4	flavanone	flavanone	NOUN
admet-647	125	5	glycoside	glycoside	NOUN
admet-647	125	6	obtained	obtain	VERB
admet-647	125	7	from	from	ADP
admet-647	125	8	citrus	citrus	NOUN
admet-647	125	9	fruits	fruit	NOUN
admet-647	125	10	.	.	PUNCT
admet-647	126	1	naringin	naringin	NOUN
admet-647	126	2	possess	possess	VERB
admet-647	126	3	diverse	diverse	ADJ
admet-647	126	4	pharmacological	pharmacological	ADJ
admet-647	126	5	properties	property	NOUN
admet-647	126	6	.	.	PUNCT
admet-647	127	1	previously	previously	ADV
admet-647	127	2	,	,	PUNCT
admet-647	127	3	it	it	PRON
admet-647	127	4	was	be	AUX
admet-647	127	5	reported	report	VERB
admet-647	127	6	that	that	SCONJ
admet-647	127	7	supplementation	supplementation	NOUN
admet-647	127	8	with	with	ADP
admet-647	127	9	naringin	naringin	NOUN
admet-647	127	10	for	for	ADP
admet-647	127	11	3	3	NUM
admet-647	127	12	weeks	week	NOUN
admet-647	127	13	did	do	AUX
admet-647	127	14	not	not	PART
admet-647	127	15	exhibit	exhibit	VERB
admet-647	127	16	a	a	DET
admet-647	127	17	hypolipidemic	hypolipidemic	ADJ
admet-647	127	18	effect	effect	NOUN
admet-647	127	19	,	,	PUNCT
admet-647	127	20	however	however	ADV
admet-647	127	21	it	it	PRON
admet-647	127	22	reported	report	VERB
admet-647	127	23	to	to	PART
admet-647	127	24	show	show	VERB
admet-647	127	25	beneficial	beneficial	ADJ
admet-647	127	26	effects	effect	NOUN
admet-647	127	27	of	of	ADP
admet-647	127	28	lowering	lower	VERB
admet-647	127	29	hepatic	hepatic	ADJ
admet-647	127	30	cholesterol	cholesterol	NOUN
admet-647	127	31	biosynthesis	biosynthesis	NOUN
admet-647	127	32	and	and	CCONJ
admet-647	127	33	levels	level	NOUN
admet-647	127	34	of	of	ADP
admet-647	127	35	plasma	plasma	NOUN
admet-647	127	36	lipids	lipid	NOUN
admet-647	127	37	when	when	SCONJ
admet-647	127	38	supplemented	supplement	VERB
admet-647	127	39	for	for	ADP
admet-647	127	40	6	6	NUM
admet-647	127	41	weeks	week	NOUN
admet-647	127	42	in	in	ADP
admet-647	127	43	a	a	DET
admet-647	127	44	high	high	ADJ
admet-647	127	45	fructose	fructose	NOUN
admet-647	127	46	and	and	CCONJ
admet-647	127	47	high	high	ADJ
admet-647	127	48	cholesterol	cholesterol	NOUN
admet-647	127	49	fed	feed	VERB
admet-647	127	50	rat	rat	NOUN
admet-647	127	51	model	model	NOUN
admet-647	128	1	[	[	X
admet-647	128	2	27	27	NUM
admet-647	128	3	]	]	PUNCT
admet-647	128	4	.	.	PUNCT
admet-647	129	1	naringin	naringin	PROPN
admet-647	129	2	is	be	AUX
admet-647	129	3	known	know	VERB
admet-647	129	4	to	to	ADP
admet-647	129	5	enhancement	enhancement	NOUN
admet-647	129	6	of	of	ADP
admet-647	129	7	bioavailability	bioavailability	NOUN
admet-647	129	8	of	of	ADP
admet-647	129	9	various	various	ADJ
admet-647	129	10	structurally	structurally	ADV
admet-647	129	11	and	and	CCONJ
admet-647	129	12	therapeutically	therapeutically	ADV
admet-647	129	13	diverse	diverse	ADJ
admet-647	129	14	drugs	drug	NOUN
admet-647	129	15	(	(	PUNCT
admet-647	129	16	verapamil	verapamil	NOUN
admet-647	129	17	,	,	PUNCT
admet-647	129	18	diltiazem	diltiazem	NOUN
admet-647	129	19	,	,	PUNCT
admet-647	129	20	paclitaxel	paclitaxel	NOUN
admet-647	129	21	,	,	PUNCT
admet-647	129	22	tamoxifen	tamoxifen	PROPN
admet-647	129	23	)	)	PUNCT
admet-647	129	24	in	in	ADP
admet-647	129	25	rats	rat	NOUN
admet-647	129	26	by	by	ADP
admet-647	129	27	inhibition	inhibition	NOUN
admet-647	129	28	of	of	ADP
admet-647	129	29	cyp	cyp	ADJ
admet-647	129	30	mediated	mediate	VERB
admet-647	129	31	metabolism	metabolism	NOUN
admet-647	129	32	and/or	and/or	CCONJ
admet-647	129	33	p	p	NOUN
admet-647	129	34	-	-	PUNCT
admet-647	129	35	gp	gp	NOUN
admet-647	129	36	mediated	mediate	VERB
admet-647	129	37	permeability	permeability	NOUN
admet-647	129	38	[	[	PUNCT
admet-647	129	39	19	19	NUM
admet-647	129	40	-	-	SYM
admet-647	129	41	22	22	NUM
admet-647	129	42	]	]	PUNCT
admet-647	129	43	.	.	PUNCT
admet-647	130	1	ast	ast	PROPN
admet-647	130	2	is	be	AUX
admet-647	130	3	an	an	DET
admet-647	130	4	antihyperlipidemic	antihyperlipidemic	ADJ
admet-647	130	5	agent	agent	NOUN
admet-647	130	6	belongs	belong	VERB
admet-647	130	7	to	to	ADP
admet-647	130	8	statin	statin	PROPN
admet-647	130	9	family	family	NOUN
admet-647	130	10	.	.	PUNCT
admet-647	131	1	it	it	PRON
admet-647	131	2	acts	act	VERB
admet-647	131	3	by	by	ADP
admet-647	131	4	blocking	block	VERB
admet-647	131	5	the	the	DET
admet-647	131	6	enzyme	enzyme	NOUN
admet-647	131	7	responsible	responsible	ADJ
admet-647	131	8	for	for	ADP
admet-647	131	9	cholesterol	cholesterol	NOUN
admet-647	131	10	biosynthesis	biosynthesis	NOUN
admet-647	131	11	known	know	VERB
admet-647	131	12	as	as	ADP
admet-647	131	13	hmg	hmg	NOUN
admet-647	131	14	co	co	NOUN
admet-647	131	15	-	-	NOUN
admet-647	131	16	a	a	DET
admet-647	131	17	reductase	reductase	NOUN
admet-647	131	18	.	.	PUNCT
admet-647	132	1	ast	ast	PROPN
admet-647	132	2	is	be	AUX
admet-647	132	3	a	a	DET
admet-647	132	4	potent	potent	ADJ
admet-647	132	5	dyslipidemic	dyslipidemic	ADJ
admet-647	132	6	agent	agent	NOUN
admet-647	132	7	having	have	VERB
admet-647	132	8	significant	significant	ADJ
admet-647	132	9	use	use	NOUN
admet-647	132	10	in	in	ADP
admet-647	132	11	lowering	lower	VERB
admet-647	132	12	the	the	DET
admet-647	132	13	blood	blood	NOUN
admet-647	132	14	circulation	circulation	NOUN
admet-647	132	15	lipids	lipids	ADP
admet-647	132	16	such	such	ADJ
admet-647	132	17	as	as	ADP
admet-647	132	18	low	low	ADJ
admet-647	132	19	density	density	NOUN
admet-647	132	20	lipoprotein	lipoprotein	ADJ
admet-647	132	21	(	(	PUNCT
admet-647	132	22	ldl	ldl	NOUN
admet-647	132	23	)	)	PUNCT
admet-647	132	24	,	,	PUNCT
admet-647	132	25	totalcholesterol	totalcholesterol	NOUN
admet-647	132	26	(	(	PUNCT
admet-647	132	27	tc	tc	NOUN
admet-647	132	28	)	)	PUNCT
admet-647	132	29	,	,	PUNCT
admet-647	132	30	triglycerides	triglyceride	NOUN
admet-647	132	31	(	(	PUNCT
admet-647	132	32	tg	tg	NOUN
admet-647	132	33	)	)	PUNCT
admet-647	132	34	and	and	CCONJ
admet-647	132	35	apolipoproteins	apolipoprotein	NOUN
admet-647	132	36	.	.	PUNCT
admet-647	133	1	ast	ast	NOUN
admet-647	133	2	is	be	AUX
admet-647	133	3	metabolized	metabolize	VERB
admet-647	133	4	by	by	ADP
admet-647	133	5	cyp3a4	cyp3a4	PROPN
admet-647	133	6	.	.	PUNCT
admet-647	134	1	in	in	ADP
admet-647	134	2	the	the	DET
admet-647	134	3	present	present	ADJ
admet-647	134	4	study	study	NOUN
admet-647	134	5	,	,	PUNCT
admet-647	134	6	the	the	DET
admet-647	134	7	effect	effect	NOUN
admet-647	134	8	of	of	ADP
admet-647	134	9	naringin	naringin	NOUN
admet-647	134	10	on	on	ADP
admet-647	134	11	antihyperlipidemic	antihyperlipidemic	ADJ
admet-647	134	12	properties	property	NOUN
admet-647	134	13	of	of	ADP
admet-647	134	14	ast	ast	NOUN
admet-647	134	15	was	be	AUX
admet-647	134	16	investigated	investigate	VERB
admet-647	134	17	with	with	ADP
admet-647	134	18	coadministration	coadministration	NOUN
admet-647	134	19	of	of	ADP
admet-647	134	20	naringin	naringin	NOUN
admet-647	134	21	in	in	ADP
admet-647	134	22	tyloxapol	tyloxapol	NOUN
admet-647	134	23	induced	induce	VERB
admet-647	134	24	hyperlipidemia	hyperlipidemia	NOUN
admet-647	134	25	in	in	ADP
admet-647	134	26	wistar	wistar	PROPN
admet-647	134	27	rats	rat	NOUN
admet-647	134	28	.	.	PUNCT
admet-647	135	1	the	the	DET
admet-647	135	2	observed	observed	ADJ
admet-647	135	3	activity	activity	NOUN
admet-647	135	4	was	be	AUX
admet-647	135	5	correlated	correlate	VERB
admet-647	135	6	with	with	ADP
admet-647	135	7	plasma	plasma	NOUN
admet-647	135	8	concentration	concentration	NOUN
admet-647	135	9	of	of	ADP
admet-647	135	10	ast	ast	NOUN
admet-647	135	11	.	.	PUNCT
admet-647	136	1	conclusions	conclusion	NOUN
admet-647	136	2	the	the	DET
admet-647	136	3	findings	finding	NOUN
admet-647	136	4	of	of	ADP
admet-647	136	5	the	the	DET
admet-647	136	6	present	present	ADJ
admet-647	136	7	study	study	NOUN
admet-647	136	8	suggest	suggest	VERB
admet-647	136	9	that	that	SCONJ
admet-647	136	10	increased	increase	VERB
admet-647	136	11	in	in	ADP
admet-647	136	12	plasma	plasma	NOUN
admet-647	136	13	concentration	concentration	NOUN
admet-647	136	14	of	of	ADP
admet-647	136	15	ast	ast	NOUN
admet-647	136	16	may	may	AUX
admet-647	136	17	be	be	AUX
admet-647	136	18	due	due	ADJ
admet-647	136	19	to	to	ADP
admet-647	136	20	inhibition	inhibition	NOUN
admet-647	136	21	of	of	ADP
admet-647	136	22	cyps	cyp	NOUN
admet-647	136	23	and	and	CCONJ
admet-647	136	24	p	p	NOUN
admet-647	136	25	-	-	PUNCT
admet-647	136	26	gp	gp	NOUN
admet-647	136	27	by	by	ADP
admet-647	136	28	naringin	naringin	NOUN
admet-647	136	29	,	,	PUNCT
admet-647	136	30	which	which	PRON
admet-647	136	31	may	may	AUX
admet-647	136	32	be	be	AUX
admet-647	136	33	responsible	responsible	ADJ
admet-647	136	34	for	for	ADP
admet-647	136	35	higher	high	ADJ
admet-647	136	36	percent	percent	NOUN
admet-647	136	37	reduction	reduction	NOUN
admet-647	136	38	in	in	ADP
admet-647	136	39	both	both	CCONJ
admet-647	136	40	cholesterol	cholesterol	NOUN
admet-647	136	41	and	and	CCONJ
admet-647	136	42	triglycerides	triglyceride	NOUN
admet-647	136	43	levels	level	NOUN
admet-647	136	44	by	by	ADP
admet-647	136	45	ast	ast	NOUN
admet-647	136	46	.	.	PUNCT
admet-647	137	1	the	the	DET
admet-647	137	2	treatment	treatment	NOUN
admet-647	137	3	of	of	ADP
admet-647	137	4	hyperlipidemic	hyperlipidemic	ADJ
admet-647	137	5	patients	patient	NOUN
admet-647	137	6	with	with	ADP
admet-647	137	7	ast	ast	NOUN
admet-647	137	8	along	along	ADP
admet-647	137	9	with	with	ADP
admet-647	137	10	naringin	naringin	NOUN
admet-647	137	11	rich	rich	ADJ
admet-647	137	12	diet	diet	NOUN
admet-647	137	13	may	may	AUX
admet-647	137	14	potentiate	potentiate	VERB
admet-647	137	15	the	the	DET
admet-647	137	16	therapeutic	therapeutic	ADJ
admet-647	137	17	efficacy	efficacy	NOUN
admet-647	137	18	of	of	ADP
admet-647	137	19	ast	ast	NOUN
admet-647	137	20	and	and	CCONJ
admet-647	137	21	could	could	AUX
admet-647	137	22	be	be	AUX
admet-647	137	23	exploited	exploit	VERB
admet-647	137	24	to	to	PART
admet-647	137	25	achieve	achieve	VERB
admet-647	137	26	better	well	ADJ
admet-647	137	27	therapeutic	therapeutic	ADJ
admet-647	137	28	control	control	NOUN
admet-647	137	29	and	and	CCONJ
admet-647	137	30	patient	patient	ADJ
admet-647	137	31	compliance	compliance	NOUN
admet-647	137	32	.	.	PUNCT
admet-647	138	1	admet	admet	PROPN
admet-647	138	2	&	&	CCONJ
admet-647	138	3	dmpk	dmpk	PROPN
admet-647	138	4	7(3	7(3	NUM
admet-647	138	5	)	)	PUNCT
admet-647	138	6	(	(	PUNCT
admet-647	138	7	2019	2019	NUM
admet-647	138	8	)	)	PUNCT
admet-647	138	9	174	174	NUM
admet-647	138	10	-	-	SYM
admet-647	138	11	182	182	NUM
admet-647	138	12	effect	effect	NOUN
admet-647	138	13	of	of	ADP
admet-647	138	14	naringin	naringin	NOUN
admet-647	138	15	on	on	ADP
admet-647	138	16	atorvastatin	atorvastatin	PROPN
admet-647	138	17	doi	doi	PROPN
admet-647	138	18	:	:	PUNCT
admet-647	138	19	10.5599	10.5599	NUM
admet-647	138	20	/	/	SYM
admet-647	138	21	admet.647	admet.647	ADJ
admet-647	138	22	181	181	NUM
admet-647	138	23	acknowledgments	acknowledgment	NOUN
admet-647	138	24	the	the	DET
admet-647	138	25	authors	author	NOUN
admet-647	138	26	wish	wish	VERB
admet-647	138	27	to	to	PART
admet-647	138	28	thank	thank	VERB
admet-647	138	29	the	the	DET
admet-647	138	30	aicte	aicte	NOUN
admet-647	138	31	for	for	ADP
admet-647	138	32	providing	provide	VERB
admet-647	138	33	financial	financial	ADJ
admet-647	138	34	support	support	NOUN
admet-647	138	35	and	and	CCONJ
admet-647	138	36	college	college	NOUN
admet-647	138	37	management	management	NOUN
admet-647	138	38	for	for	ADP
admet-647	138	39	encouragement	encouragement	NOUN
admet-647	138	40	and	and	CCONJ
admet-647	138	41	providing	provide	VERB
admet-647	138	42	facilities	facility	NOUN
admet-647	138	43	.	.	PUNCT
admet-647	139	1	conflict	conflict	NOUN
admet-647	139	2	of	of	ADP
admet-647	139	3	interest	interest	NOUN
admet-647	139	4	:	:	PUNCT
admet-647	139	5	ramesh	ramesh	PROPN
admet-647	139	6	mullangi	mullangi	PROPN
admet-647	139	7	is	be	AUX
admet-647	139	8	vice	vice	NOUN
admet-647	139	9	president	president	NOUN
admet-647	139	10	of	of	ADP
admet-647	139	11	jubilantbiosys	jubilantbiosys	PROPN
admet-647	139	12	.	.	PUNCT
admet-647	140	1	references	reference	NOUN
admet-647	140	2	[	[	X
admet-647	140	3	1	1	NUM
admet-647	140	4	]	]	X
admet-647	140	5	n.	n.	PROPN
admet-647	140	6	atal	atal	PROPN
admet-647	140	7	,	,	PUNCT
admet-647	140	8	k.l	k.l	PROPN
admet-647	140	9	.	.	PROPN
admet-647	140	10	bedi	bedi	PROPN
admet-647	140	11	.	.	PUNCT
admet-647	141	1	bioenhancers	bioenhancer	NOUN
admet-647	141	2	:	:	PUNCT
admet-647	141	3	revolutionary	revolutionary	ADJ
admet-647	141	4	concept	concept	NOUN
admet-647	141	5	to	to	ADP
admet-647	141	6	market	market	NOUN
admet-647	141	7	.	.	PUNCT
admet-647	142	1	journal	journal	NOUN
admet-647	142	2	of	of	ADP
admet-647	142	3	ayurveda	ayurveda	NOUN
admet-647	142	4	and	and	CCONJ
admet-647	142	5	integrative	integrative	ADJ
admet-647	142	6	medicine	medicine	NOUN
admet-647	142	7	1	1	NUM
admet-647	142	8	(	(	PUNCT
admet-647	142	9	2010	2010	NUM
admet-647	142	10	)	)	PUNCT
admet-647	142	11	96	96	NUM
admet-647	142	12	-	-	SYM
admet-647	142	13	99	99	NUM
admet-647	142	14	.	.	PUNCT
admet-647	143	1	[	[	X
admet-647	143	2	2	2	NUM
admet-647	143	3	]	]	X
admet-647	143	4	k.g	k.g	PROPN
admet-647	143	5	.	.	PROPN
admet-647	143	6	bose	bose	PROPN
admet-647	143	7	.	.	PUNCT
admet-647	144	1	1929	1929	NUM
admet-647	144	2	.	.	PUNCT
admet-647	145	1	pharmacographia	pharmacographia	NOUN
admet-647	145	2	indica	indica	PROPN
admet-647	145	3	,	,	PUNCT
admet-647	145	4	bose	bose	NOUN
admet-647	145	5	laboratories	laboratory	NOUN
admet-647	145	6	,	,	PUNCT
admet-647	145	7	calcutta	calcutta	NOUN
admet-647	145	8	,	,	PUNCT
admet-647	145	9	india	india	PROPN
admet-647	145	10	.	.	PUNCT
admet-647	146	1	[	[	X
admet-647	146	2	3	3	X
admet-647	146	3	]	]	X
admet-647	146	4	r.	r.	PROPN
admet-647	146	5	singh	singh	PROPN
admet-647	146	6	,	,	PUNCT
admet-647	146	7	s.	s.	PROPN
admet-647	146	8	devi	devi	PROPN
admet-647	146	9	,	,	PUNCT
admet-647	146	10	j.h	j.h	PROPN
admet-647	146	11	.	.	PROPN
admet-647	146	12	patel	patel	PROPN
admet-647	146	13	.	.	PUNCT
admet-647	147	1	indian	indian	ADJ
admet-647	147	2	herbal	herbal	ADJ
admet-647	147	3	bioenhancers	bioenhancer	NOUN
admet-647	147	4	:	:	PUNCT
admet-647	147	5	a	a	DET
admet-647	147	6	review	review	NOUN
admet-647	147	7	.	.	PUNCT
admet-647	148	1	pharmacognosy	pharmacognosy	NOUN
admet-647	148	2	reviews	review	NOUN
admet-647	148	3	3	3	NUM
admet-647	148	4	(	(	PUNCT
admet-647	148	5	2009	2009	NUM
admet-647	148	6	)	)	PUNCT
admet-647	148	7	90	90	NUM
admet-647	148	8	-	-	SYM
admet-647	148	9	92	92	NUM
admet-647	148	10	.	.	PUNCT
admet-647	149	1	[	[	X
admet-647	149	2	4	4	NUM
admet-647	149	3	]	]	X
admet-647	149	4	r.f	r.f	PROPN
admet-647	149	5	.	.	PROPN
admet-647	149	6	albach	albach	PROPN
admet-647	149	7	,	,	PUNCT
admet-647	149	8	g.h	g.h	PROPN
admet-647	149	9	.	.	PROPN
admet-647	149	10	redman	redman	PROPN
admet-647	149	11	.	.	PUNCT
admet-647	150	1	composition	composition	NOUN
admet-647	150	2	and	and	CCONJ
admet-647	150	3	inheritance	inheritance	NOUN
admet-647	150	4	of	of	ADP
admet-647	150	5	flavanones	flavanone	NOUN
admet-647	150	6	in	in	ADP
admet-647	150	7	citrus	citrus	NOUN
admet-647	150	8	fruit	fruit	NOUN
admet-647	150	9	.	.	PUNCT
admet-647	151	1	phytochemistry	phytochemistry	NOUN
admet-647	151	2	8	8	NUM
admet-647	151	3	(	(	PUNCT
admet-647	151	4	1969	1969	NUM
admet-647	151	5	)	)	PUNCT
admet-647	151	6	127	127	NUM
admet-647	151	7	-	-	SYM
admet-647	151	8	143	143	NUM
admet-647	151	9	.	.	PUNCT
admet-647	152	1	[	[	X
admet-647	152	2	5	5	X
admet-647	152	3	]	]	PUNCT
admet-647	152	4	g.	g.	PROPN
admet-647	152	5	scambia	scambia	PROPN
admet-647	152	6	,	,	PUNCT
admet-647	152	7	f.o	f.o	PROPN
admet-647	152	8	.	.	PROPN
admet-647	152	9	ranelletti	ranelletti	PROPN
admet-647	152	10	,	,	PUNCT
admet-647	152	11	p.b	p.b	PROPN
admet-647	152	12	.	.	PROPN
admet-647	152	13	panici	panici	PROPN
admet-647	152	14	,	,	PUNCT
admet-647	152	15	d.r	d.r	PROPN
admet-647	152	16	.	.	PROPN
admet-647	152	17	vincenzo	vincenzo	PROPN
admet-647	152	18	,	,	PUNCT
admet-647	152	19	g.	g.	PROPN
admet-647	152	20	bonanno	bonanno	PROPN
admet-647	152	21	,	,	PUNCT
admet-647	152	22	g.	g.	PROPN
admet-647	152	23	frrandina	frrandina	PROPN
admet-647	152	24	,	,	PUNCT
admet-647	152	25	m.	m.	NOUN
admet-647	152	26	paiantelle	paiantelle	PROPN
admet-647	152	27	,	,	PUNCT
admet-647	152	28	s.	s.	PROPN
admet-647	152	29	bussa	bussa	PROPN
admet-647	152	30	,	,	PUNCT
admet-647	152	31	c.	c.	PROPN
admet-647	152	32	rumi	rumi	PROPN
admet-647	152	33	,	,	PUNCT
admet-647	152	34	m.	m.	NOUN
admet-647	152	35	ciantriglia	ciantriglia	PROPN
admet-647	152	36	.	.	PUNCT
admet-647	153	1	quercetin	quercetin	NOUN
admet-647	153	2	potentiates	potentiate	VERB
admet-647	153	3	the	the	DET
admet-647	153	4	effect	effect	NOUN
admet-647	153	5	of	of	ADP
admet-647	153	6	adriamycin	adriamycin	NOUN
admet-647	153	7	in	in	ADP
admet-647	153	8	a	a	DET
admet-647	153	9	multidurgresistant	multidurgresistant	NOUN
admet-647	153	10	mcf-7	mcf-7	PUNCT
admet-647	153	11	human	human	ADJ
admet-647	153	12	breast	breast	NOUN
admet-647	153	13	-	-	PUNCT
admet-647	153	14	cancer	cancer	NOUN
admet-647	153	15	cell	cell	NOUN
admet-647	153	16	line	line	NOUN
admet-647	153	17	:	:	PUNCT
admet-647	153	18	p	p	X
admet-647	153	19	-	-	PUNCT
admet-647	153	20	glycoprotein	glycoprotein	NOUN
admet-647	153	21	as	as	ADP
admet-647	153	22	a	a	DET
admet-647	153	23	possible	possible	ADJ
admet-647	153	24	target	target	NOUN
admet-647	153	25	.	.	PUNCT
admet-647	154	1	cancer	cancer	NOUN
admet-647	154	2	chemotherapy	chemotherapy	NOUN
admet-647	154	3	and	and	CCONJ
admet-647	154	4	pharmacology	pharmacology	NOUN
admet-647	154	5	36	36	NUM
admet-647	154	6	(	(	PUNCT
admet-647	154	7	1995	1995	NUM
admet-647	154	8	)	)	PUNCT
admet-647	154	9	448	448	NUM
admet-647	154	10	-	-	SYM
admet-647	154	11	450	450	NUM
admet-647	154	12	.	.	PUNCT
admet-647	155	1	[	[	X
admet-647	155	2	6	6	NUM
admet-647	155	3	]	]	X
admet-647	155	4	d.g	d.g	PROPN
admet-647	155	5	.	.	PROPN
admet-647	155	6	bailey	bailey	PROPN
admet-647	155	7	,	,	PUNCT
admet-647	155	8	j.m	j.m	PROPN
admet-647	155	9	.	.	PROPN
admet-647	155	10	arnold	arnold	PROPN
admet-647	155	11	,	,	PUNCT
admet-647	155	12	j.d	j.d	PROPN
admet-647	155	13	.	.	PROPN
admet-647	155	14	munoz	munoz	PROPN
admet-647	155	15	spence	spence	PROPN
admet-647	155	16	.	.	PUNCT
admet-647	156	1	grapefruit	grapefruit	PROPN
admet-647	156	2	juice	juice	PROPN
admet-647	156	3	-	-	PUNCT
admet-647	156	4	felodipine	felodipine	NOUN
admet-647	156	5	interaction	interaction	NOUN
admet-647	156	6	:	:	PUNCT
admet-647	156	7	mechanism	mechanism	NOUN
admet-647	156	8	,	,	PUNCT
admet-647	156	9	predictability	predictability	NOUN
admet-647	156	10	,	,	PUNCT
admet-647	156	11	and	and	CCONJ
admet-647	156	12	effect	effect	NOUN
admet-647	156	13	of	of	ADP
admet-647	156	14	naringin	naringin	NOUN
admet-647	156	15	.	.	PUNCT
admet-647	157	1	clinical	clinical	ADJ
admet-647	157	2	pharmacology	pharmacology	NOUN
admet-647	157	3	&	&	CCONJ
admet-647	157	4	therapeutics	therapeutic	NOUN
admet-647	157	5	53	53	NUM
admet-647	157	6	(	(	PUNCT
admet-647	157	7	1993	1993	NUM
admet-647	157	8	)	)	PUNCT
admet-647	157	9	637	637	NUM
admet-647	157	10	-	-	SYM
admet-647	157	11	642	642	NUM
admet-647	157	12	.	.	PUNCT
admet-647	158	1	[	[	X
admet-647	158	2	7	7	X
admet-647	158	3	]	]	X
admet-647	158	4	h.	h.	PROPN
admet-647	158	5	peter	peter	PROPN
admet-647	158	6	,	,	PUNCT
admet-647	158	7	t.	t.	PROPN
admet-647	158	8	pavel	pavel	PROPN
admet-647	158	9	,	,	PUNCT
admet-647	158	10	s.	s.	PROPN
admet-647	158	11	marie	marie	PROPN
admet-647	158	12	.	.	PUNCT
admet-647	159	1	flavoniods	flavoniod	NOUN
admet-647	159	2	-	-	PUNCT
admet-647	159	3	potent	potent	ADJ
admet-647	159	4	and	and	CCONJ
admet-647	159	5	versatile	versatile	ADV
admet-647	159	6	biologically	biologically	ADV
admet-647	159	7	active	active	ADJ
admet-647	159	8	compounds	compound	NOUN
admet-647	159	9	interacting	interact	VERB
admet-647	159	10	with	with	ADP
admet-647	159	11	cytochrome	cytochrome	ADJ
admet-647	159	12	p450	p450	PROPN
admet-647	159	13	.	.	PUNCT
admet-647	160	1	chemico	chemico	ADJ
admet-647	160	2	-	-	ADJ
admet-647	160	3	biological	biological	ADJ
admet-647	160	4	interactions	interaction	NOUN
admet-647	160	5	139	139	NUM
admet-647	160	6	(	(	PUNCT
admet-647	160	7	2002	2002	NUM
admet-647	160	8	)	)	PUNCT
admet-647	160	9	1	1	NUM
admet-647	160	10	-	-	SYM
admet-647	160	11	12	12	NUM
admet-647	160	12	.	.	PUNCT
admet-647	161	1	[	[	X
admet-647	161	2	8	8	X
admet-647	161	3	]	]	X
admet-647	161	4	h.	h.	PROPN
admet-647	161	5	doostdar	doostdar	PROPN
admet-647	161	6	,	,	PUNCT
admet-647	161	7	m.d	m.d	PROPN
admet-647	161	8	.	.	PROPN
admet-647	161	9	burke	burke	PROPN
admet-647	161	10	,	,	PUNCT
admet-647	161	11	r.t	r.t	PROPN
admet-647	161	12	.	.	PROPN
admet-647	161	13	mayer	mayer	PROPN
admet-647	161	14	.	.	PUNCT
admet-647	162	1	bioflavonoids	bioflavonoid	NOUN
admet-647	162	2	:	:	PUNCT
admet-647	162	3	selective	selective	ADJ
admet-647	162	4	substrates	substrate	NOUN
admet-647	162	5	and	and	CCONJ
admet-647	162	6	inhibitors	inhibitor	NOUN
admet-647	162	7	for	for	ADP
admet-647	162	8	cytochrome	cytochrome	ADJ
admet-647	162	9	p450	p450	PROPN
admet-647	162	10	(	(	PUNCT
admet-647	162	11	cyp1a	cyp1a	X
admet-647	162	12	and	and	CCONJ
admet-647	162	13	cyp1b1	cyp1b1	NOUN
admet-647	162	14	)	)	PUNCT
admet-647	162	15	.	.	PUNCT
admet-647	163	1	toxicology	toxicology	NOUN
admet-647	163	2	144	144	NUM
admet-647	163	3	(	(	PUNCT
admet-647	163	4	2000	2000	NUM
admet-647	163	5	)	)	PUNCT
admet-647	163	6	31	31	NUM
admet-647	163	7	-	-	SYM
admet-647	163	8	38	38	NUM
admet-647	163	9	.	.	PUNCT
admet-647	164	1	[	[	X
admet-647	164	2	9	9	NUM
admet-647	164	3	]	]	X
admet-647	164	4	f.	f.	PROPN
admet-647	164	5	fukuda	fukuda	PROPN
admet-647	164	6	,	,	PUNCT
admet-647	164	7	t.	t.	PROPN
admet-647	164	8	ohta	ohta	PROPN
admet-647	164	9	,	,	PUNCT
admet-647	164	10	y.	y.	PROPN
admet-647	164	11	yamazoe	yamazoe	PROPN
admet-647	164	12	.	.	PUNCT
admet-647	165	1	grapefruit	grapefruit	NOUN
admet-647	165	2	component	component	NOUN
admet-647	165	3	interacting	interact	VERB
admet-647	165	4	with	with	ADP
admet-647	165	5	rat	rat	NOUN
admet-647	165	6	and	and	CCONJ
admet-647	165	7	human	human	ADJ
admet-647	165	8	p450	p450	PROPN
admet-647	165	9	cyp3a	cyp3a	PROPN
admet-647	165	10	:	:	PUNCT
admet-647	165	11	possible	possible	ADJ
admet-647	165	12	involvement	involvement	NOUN
admet-647	165	13	of	of	ADP
admet-647	165	14	non	non	ADJ
admet-647	165	15	-	-	ADJ
admet-647	165	16	flavonoid	flavonoid	ADJ
admet-647	165	17	components	component	NOUN
admet-647	165	18	in	in	ADP
admet-647	165	19	drug	drug	NOUN
admet-647	165	20	interaction	interaction	NOUN
admet-647	165	21	.	.	PUNCT
admet-647	166	1	biological	biological	ADJ
admet-647	166	2	and	and	CCONJ
admet-647	166	3	pharmaceutical	pharmaceutical	ADJ
admet-647	166	4	bulletin	bulletin	NOUN
admet-647	166	5	20	20	NUM
admet-647	166	6	(	(	PUNCT
admet-647	166	7	1997	1997	NUM
admet-647	166	8	)	)	PUNCT
admet-647	166	9	560	560	NUM
admet-647	166	10	-	-	SYM
admet-647	166	11	564	564	NUM
admet-647	166	12	.	.	PUNCT
admet-647	167	1	[	[	X
admet-647	167	2	10	10	NUM
admet-647	167	3	]	]	X
admet-647	167	4	a.a	a.a	PROPN
admet-647	167	5	.	.	PROPN
admet-647	167	6	gammal	gammal	PROPN
admet-647	167	7	,	,	PUNCT
admet-647	167	8	r.m	r.m	PROPN
admet-647	167	9	.	.	PROPN
admet-647	167	10	mansour	mansour	PROPN
admet-647	167	11	.	.	PROPN
admet-647	167	12	antimicrobial	antimicrobial	ADJ
admet-647	167	13	activities	activity	NOUN
admet-647	167	14	of	of	ADP
admet-647	167	15	some	some	DET
admet-647	167	16	flavonoid	flavonoid	NOUN
admet-647	167	17	compound	compound	NOUN
admet-647	167	18	.	.	PUNCT
admet-647	168	1	zentralbl	zentralbl	PROPN
admet-647	168	2	mikrobiol[ta	mikrobiol[ta	PROPN
admet-647	168	3	]	]	X
admet-647	168	4	141	141	NUM
admet-647	168	5	(	(	PUNCT
admet-647	168	6	1986	1986	NUM
admet-647	168	7	)	)	PUNCT
admet-647	168	8	561	561	NUM
admet-647	168	9	-	-	SYM
admet-647	168	10	565	565	NUM
admet-647	168	11	.	.	PUNCT
admet-647	169	1	[	[	X
admet-647	169	2	11	11	NUM
admet-647	169	3	]	]	X
admet-647	169	4	v.s.	v.s.	PROPN
admet-647	169	5	aboobaker	aboobaker	PROPN
admet-647	169	6	,	,	PUNCT
admet-647	169	7	a.d	a.d	PROPN
admet-647	169	8	.	.	PROPN
admet-647	169	9	balgi	balgi	PROPN
admet-647	169	10	,	,	PUNCT
admet-647	169	11	r.k	r.k	PROPN
admet-647	169	12	.	.	PROPN
admet-647	169	13	bhattacharya	bhattacharya	PROPN
admet-647	169	14	.	.	PUNCT
admet-647	170	1	in	in	ADP
admet-647	170	2	vivo	vivo	ADJ
admet-647	170	3	effect	effect	NOUN
admet-647	170	4	of	of	ADP
admet-647	170	5	dietary	dietary	ADJ
admet-647	170	6	factors	factor	NOUN
admet-647	170	7	on	on	ADP
admet-647	170	8	the	the	DET
admet-647	170	9	molecular	molecular	ADJ
admet-647	170	10	action	action	NOUN
admet-647	170	11	of	of	ADP
admet-647	170	12	aflatoxin	aflatoxin	NOUN
admet-647	170	13	b1	b1	NOUN
admet-647	170	14	:	:	PUNCT
admet-647	170	15	role	role	NOUN
admet-647	170	16	of	of	ADP
admet-647	170	17	non	non	ADJ
admet-647	170	18	-	-	ADJ
admet-647	170	19	nutrient	nutrient	ADJ
admet-647	170	20	phenolic	phenolic	NOUN
admet-647	170	21	compounds	compound	NOUN
admet-647	170	22	on	on	ADP
admet-647	170	23	the	the	DET
admet-647	170	24	catalytic	catalytic	ADJ
admet-647	170	25	activity	activity	NOUN
admet-647	170	26	of	of	ADP
admet-647	170	27	liver	liver	NOUN
admet-647	170	28	fraction	fraction	NOUN
admet-647	170	29	.	.	PUNCT
admet-647	171	1	in	in	ADP
admet-647	171	2	vivo	vivo	NOUN
admet-647	171	3	8	8	NUM
admet-647	171	4	(	(	PUNCT
admet-647	171	5	1994	1994	NUM
admet-647	171	6	)	)	PUNCT
admet-647	171	7	1095	1095	NUM
admet-647	171	8	-	-	SYM
admet-647	171	9	1098	1098	NUM
admet-647	171	10	.	.	PUNCT
admet-647	172	1	[	[	X
admet-647	172	2	12	12	NUM
admet-647	172	3	]	]	X
admet-647	172	4	p.b	p.b	PROPN
admet-647	172	5	.	.	PROPN
admet-647	172	6	gordon	gordon	PROPN
admet-647	172	7	,	,	PUNCT
admet-647	172	8	i.	i.	PROPN
admet-647	172	9	holen	holen	PROPN
admet-647	172	10	,	,	PUNCT
admet-647	172	11	p.o	p.o	PROPN
admet-647	172	12	.	.	PROPN
admet-647	172	13	seglen	seglen	PROPN
admet-647	172	14	.	.	PUNCT
admet-647	173	1	protection	protection	NOUN
admet-647	173	2	by	by	ADP
admet-647	173	3	naringin	naringin	NOUN
admet-647	173	4	and	and	CCONJ
admet-647	173	5	some	some	DET
admet-647	173	6	other	other	ADJ
admet-647	173	7	flavonoids	flavonoid	NOUN
admet-647	173	8	of	of	ADP
admet-647	173	9	hepatocytic	hepatocytic	ADJ
admet-647	173	10	autophagy	autophagy	NOUN
admet-647	173	11	and	and	CCONJ
admet-647	173	12	endocytosis	endocytosis	NOUN
admet-647	173	13	against	against	ADP
admet-647	173	14	inhibition	inhibition	NOUN
admet-647	173	15	by	by	ADP
admet-647	173	16	okadaic	okadaic	ADJ
admet-647	173	17	acid	acid	PROPN
admet-647	173	18	.	.	PUNCT
admet-647	174	1	journal	journal	NOUN
admet-647	174	2	of	of	ADP
admet-647	174	3	biological	biological	ADJ
admet-647	174	4	chemistry	chemistry	NOUN
admet-647	174	5	270	270	NUM
admet-647	174	6	(	(	PUNCT
admet-647	174	7	1995	1995	NUM
admet-647	174	8	)	)	PUNCT
admet-647	174	9	5830	5830	NUM
admet-647	174	10	-	-	SYM
admet-647	174	11	5838	5838	NUM
admet-647	174	12	.	.	PUNCT
admet-647	175	1	[	[	X
admet-647	175	2	13	13	NUM
admet-647	175	3	]	]	X
admet-647	175	4	j.g	j.g	PROPN
admet-647	175	5	.	.	PROPN
admet-647	175	6	liu	liu	PROPN
admet-647	175	7	,	,	PUNCT
admet-647	175	8	y.m	y.m	PROPN
admet-647	175	9	.	.	PROPN
admet-647	175	10	xie	xie	PROPN
admet-647	175	11	,	,	PUNCT
admet-647	175	12	w.l	w.l	PROPN
admet-647	175	13	.	.	PROPN
admet-647	175	14	deng	deng	PROPN
admet-647	175	15	.	.	PUNCT
admet-647	175	16	experimental	experimental	ADJ
admet-647	175	17	study	study	NOUN
admet-647	175	18	on	on	ADP
admet-647	175	19	anti	anti	ADJ
admet-647	175	20	-	-	ADJ
admet-647	175	21	inflammation	inflammation	ADJ
admet-647	175	22	effect	effect	NOUN
admet-647	175	23	of	of	ADP
admet-647	175	24	assemble	assemble	ADJ
admet-647	175	25	flavonoids	flavonoid	NOUN
admet-647	175	26	of	of	ADP
admet-647	175	27	rhizomadrynariae	rhizomadrynariae	NOUN
admet-647	175	28	.	.	PUNCT
admet-647	176	1	chinese	chinese	ADJ
admet-647	176	2	journal	journal	PROPN
admet-647	176	3	of	of	ADP
admet-647	176	4	natural	natural	ADJ
admet-647	176	5	medicines	medicine	NOUN
admet-647	176	6	2	2	NUM
admet-647	176	7	(	(	PUNCT
admet-647	176	8	2004	2004	NUM
admet-647	176	9	)	)	PUNCT
admet-647	176	10	232	232	NUM
admet-647	176	11	-	-	SYM
admet-647	176	12	234	234	NUM
admet-647	176	13	.	.	PUNCT
admet-647	177	1	[	[	X
admet-647	177	2	14	14	NUM
admet-647	177	3	]	]	X
admet-647	177	4	g.	g.	PROPN
admet-647	177	5	ekambaram	ekambaram	PROPN
admet-647	177	6	,	,	PUNCT
admet-647	177	7	p.	p.	NOUN
admet-647	177	8	rajendran	rajendran	NOUN
admet-647	177	9	,	,	PUNCT
admet-647	177	10	v.	v.	PROPN
admet-647	177	11	magesh	magesh	PROPN
admet-647	177	12	,	,	PUNCT
admet-647	177	13	d.	d.	PROPN
admet-647	177	14	sakthisekaran	sakthisekaran	PROPN
admet-647	177	15	.	.	PUNCT
admet-647	178	1	naringenin	naringenin	PROPN
admet-647	178	2	reduces	reduce	VERB
admet-647	178	3	tumor	tumor	NOUN
admet-647	178	4	size	size	NOUN
admet-647	178	5	and	and	CCONJ
admet-647	178	6	weight	weight	NOUN
admet-647	178	7	lost	lose	VERB
admet-647	178	8	in	in	ADP
admet-647	178	9	n	n	CCONJ
admet-647	178	10	-	-	PUNCT
admet-647	178	11	methyl	methyl	NOUN
admet-647	178	12	-	-	PUNCT
admet-647	178	13	n′-nitro	n′-nitro	NUM
admet-647	178	14	-	-	PUNCT
admet-647	178	15	n	n	CCONJ
admet-647	178	16	-	-	PUNCT
admet-647	178	17	nitrosoguanidine	nitrosoguanidine	NOUN
admet-647	178	18	–	–	PUNCT
admet-647	178	19	induced	induce	VERB
admet-647	178	20	gastric	gastric	ADJ
admet-647	178	21	carcinogenesis	carcinogenesis	NOUN
admet-647	178	22	in	in	ADP
admet-647	178	23	rats	rat	NOUN
admet-647	178	24	.	.	PUNCT
admet-647	179	1	nutrition	nutrition	NOUN
admet-647	179	2	research	research	NOUN
admet-647	179	3	28	28	NUM
admet-647	179	4	(	(	PUNCT
admet-647	179	5	2008	2008	NUM
admet-647	179	6	)	)	PUNCT
admet-647	179	7	106	106	NUM
admet-647	179	8	-	-	SYM
admet-647	179	9	112	112	NUM
admet-647	179	10	.	.	PUNCT
admet-647	180	1	[	[	X
admet-647	180	2	15	15	NUM
admet-647	180	3	]	]	X
admet-647	180	4	y.c	y.c	PROPN
admet-647	180	5	.	.	PROPN
admet-647	180	6	hsiao	hsiao	PROPN
admet-647	180	7	,	,	PUNCT
admet-647	180	8	w.h	w.h	PROPN
admet-647	180	9	.	.	PROPN
admet-647	180	10	kuo	kuo	PROPN
admet-647	180	11	,	,	PUNCT
admet-647	180	12	p.n	p.n	PROPN
admet-647	180	13	.	.	PROPN
admet-647	180	14	chen	chen	PROPN
admet-647	180	15	,	,	PUNCT
admet-647	180	16	h.r	h.r	PROPN
admet-647	180	17	.	.	PROPN
admet-647	180	18	chang	chang	PROPN
admet-647	180	19	,	,	PUNCT
admet-647	180	20	t.h	t.h	PROPN
admet-647	180	21	lin	lin	PROPN
admet-647	180	22	,	,	PUNCT
admet-647	180	23	w.e	w.e	PROPN
admet-647	180	24	.	.	PROPN
admet-647	180	25	yang	yang	PROPN
admet-647	180	26	.	.	PUNCT
admet-647	181	1	flavanone	flavanone	NOUN
admet-647	181	2	and	and	CCONJ
admet-647	181	3	2′-oh	2′-oh	NUM
admet-647	181	4	flavanone	flavanone	NOUN
admet-647	181	5	inhibit	inhibit	NOUN
admet-647	181	6	metastasis	metastasis	NOUN
admet-647	181	7	of	of	ADP
admet-647	181	8	lung	lung	NOUN
admet-647	181	9	cancer	cancer	NOUN
admet-647	181	10	cells	cell	NOUN
admet-647	181	11	via	via	ADP
admet-647	181	12	down	down	ADP
admet-647	181	13	-	-	PUNCT
admet-647	181	14	regulation	regulation	NOUN
admet-647	181	15	of	of	ADP
admet-647	181	16	proteinases	proteinase	NOUN
admet-647	181	17	activities	activity	NOUN
admet-647	181	18	and	and	CCONJ
admet-647	181	19	mapk	mapk	ADJ
admet-647	181	20	pathway	pathway	NOUN
admet-647	181	21	.	.	PUNCT
admet-647	182	1	chemico	chemico	PROPN
admet-647	182	2	biological	biological	ADJ
admet-647	182	3	interactions	interaction	NOUN
admet-647	182	4	167	167	NUM
admet-647	182	5	(	(	PUNCT
admet-647	182	6	2007	2007	NUM
admet-647	182	7	)	)	PUNCT
admet-647	182	8	193	193	NUM
admet-647	182	9	-	-	SYM
admet-647	182	10	206	206	NUM
admet-647	182	11	.	.	PUNCT
admet-647	183	1	[	[	X
admet-647	183	2	16	16	NUM
admet-647	183	3	]	]	X
admet-647	183	4	d.	d.	PROPN
admet-647	183	5	ozyurt	ozyurt	PROPN
admet-647	183	6	,	,	PUNCT
admet-647	183	7	b.	b.	PROPN
admet-647	183	8	demirata	demirata	PROPN
admet-647	183	9	,	,	PUNCT
admet-647	183	10	r.	r.	PROPN
admet-647	183	11	apak	apak	PROPN
admet-647	183	12	.	.	PUNCT
admet-647	184	1	determination	determination	NOUN
admet-647	184	2	of	of	ADP
admet-647	184	3	total	total	ADJ
admet-647	184	4	antioxidant	antioxidant	ADJ
admet-647	184	5	capacity	capacity	NOUN
admet-647	184	6	by	by	ADP
admet-647	184	7	a	a	DET
admet-647	184	8	new	new	ADJ
admet-647	184	9	spectrophotometric	spectrophotometric	ADJ
admet-647	184	10	method	method	NOUN
admet-647	184	11	based	base	VERB
admet-647	184	12	on	on	ADP
admet-647	184	13	ce	ce	PROPN
admet-647	184	14	(	(	PUNCT
admet-647	184	15	iv	iv	X
admet-647	184	16	)	)	PUNCT
admet-647	184	17	reducing	reduce	VERB
admet-647	184	18	capacity	capacity	NOUN
admet-647	184	19	measurement	measurement	NOUN
admet-647	184	20	.	.	PUNCT
admet-647	185	1	talanta	talanta	PROPN
admet-647	185	2	71	71	NUM
admet-647	185	3	(	(	PUNCT
admet-647	185	4	2007	2007	NUM
admet-647	185	5	)	)	PUNCT
admet-647	185	6	1155	1155	NUM
admet-647	185	7	-	-	SYM
admet-647	185	8	1165	1165	NUM
admet-647	185	9	.	.	PUNCT
admet-647	186	1	r.	r.	PROPN
admet-647	186	2	mullangi	mullangi	VERB
admet-647	186	3	et	et	PROPN
admet-647	186	4	al	al	PROPN
admet-647	186	5	.	.	PROPN
admet-647	186	6	admet	admet	PROPN
admet-647	186	7	&	&	CCONJ
admet-647	186	8	dmpk	dmpk	PROPN
admet-647	186	9	7(3	7(3	NUM
admet-647	186	10	)	)	PUNCT
admet-647	186	11	(	(	PUNCT
admet-647	186	12	2019	2019	NUM
admet-647	186	13	)	)	PUNCT
admet-647	186	14	174	174	NUM
admet-647	186	15	-	-	SYM
admet-647	186	16	182	182	NUM
admet-647	186	17	182	182	NUM
admet-647	186	18	[	[	X
admet-647	186	19	17	17	NUM
admet-647	186	20	]	]	X
admet-647	186	21	a.k	a.k	PROPN
admet-647	186	22	.	.	PROPN
admet-647	186	23	ratty	ratty	PROPN
admet-647	186	24	,	,	PUNCT
admet-647	186	25	n.f	n.f	PROPN
admet-647	186	26	.	.	PUNCT
admet-647	186	27	das	das	PROPN
admet-647	186	28	.	.	PUNCT
admet-647	187	1	effects	effect	NOUN
admet-647	187	2	of	of	ADP
admet-647	187	3	flavonoids	flavonoid	NOUN
admet-647	187	4	on	on	ADP
admet-647	187	5	nonenzymatic	nonenzymatic	ADJ
admet-647	187	6	lipid	lipid	NOUN
admet-647	187	7	peroxidation	peroxidation	NOUN
admet-647	187	8	:	:	PUNCT
admet-647	187	9	structure	structure	NOUN
admet-647	187	10	–	–	PUNCT
admet-647	187	11	activity	activity	NOUN
admet-647	187	12	relationship	relationship	NOUN
admet-647	187	13	.	.	PUNCT
admet-647	188	1	biochemical	biochemical	ADJ
admet-647	188	2	medicine	medicine	NOUN
admet-647	188	3	and	and	CCONJ
admet-647	188	4	metabolic	metabolic	NOUN
admet-647	188	5	biology	biology	NOUN
admet-647	188	6	39	39	NUM
admet-647	188	7	(	(	PUNCT
admet-647	188	8	1988	1988	NUM
admet-647	188	9	)	)	PUNCT
admet-647	188	10	69	69	NUM
admet-647	188	11	-	-	SYM
admet-647	188	12	79	79	NUM
admet-647	188	13	.	.	PUNCT
admet-647	189	1	[	[	X
admet-647	189	2	18	18	NUM
admet-647	189	3	]	]	X
admet-647	189	4	s.h	s.h	PROPN
admet-647	189	5	.	.	PROPN
admet-647	189	6	bok	bok	PROPN
admet-647	189	7	,	,	PUNCT
admet-647	189	8	t.s	t.s	PROPN
admet-647	189	9	.	.	PROPN
admet-647	189	10	jeong	jeong	PROPN
admet-647	189	11	,	,	PUNCT
admet-647	189	12	k.h	k.h	PROPN
admet-647	189	13	.	.	PROPN
admet-647	189	14	bae	bae	PROPN
admet-647	189	15	,	,	PUNCT
admet-647	189	16	y.b	y.b	PROPN
admet-647	189	17	.	.	PROPN
admet-647	189	18	park	park	PROPN
admet-647	189	19	,	,	PUNCT
admet-647	189	20	m.s	m.s	PROPN
admet-647	189	21	.	.	PROPN
admet-647	189	22	choi	choi	PROPN
admet-647	189	23	,	,	PUNCT
admet-647	189	24	s.s	s.s	PROPN
admet-647	189	25	.	.	PROPN
admet-647	189	26	moon	moon	PROPN
admet-647	189	27	.	.	PUNCT
admet-647	190	1	naringin	naringin	PROPN
admet-647	190	2	and	and	CCONJ
admet-647	190	3	naringenin	naringenin	NOUN
admet-647	190	4	as	as	ADP
admet-647	190	5	inhibitors	inhibitor	NOUN
admet-647	190	6	of	of	ADP
admet-647	190	7	acyl	acyl	ADJ
admet-647	190	8	coa	coa	NOUN
admet-647	190	9	-	-	PUNCT
admet-647	190	10	cholesterol	cholesterol	NOUN
admet-647	190	11	-	-	PUNCT
admet-647	190	12	o	o	NOUN
admet-647	190	13	-	-	NOUN
admet-647	190	14	acyltransferase	acyltransferase	NOUN
admet-647	190	15	.	.	PUNCT
admet-647	191	1	united	united	PROPN
admet-647	191	2	states	states	PROPN
admet-647	191	3	patent	patent	PROPN
admet-647	191	4	,	,	PUNCT
admet-647	191	5	patent	patent	NOUN
admet-647	191	6	number	number	NOUN
admet-647	191	7	us006165984a	us006165984a	PROPN
admet-647	191	8	(	(	PUNCT
admet-647	191	9	2000	2000	NUM
admet-647	191	10	)	)	PUNCT
admet-647	191	11	.	.	PUNCT
admet-647	192	1	[	[	X
admet-647	192	2	19	19	NUM
admet-647	192	3	]	]	X
admet-647	192	4	h.j	h.j	PROPN
admet-647	192	5	.	.	PROPN
admet-647	192	6	kim	kim	PROPN
admet-647	192	7	,	,	PUNCT
admet-647	192	8	j.s	j.s	PROPN
admet-647	192	9	.	.	PROPN
admet-647	192	10	choi	choi	PROPN
admet-647	192	11	.	.	PUNCT
admet-647	193	1	effects	effect	NOUN
admet-647	193	2	of	of	ADP
admet-647	193	3	naringin	naringin	NOUN
admet-647	193	4	on	on	ADP
admet-647	193	5	the	the	DET
admet-647	193	6	pharmacokinetics	pharmacokinetic	NOUN
admet-647	193	7	of	of	ADP
admet-647	193	8	verapamil	verapamil	NOUN
admet-647	193	9	and	and	CCONJ
admet-647	193	10	one	one	NUM
admet-647	193	11	of	of	ADP
admet-647	193	12	its	its	PRON
admet-647	193	13	metabolites	metabolite	NOUN
admet-647	193	14	,	,	PUNCT
admet-647	193	15	norverapamil	norverapamil	NOUN
admet-647	193	16	in	in	ADP
admet-647	193	17	rabbit	rabbit	NOUN
admet-647	193	18	.	.	PUNCT
admet-647	194	1	biopharmaceutics	biopharmaceutics	NOUN
admet-647	194	2	and	and	CCONJ
admet-647	194	3	drug	drug	NOUN
admet-647	194	4	disposition	disposition	NOUN
admet-647	194	5	26	26	NUM
admet-647	194	6	(	(	PUNCT
admet-647	194	7	2005	2005	NUM
admet-647	194	8	)	)	PUNCT
admet-647	194	9	295	295	NUM
admet-647	194	10	-	-	SYM
admet-647	194	11	300	300	NUM
admet-647	194	12	.	.	PUNCT
admet-647	195	1	[	[	X
admet-647	195	2	20	20	NUM
admet-647	195	3	]	]	X
admet-647	195	4	j.s	j.s	PROPN
admet-647	195	5	.	.	PROPN
admet-647	195	6	choi	choi	PROPN
admet-647	195	7	,	,	PUNCT
admet-647	195	8	k.h	k.h	PROPN
admet-647	195	9	.	.	PROPN
admet-647	195	10	han	han	PROPN
admet-647	195	11	.	.	PROPN
admet-647	196	1	enhanced	enhance	VERB
admet-647	196	2	oral	oral	ADJ
admet-647	196	3	exposure	exposure	NOUN
admet-647	196	4	of	of	ADP
admet-647	196	5	diltiazem	diltiazem	NOUN
admet-647	196	6	by	by	ADP
admet-647	196	7	the	the	DET
admet-647	196	8	concomitant	concomitant	ADJ
admet-647	196	9	use	use	NOUN
admet-647	196	10	of	of	ADP
admet-647	196	11	naringin	naringin	NOUN
admet-647	196	12	in	in	ADP
admet-647	196	13	rats	rat	NOUN
admet-647	196	14	.	.	PUNCT
admet-647	197	1	international	international	ADJ
admet-647	197	2	journal	journal	PROPN
admet-647	197	3	of	of	ADP
admet-647	197	4	pharmaceutics	pharmaceutic	NOUN
admet-647	197	5	305	305	NUM
admet-647	197	6	(	(	PUNCT
admet-647	197	7	2005	2005	NUM
admet-647	197	8	)	)	PUNCT
admet-647	197	9	122	122	NUM
admet-647	197	10	-	-	SYM
admet-647	197	11	128	128	NUM
admet-647	197	12	.	.	PUNCT
admet-647	198	1	[	[	X
admet-647	198	2	21	21	NUM
admet-647	198	3	]	]	X
admet-647	198	4	j.s	j.s	PROPN
admet-647	198	5	.	.	PROPN
admet-647	198	6	choi	choi	PROPN
admet-647	198	7	,	,	PUNCT
admet-647	198	8	s.c	s.c	PROPN
admet-647	198	9	.	.	PROPN
admet-647	198	10	shin	shin	PROPN
admet-647	198	11	.	.	PUNCT
admet-647	199	1	enhanced	enhance	VERB
admet-647	199	2	paclitaxel	paclitaxel	PROPN
admet-647	199	3	bioavailability	bioavailability	NOUN
admet-647	199	4	after	after	ADP
admet-647	199	5	oral	oral	ADJ
admet-647	199	6	co	co	NOUN
admet-647	199	7	-	-	NOUN
admet-647	199	8	administration	administration	NOUN
admet-647	199	9	of	of	ADP
admet-647	199	10	paclitaxel	paclitaxel	PROPN
admet-647	199	11	prodrug	prodrug	VERB
admet-647	199	12	with	with	ADP
admet-647	199	13	naringin	naringin	NOUN
admet-647	199	14	to	to	ADP
admet-647	199	15	rats	rat	NOUN
admet-647	199	16	.	.	PUNCT
admet-647	200	1	international	international	ADJ
admet-647	200	2	journal	journal	PROPN
admet-647	200	3	of	of	ADP
admet-647	200	4	pharmaceutics	pharmaceutic	NOUN
admet-647	200	5	292	292	NUM
admet-647	200	6	(	(	PUNCT
admet-647	200	7	2005	2005	NUM
admet-647	200	8	)	)	PUNCT
admet-647	200	9	149	149	NUM
admet-647	200	10	-	-	SYM
admet-647	200	11	56	56	NUM
admet-647	200	12	.	.	PUNCT
admet-647	201	1	[	[	X
admet-647	201	2	22	22	NUM
admet-647	201	3	]	]	X
admet-647	201	4	j.s	j.s	PROPN
admet-647	201	5	.	.	PROPN
admet-647	201	6	choi	choi	PROPN
admet-647	201	7	,	,	PUNCT
admet-647	201	8	k.w	k.w	PROPN
admet-647	201	9	.	.	PROPN
admet-647	201	10	kang	kang	PROPN
admet-647	201	11	.	.	PROPN
admet-647	202	1	enhanced	enhance	VERB
admet-647	202	2	tamoxifen	tamoxifen	NOUN
admet-647	202	3	bioavailability	bioavailability	NOUN
admet-647	202	4	after	after	ADP
admet-647	202	5	oral	oral	ADJ
admet-647	202	6	administration	administration	NOUN
admet-647	202	7	of	of	ADP
admet-647	202	8	tamoxifen	tamoxifen	PROPN
admet-647	202	9	in	in	ADP
admet-647	202	10	rats	rat	NOUN
admet-647	202	11	pretreated	pretreate	VERB
admet-647	202	12	with	with	ADP
admet-647	202	13	naringin	naringin	NOUN
admet-647	202	14	.	.	PUNCT
admet-647	203	1	archives	archive	NOUN
admet-647	203	2	of	of	ADP
admet-647	203	3	pharmcal	pharmcal	ADJ
admet-647	203	4	research	research	NOUN
admet-647	203	5	31	31	NUM
admet-647	203	6	(	(	PUNCT
admet-647	203	7	2008	2008	NUM
admet-647	203	8	)	)	PUNCT
admet-647	203	9	1631	1631	NUM
admet-647	203	10	-	-	SYM
admet-647	203	11	1636	1636	NUM
admet-647	203	12	.	.	PUNCT
admet-647	204	1	[	[	X
admet-647	204	2	23	23	NUM
admet-647	204	3	]	]	PUNCT
admet-647	204	4	lipitor	lipitor	NOUN
admet-647	204	5	®	®	NOUN
admet-647	204	6	(	(	PUNCT
admet-647	204	7	atorvastatin	atorvastatin	PROPN
admet-647	204	8	)	)	PUNCT
admet-647	204	9	.	.	PUNCT
admet-647	205	1	data	datum	NOUN
admet-647	205	2	sheet	sheet	NOUN
admet-647	205	3	.	.	PUNCT
admet-647	206	1	pfizer	pfizer	PROPN
admet-647	206	2	new	new	PROPN
admet-647	206	3	zealand	zealand	PROPN
admet-647	206	4	ltd	ltd	PROPN
admet-647	206	5	,	,	PUNCT
admet-647	206	6	new	new	PROPN
admet-647	206	7	zealand	zealand	PROPN
admet-647	206	8	.	.	PROPN
admet-647	206	9	2012	2012	NUM
admet-647	206	10	,	,	PUNCT
admet-647	206	11	p.	p.	NOUN
admet-647	206	12	1	1	NUM
admet-647	206	13	-	-	SYM
admet-647	206	14	24	24	NUM
admet-647	206	15	.	.	PUNCT
admet-647	207	1	[	[	X
admet-647	207	2	24	24	NUM
admet-647	207	3	]	]	PUNCT
admet-647	207	4	product	product	NOUN
admet-647	207	5	monograph	monograph	NOUN
admet-647	207	6	,	,	PUNCT
admet-647	207	7	gd	gd	NOUN
admet-647	207	8	-	-	PUNCT
admet-647	207	9	atorvastatin	atorvastatin	NOUN
admet-647	207	10	(	(	PUNCT
admet-647	207	11	atorvastatin	atorvastatin	NOUN
admet-647	207	12	calcium	calcium	NOUN
admet-647	207	13	tablets	tablet	NOUN
admet-647	207	14	)	)	PUNCT
admet-647	207	15	.	.	PUNCT
admet-647	208	1	lipid	lipid	ADJ
admet-647	208	2	metabolism	metabolism	NOUN
admet-647	208	3	regulator	regulator	NOUN
admet-647	208	4	,	,	PUNCT
admet-647	208	5	gen	gen	PROPN
admet-647	208	6	med	med	PROPN
admet-647	208	7	,	,	PUNCT
admet-647	208	8	a	a	DET
admet-647	208	9	division	division	NOUN
admet-647	208	10	of	of	ADP
admet-647	208	11	pfizer	pfizer	PROPN
admet-647	208	12	canada	canada	PROPN
admet-647	208	13	inc	inc	PROPN
admet-647	208	14	.	.	PROPN
admet-647	208	15	2012	2012	NUM
admet-647	208	16	,	,	PUNCT
admet-647	208	17	p.	p.	NOUN
admet-647	208	18	1	1	NUM
admet-647	208	19	-	-	SYM
admet-647	208	20	54	54	NUM
admet-647	208	21	.	.	PUNCT
admet-647	209	1	[	[	X
admet-647	209	2	25	25	NUM
admet-647	209	3	]	]	X
admet-647	209	4	h.	h.	PROPN
admet-647	209	5	g.	g.	PROPN
admet-647	209	6	vogel	vogel	PROPN
admet-647	209	7	.	.	PUNCT
admet-647	209	8	drug	drug	NOUN
admet-647	209	9	discovery	discovery	PROPN
admet-647	209	10	and	and	CCONJ
admet-647	209	11	evaluation	evaluation	NOUN
admet-647	209	12	.	.	PUNCT
admet-647	210	1	pharmacological	pharmacological	ADJ
admet-647	210	2	assays	assay	NOUN
admet-647	210	3	.	.	PUNCT
admet-647	211	1	ed(2	ed(2	NOUN
admet-647	211	2	)	)	PUNCT
admet-647	211	3	.	.	PUNCT
admet-647	212	1	springer	springer	NOUN
admet-647	212	2	,	,	PUNCT
admet-647	212	3	2002	2002	NUM
admet-647	212	4	,	,	PUNCT
admet-647	212	5	p.	p.	NOUN
admet-647	212	6	11061107	11061107	NUM
admet-647	212	7	.	.	PUNCT
admet-647	213	1	[	[	X
admet-647	213	2	26	26	NUM
admet-647	213	3	]	]	PUNCT
admet-647	213	4	a.	a.	NOUN
admet-647	213	5	mohammadi	mohammadi	NOUN
admet-647	213	6	,	,	PUNCT
admet-647	213	7	n.	n.	NOUN
admet-647	213	8	rezanour	rezanour	NOUN
admet-647	213	9	,	,	PUNCT
admet-647	213	10	m.	m.	NOUN
admet-647	213	11	ansari	ansari	PROPN
admet-647	213	12	dogaheh	dogaheh	PROPN
admet-647	213	13	,	,	PUNCT
admet-647	213	14	f.	f.	PROPN
admet-647	213	15	ghorbani	ghorbani	PROPN
admet-647	213	16	bidkorbeh	bidkorbeh	PROPN
admet-647	213	17	,	,	PUNCT
admet-647	213	18	m.	m.	PROPN
admet-647	213	19	hashem	hashem	PROPN
admet-647	213	20	,	,	PUNCT
admet-647	213	21	r.	r.	PROPN
admet-647	213	22	walker	walker	PROPN
admet-647	213	23	.	.	PUNCT
admet-647	214	1	a	a	DET
admet-647	214	2	stability	stability	NOUN
admet-647	214	3	–	–	PUNCT
admet-647	214	4	indicating	indicate	VERB
admet-647	214	5	high	high	ADJ
admet-647	214	6	performance	performance	NOUN
admet-647	214	7	liquid	liquid	ADJ
admet-647	214	8	chromatographic	chromatographic	ADJ
admet-647	214	9	(	(	PUNCT
admet-647	214	10	hplc	hplc	NOUN
admet-647	214	11	)	)	PUNCT
admet-647	214	12	assay	assay	VERB
admet-647	214	13	for	for	ADP
admet-647	214	14	the	the	DET
admet-647	214	15	simultaneous	simultaneous	ADJ
admet-647	214	16	determination	determination	NOUN
admet-647	214	17	of	of	ADP
admet-647	214	18	atorvastatin	atorvastatin	NOUN
admet-647	214	19	and	and	CCONJ
admet-647	214	20	amlodipine	amlodipine	NOUN
admet-647	214	21	in	in	ADP
admet-647	214	22	commercial	commercial	ADJ
admet-647	214	23	tablets	tablet	NOUN
admet-647	214	24	.	.	PUNCT
admet-647	215	1	journal	journal	PROPN
admet-647	215	2	of	of	ADP
admet-647	215	3	chromatography	chromatography	PROPN
admet-647	215	4	b	b	PROPN
admet-647	215	5	846	846	NUM
admet-647	215	6	(	(	PUNCT
admet-647	215	7	2007	2007	NUM
admet-647	215	8	)	)	PUNCT
admet-647	215	9	215	215	NUM
admet-647	215	10	-	-	SYM
admet-647	215	11	221	221	NUM
admet-647	215	12	.	.	PUNCT
admet-647	216	1	[	[	X
admet-647	216	2	27	27	NUM
admet-647	216	3	]	]	SYM
admet-647	216	4	s.y	s.y	PROPN
admet-647	216	5	.	.	PUNCT
admet-647	217	1	kim	kim	PROPN
admet-647	217	2	,	,	PUNCT
admet-647	217	3	h.j	h.j	PROPN
admet-647	217	4	.	.	PROPN
admet-647	217	5	kim	kim	PROPN
admet-647	217	6	,	,	PUNCT
admet-647	217	7	m.k	m.k	PROPN
admet-647	217	8	.	.	PROPN
admet-647	217	9	lee	lee	PROPN
admet-647	217	10	,	,	PUNCT
admet-647	217	11	s.m	s.m	PROPN
admet-647	217	12	.	.	PROPN
admet-647	217	13	jeon	jeon	PROPN
admet-647	217	14	,	,	PUNCT
admet-647	217	15	g.m	g.m	PROPN
admet-647	217	16	.	.	PROPN
admet-647	218	1	do	do	AUX
admet-647	218	2	,	,	PUNCT
admet-647	218	3	e.y	e.y	PROPN
admet-647	218	4	.	.	PROPN
admet-647	218	5	kwon	kwon	PROPN
admet-647	218	6	,	,	PUNCT
admet-647	218	7	y.y	y.y	PROPN
admet-647	218	8	.	.	PROPN
admet-647	218	9	cho	cho	PROPN
admet-647	218	10	,	,	PUNCT
admet-647	218	11	d.j	d.j	PROPN
admet-647	218	12	.	.	PROPN
admet-647	218	13	kim	kim	PROPN
admet-647	218	14	,	,	PUNCT
admet-647	218	15	k.s	k.s	PROPN
admet-647	218	16	.	.	PROPN
admet-647	218	17	jeong	jeong	PROPN
admet-647	218	18	,	,	PUNCT
admet-647	218	19	y.b	y.b	PROPN
admet-647	218	20	.	.	PROPN
admet-647	218	21	park	park	PROPN
admet-647	218	22	,	,	PUNCT
admet-647	218	23	t.y	t.y	PROPN
admet-647	218	24	.	.	PUNCT
admet-647	219	1	ha	ha	PROPN
admet-647	219	2	,	,	PUNCT
admet-647	219	3	m.s	m.s	PROPN
admet-647	219	4	.	.	PROPN
admet-647	219	5	choi	choi	PROPN
admet-647	219	6	.	.	PUNCT
admet-647	220	1	naringin	naringin	NOUN
admet-647	220	2	time	time	NOUN
admet-647	220	3	-	-	PUNCT
admet-647	220	4	dependently	dependently	ADV
admet-647	220	5	lowers	lower	VERB
admet-647	220	6	hepatic	hepatic	ADJ
admet-647	220	7	cholesterol	cholesterol	NOUN
admet-647	220	8	biosynthesis	biosynthesis	NOUN
admet-647	220	9	and	and	CCONJ
admet-647	220	10	plasma	plasma	NOUN
admet-647	220	11	cholesterol	cholesterol	NOUN
admet-647	220	12	in	in	ADP
admet-647	220	13	rats	rat	NOUN
admet-647	220	14	fed	feed	VERB
admet-647	220	15	high	high	ADJ
admet-647	220	16	-	-	PUNCT
admet-647	220	17	fat	fat	NOUN
admet-647	220	18	and	and	CCONJ
admet-647	220	19	high	high	ADJ
admet-647	220	20	-	-	PUNCT
admet-647	220	21	cholesterol	cholesterol	NOUN
admet-647	220	22	diet	diet	NOUN
admet-647	220	23	.	.	PUNCT
admet-647	221	1	journal	journal	PROPN
admet-647	221	2	of	of	ADP
admet-647	221	3	medicinal	medicinal	ADJ
admet-647	221	4	food	food	NOUN
admet-647	221	5	9	9	NUM
admet-647	221	6	(	(	PUNCT
admet-647	221	7	2006	2006	NUM
admet-647	221	8	)	)	PUNCT
admet-647	221	9	582586	582586	NUM
admet-647	221	10	.	.	PUNCT
admet-647	222	1	[	[	X
admet-647	222	2	28	28	NUM
admet-647	222	3	]	]	X
admet-647	222	4	t.	t.	PROPN
admet-647	222	5	ishikawa	ishikawa	PROPN
admet-647	222	6	,	,	PUNCT
admet-647	222	7	n.	n.	NOUN
admet-647	222	8	fidge	fidge	PROPN
admet-647	222	9	.	.	PUNCT
admet-647	223	1	changes	change	NOUN
admet-647	223	2	in	in	ADP
admet-647	223	3	the	the	DET
admet-647	223	4	concentration	concentration	NOUN
admet-647	223	5	of	of	ADP
admet-647	223	6	plasma	plasma	NOUN
admet-647	223	7	lipoproteins	lipoprotein	NOUN
admet-647	223	8	and	and	CCONJ
admet-647	223	9	apo	apo	NOUN
admet-647	223	10	proteins	protein	NOUN
admet-647	223	11	following	follow	VERB
admet-647	223	12	the	the	DET
admet-647	223	13	administration	administration	NOUN
admet-647	223	14	of	of	ADP
admet-647	223	15	triton	triton	PROPN
admet-647	223	16	wr	wr	PROPN
admet-647	223	17	1339	1339	NUM
admet-647	223	18	to	to	ADP
admet-647	223	19	rats	rat	NOUN
admet-647	223	20	.	.	PUNCT
admet-647	224	1	journal	journal	NOUN
admet-647	224	2	of	of	ADP
admet-647	224	3	lipid	lipid	PROPN
admet-647	224	4	research	research	NOUN
admet-647	224	5	20	20	NUM
admet-647	224	6	(	(	PUNCT
admet-647	224	7	1979	1979	NUM
admet-647	224	8	)	)	PUNCT
admet-647	224	9	254264	254264	NUM
admet-647	224	10	.	.	PUNCT
admet-647	225	1	[	[	X
admet-647	225	2	29	29	NUM
admet-647	225	3	]	]	PUNCT
admet-647	225	4	m.	m.	NOUN
admet-647	225	5	kuroda	kuroda	PROPN
admet-647	225	6	,	,	PUNCT
admet-647	225	7	k.	k.	PROPN
admet-647	225	8	tanzawa	tanzawa	PROPN
admet-647	225	9	,	,	PUNCT
admet-647	225	10	y.	y.	PROPN
admet-647	225	11	tsujita	tsujita	PROPN
admet-647	225	12	,	,	PUNCT
admet-647	225	13	a.	a.	PROPN
admet-647	225	14	endo	endo	PROPN
admet-647	225	15	.	.	PUNCT
admet-647	226	1	mechanism	mechanism	NOUN
admet-647	226	2	for	for	ADP
admet-647	226	3	elevation	elevation	NOUN
admet-647	226	4	of	of	ADP
admet-647	226	5	hepatic	hepatic	ADJ
admet-647	226	6	cholesterol	cholesterol	NOUN
admet-647	226	7	synthesis	synthesis	NOUN
admet-647	226	8	and	and	CCONJ
admet-647	226	9	serum	serum	VERB
admet-647	226	10	cholesterol	cholesterol	NOUN
admet-647	226	11	levels	level	NOUN
admet-647	226	12	in	in	ADP
admet-647	226	13	triton	triton	PROPN
admet-647	226	14	wr-1339	wr-1339	ADV
admet-647	226	15	-	-	PUNCT
admet-647	226	16	induced	induce	VERB
admet-647	226	17	hyperlipidemia	hyperlipidemia	NOUN
admet-647	226	18	.	.	PUNCT
admet-647	227	1	biochimica	biochimica	PROPN
admet-647	227	2	et	et	PROPN
admet-647	227	3	biophysica	biophysica	PROPN
admet-647	227	4	acta	acta	PROPN
admet-647	227	5	489	489	NUM
admet-647	227	6	(	(	PUNCT
admet-647	227	7	1977	1977	NUM
admet-647	227	8	)	)	PUNCT
admet-647	227	9	119	119	NUM
admet-647	227	10	-	-	SYM
admet-647	227	11	125	125	NUM
admet-647	227	12	.	.	PUNCT
admet-647	228	1	[	[	X
admet-647	228	2	30	30	NUM
admet-647	228	3	]	]	PUNCT
admet-647	228	4	a.	a.	NOUN
admet-647	228	5	scanu	scanu	PROPN
admet-647	228	6	,	,	PUNCT
admet-647	228	7	p.	p.	NOUN
admet-647	228	8	oriente	oriente	PROPN
admet-647	228	9	.	.	PUNCT
admet-647	229	1	triton	triton	PROPN
admet-647	229	2	hyperlipidemia	hyperlipidemia	NOUN
admet-647	229	3	in	in	ADP
admet-647	229	4	dogs	dog	NOUN
admet-647	229	5	:	:	PUNCT
admet-647	229	6	in	in	ADP
admet-647	229	7	vitro	vitro	X
admet-647	229	8	effects	effect	NOUN
admet-647	229	9	of	of	ADP
admet-647	229	10	the	the	DET
admet-647	229	11	detergent	detergent	NOUN
admet-647	229	12	on	on	ADP
admet-647	229	13	serum	serum	NOUN
admet-647	229	14	lipoproteins	lipoprotein	NOUN
admet-647	229	15	and	and	CCONJ
admet-647	229	16	chylomicrons	chylomicron	NOUN
admet-647	229	17	.	.	PUNCT
admet-647	230	1	journal	journal	NOUN
admet-647	230	2	of	of	ADP
admet-647	230	3	experimental	experimental	ADJ
admet-647	230	4	medicine	medicine	NOUN
admet-647	230	5	113	113	NUM
admet-647	230	6	(	(	PUNCT
admet-647	230	7	1961	1961	NUM
admet-647	230	8	)	)	PUNCT
admet-647	230	9	735	735	NUM
admet-647	230	10	-	-	SYM
admet-647	230	11	757	757	NUM
admet-647	230	12	.	.	PUNCT
admet-647	231	1	[	[	X
admet-647	231	2	31	31	NUM
admet-647	231	3	]	]	X
admet-647	231	4	p.e	p.e	PROPN
admet-647	231	5	.	.	PROPN
admet-647	231	6	schurr	schurr	PROPN
admet-647	231	7	,	,	PUNCT
admet-647	231	8	j.r	j.r	PROPN
admet-647	231	9	.	.	PROPN
admet-647	231	10	schultz	schultz	PROPN
admet-647	231	11	,	,	PUNCT
admet-647	231	12	t.m	t.m	PROPN
admet-647	231	13	.	.	PROPN
admet-647	231	14	parkinson	parkinson	NOUN
admet-647	231	15	.	.	PUNCT
admet-647	232	1	triton	triton	PROPN
admet-647	232	2	induced	induce	VERB
admet-647	232	3	hyperlipidaemia	hyperlipidaemia	NOUN
admet-647	232	4	in	in	ADP
admet-647	232	5	rats	rat	NOUN
admet-647	232	6	as	as	ADP
admet-647	232	7	an	an	DET
admet-647	232	8	animal	animal	NOUN
admet-647	232	9	model	model	NOUN
admet-647	232	10	for	for	ADP
admet-647	232	11	screening	screen	VERB
admet-647	232	12	hypolipideamic	hypolipideamic	ADJ
admet-647	232	13	drugs	drug	NOUN
admet-647	232	14	.	.	PUNCT
admet-647	233	1	lipids	lipid	NOUN
admet-647	233	2	7	7	NUM
admet-647	233	3	(	(	PUNCT
admet-647	233	4	1972	1972	NUM
admet-647	233	5	)	)	PUNCT
admet-647	233	6	68	68	NUM
admet-647	233	7	-	-	SYM
admet-647	233	8	74	74	NUM
admet-647	233	9	.	.	PUNCT
admet-647	234	1	©	©	SYM
admet-647	234	2	2019	2019	NUM
admet-647	234	3	by	by	ADP
admet-647	234	4	the	the	DET
admet-647	234	5	authors	author	NOUN
admet-647	234	6	;	;	PUNCT
admet-647	234	7	licensee	licensee	PROPN
admet-647	234	8	iapc	iapc	PROPN
admet-647	234	9	,	,	PUNCT
admet-647	234	10	zagreb	zagreb	PROPN
admet-647	234	11	,	,	PUNCT
admet-647	234	12	croatia	croatia	PROPN
admet-647	234	13	.	.	PUNCT
admet-647	235	1	this	this	DET
admet-647	235	2	article	article	NOUN
admet-647	235	3	is	be	AUX
admet-647	235	4	an	an	DET
admet-647	235	5	open	open	ADJ
admet-647	235	6	-	-	PUNCT
admet-647	235	7	access	access	NOUN
admet-647	235	8	article	article	NOUN
admet-647	235	9	distributed	distribute	VERB
admet-647	235	10	under	under	ADP
admet-647	235	11	the	the	DET
admet-647	235	12	terms	term	NOUN
admet-647	235	13	and	and	CCONJ
admet-647	235	14	conditions	condition	NOUN
admet-647	235	15	of	of	ADP
admet-647	235	16	the	the	DET
admet-647	235	17	creative	creative	ADJ
admet-647	235	18	commons	common	NOUN
admet-647	235	19	attribution	attribution	NOUN
admet-647	235	20	license	license	NOUN
admet-647	235	21	(	(	PUNCT
admet-647	235	22	http://creativecommons.org/licenses/by/3.0/	http://creativecommons.org/licenses/by/3.0/	PROPN
admet-647	235	23	)	)	PUNCT
admet-647	235	24	http://creativecommons.org/licenses/by/3.0/	http://creativecommons.org/licenses/by/3.0/	PROPN